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Et2O	   	   	   	   Diethyl	  ether	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
EtOAc	  	  	  	  	   	   	   Ethyl	  acetate	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	  	  
EtOH	   	   	   	   Ethanol	  
6	  
i	   	   	   	   Iso	  
IPA	   	   	   	   Isopropanol	  
IPAC	   	   	   	   Isopropyl	  acetate	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
J	   	   	   	   Coupling	  constant	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
MeCN	   	   	   	   Acetonitrile	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
MS	   	   	   	   Molecular	  Sieves	  	  
NaOEt	   	   	   	   Sodium	  ethoxide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
NBS	   	   	   	   N-­‐Bromosuccinimide	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
NMR	   	   	   	   Nuclear	  Magnetic	  Resonance	  
Nuc	   	   	   	   Nucleophile	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
p	  	  	  	  	  	  	  	   	   	   	   Para	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Ph	   	   	   	   Phenyl	  
PhMe	   	   	   	   Toluene	  
PNN	   2-­‐((Di-­‐tert-­‐butylphosphinomethyl)-­‐6-­‐
diethylaminomethyl)pyridine	  
PyBOX	  	   	   	   Pyridine	  linked	  bisoxazoline	  ligand	  
R	   	   	   	   Unspecified	  generic	  group	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
r.t.	   	   	   	   Room	  temperature	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
t	   	   	   	   Tertiary	  
TFA	   	   	   	   Trifluoroacetic	  acid	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
THF	   	   	   	   Tetrahydrofuran	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
TLC	   	   	   	   Thin	  layer	  chromatography	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
TMS	   	   	   	   Tetramethylsilane	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
tRNA	   	   	   	   Transfer	  Ribonucleic	  Acid	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
TsCYDN	   N-­‐(1,2-­‐Diaminocyclohexane)-­‐p-­‐toluenesulfonamide	  
TsDpen	   N-­‐(2-­‐Amino-­‐1,2-­‐diphenylehtyl)-­‐p-­‐toluenesulfonamide	  








This	  thesis	  outlines	  the	  work	  carried	  out	  in	  the	  last	  three	  and	  half	  years	  concerning	  
the	  development	  of	  environmentally	  benign	  acylation	  reactions	  and	  determination	  
of	  the	  range	  of	  these	  reactions	  through	  substrate	  screening	  and	  investigations	  into	  
the	  mechanisms	  by	  which	  they	  are	  operating.	  
	  
Chapter	  1	  aims	  to	  introduce	  homogeneous	  catalysis	  as	  an	  important	  area	  of	  chemical	  
research,	  subsequently	  focusing	  of	  sulfonamides	  and	  in	  particular	  the	  N-­‐acylation	  of	  
sulfonamides	   and	   the	   current	   procedures	   that	   are	   available	   in	   the	   literature.	   The	  
introduction	   also	   covers	   transfer	   hydrogenation	   reactions	   and	   how	   this	   can	   be	  
applied	   to	   acylation	   reactions.	   Finally	   the	   introduction	   shows	   how	   asymmetric	  
transfer	  hydrogenation	  is	  currently	  performed.	  
	  
Chapter	   2	   investigates	  using	   iodide	   as	   an	   activating	   agent	   for	   acid	   chlorides	   in	   the	  
acylation	   of	   various	   substrates;	   mechanistic	   information	   was	   determined	   through	  
NMR	  studies.	  
	  
Chapter	   3	   details	   work	   investigating	   alternative	   hydrogen	   sources	   for	   asymmetric	  
transfer	  hydrogenation	  and	  the	  use	  of	  existing	  catalysts	  in	  conjunction	  with	  a	  novel	  
hydrogen	  source.	  
	  
Chapter	   4	   shows	  work	   investigating	   the	  possibility	   of	   using	   alcohol	   as	   an	   acylating	  











Chapter	  1:	  Introduction	  
1.1	  Homogeneous	  Catalysis	  
	  
Homogeneous	   catalysis	   is	   one	   of	   the	   most	   important	   areas	   of	   current	   chemical	  
research.1	   A	   homogeneous	   catalyst	   is	   a	   catalyst	   in	   the	   same	   phase	   as	   the	  
components	  of	  the	  reaction	  that	  it	  is	  catalysing.	  This	  is	  in	  contrast	  to	  heterogeneous	  
catalysts	   which	   are	   catalysts	   in	   a	   different	   phase	   from	   the	   components	   of	   the	  
reaction.2	  This	  introduction	  to	  homogenous	  catalysis	  will	  show	  examples	  of	  industrial	  
and	   fine	   chemical	   uses	   in	   order	   to	   display	   the	   variety	   of	   uses	   that	   this	   type	   of	  
catalysis	  has	  and	  also	  its	  continued	  importance	  in	  modern	  organic	  chemistry.	  
	  
1.1.1	  Industrial	  Importance	  	  
Homogeneous	  catalysis	  is	  extremely	  important	  in	  industrial	  processes.	  The	  following	  
are	  examples	  of	  some	  of	  the	  most	  important.	  Scheme	  1.1	  shows	  Wilkinson’s	  catalyst,	  






























The	  process	  relies	  on	  the	  oxidative	  addition	  of	  hydrogen	  to	  a	  rhodium	  catalyst.	  This	  
yields	  an	  octahedral	  complex	  that	  dissociates	  giving	  a	  coordinatively	  unsaturated	  16	  
electron	   species.	   The	   alkene	   can	   associate	   to	   this	   species	   and	   the	   reductive	  
elimination	  step	  occurs	  to	  yield	  the	  saturated	  alkane.	  
	  
The	  next	  example	  is	  the	  conversion	  of	  methanol	  to	  acetic	  acid,	  this	  process	  is	  carried	  
out	  on	  ~3.5	  Mt	  scale,	  per	  year,	  worldwide,	   it	   is	   called	   the	  Monsanto	  process.4	  The	  































The	  key	  steps	  in	  this	  process	  are	  nucleophilic	  substitution	  on	  methanol,	  the	  oxidative	  
addition	  of	  methyl	  iodide	  to	  the	  rhodium	  catalyst	  and	  reductive	  elimination	  of	  acetyl	  




The	   Monsanto	   process	   also	   inspired	   the	   Tennessee-­‐Eastman	   acetic	   anhydride	  
process,	  which	  relies	  on	  a	  very	  similar	  catalytic	  cycle	  where	   lithium	  iodide	  replaces	  
hydroiodic	   acid	   and	   methyl	   acetate	   replaces	   methanol,	   with	   anhydride	   as	   the	  
product.5	  
	  
One	  of	  the	  oldest	  examples	  of	  homogeneous	  catalysis	  in	  an	  industrial	  process,	  that	  is	  
still	   relevant,	   is	   Hydroformylation,	   sometimes	   referred	   to	   as	   the	   Oxo-­‐process.	  
Hydroformylation	  is	  the	  conversion	  of	  alkenes	  to	  aldehydes	  using	  carbon	  monoxide	  










































These	   industrial	   examples	   are	   not	   exhaustive;	   there	   are	   an	   extensive	   number	   of	  
homogeneous	  catalysts	  employed	  in	  both	  fine	  and	  bulk	  chemical	  synthesis.	  Another	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major	   example,	   that	   will	   not	   be	   covered	   in	   detail	   here	   is	   the	   Shell	   Higher	   Olefins	  
Process	  (SHOP),	  which	  uses	  a	  nickel	  based	  catalyst	  to	  oligomerize	  ethene.7	  	  	  
	  
1.1.2	  Fine	  Chemical	  Synthesis	  
	  
The	   previously	   discussed	   industrial	   examples	   of	   homogeneous	   catalysis	   are	  
employed	  on	  a	  vast	  scale.	  There	  are	  however,	  significant	  disadvantages	  to	  the	  large-­‐
scale	  use	  of	  homogeneous	   catalysts.	   These	   include:	   the	   cost	  of	   catalyst	  precursors	  
owing	  to	  the	  expense	  of	  precious	  metals	  used;	  asymmetric	  syntheses	  often	  rely	  on	  
chiral	  ligands	  and	  these	  are	  usually	  only	  available	  in	  small	  quantities;	  separation	  and	  
recovery	   of	   the	   catalyst	   from	   the	   product	   solution	   is	   perhaps	   the	   largest	   issue.	  
However,	  in	  fine	  chemical	  synthesis	  the	  large-­‐scale	  issues	  are	  less	  of	  an	  obstacle	  and	  
in	  this	  section	  of	  the	  introduction	  the	  aim	  is	  to	  show	  examples	  of	  the	  most	  relevant	  
homogeneous	  catalysts.	  
	  
Cross-­‐coupling	  reactions	  are	  among	  the	  most	  widely	  used	  and	  researched	  reactions	  
in	  modern	  chemistry.	  The	  Nobel	  Prize	  was	  awarded	  to	  Suzuki	  et	  al.	  in	  2010	  for	  their	  



























Scheme	  1.4	  shows	  the	  typical	  Suzuki	  cross	  coupling	  reaction,	  an	  excellent	  example	  of	  
homogeneous	  catalysis.	  Oxidative	  addition	  followed	  by	  metathesis,	  transmetallation	  

































Noyori	  won	  the	  Nobel	  Prize	  with	  others	  for	  their	  work	  on	  asymmetric	  hydrogenation,	  
the	  general	  scheme	  is	  shown	  in	  Scheme	  1.5.	  It	  involves	  catalytic	  hydrogenation	  using	  
a	   chiral	   ruthenium	   catalyst	   under	   high-­‐pressure	   hydrogen	   gas	   to	   hydrogenate	  
various	  olefins	  in	  a	  chiral	  manner.9	  
	  
The	   Heck	   reaction	   is	   another	   classic	   example	   of	   homogeneous	   catalysis	   that	   is	  
enormously	   important	  for	  organic	  chemists.	   It	   is	  a	  cross-­‐coupling	  reaction	  between	  
aryl,	   benzyl	   or	   styryl	   halides	   and	   olefins	   to	   form	   the	   corresponding	   substituted	  



























Hydrosilation,	   or	   catalytic	   hydrosilation	   is	   the	   addition	   of	   a	   Si-­‐H	   bond	   across	   an	  
unsaturated	   C-­‐C	   bond.11	   According	   to	   Ullmann’s	   encyclopedia	   of	   industrial	  
chemistry,	   hydrosilation	   is	   the	   most	   important	   application	   of	   platinum	   in	  
homogeneous	  catalysis.12	  The	  widely	  accepted	  mechanism	  for	  hydrosilation	  is	  called	  
the	  Chalk-­‐Harrod	  mechanism,13	   industrially	  hydrosilyation	  is	  often	  carried	  out	  using	  




















C-­‐H	  functionalization	  is	  a	  reaction	  that	  cleaves	  a	  carbon-­‐hydrogen	  bond.	  The	  carbon-­‐
hydrogen	  bond	   is	   a	   particularly	   strong	  bond	   and	   is	   stable	   towards	  many	   reagents,	  
with	  the	  exception	  of	  some	  reactive	  oxygen	  compounds.	  Functionalization	  requires	  
activation	   of	   a	   C-­‐H	   bond,	   one	   of	   the	   earliest	   catalytic	   example	   of	   this	   type	   of	  




















The	  ketone	  is	  ortho	  directing	  for	  C-­‐H	  activation	  and	  alkylation	  of	  aryl	  systems	  like	  this	  
can	  be	  achieved.	  Many	  advances	  have	  been	  made	  in	  the	  field	  of	  C-­‐H	  activation	  and	  it	  















The	   final	   example	   in	   this	   short	   introduction	   to	   homogeneous	   catalysis	   is	   Grubbs	  

















The	  examples	  of	  industrial	  and	  fine	  chemical	  applications	  of	  homogeneous	  catalysis	  
show	   the	   power	   and	   relevance	   of	   this	   type	   of	   catalysis	   to	   organic	   chemists.	   This	  
thesis	   focuses	   on	   three	   different	   types	   of	   homogeneous	   catalysis	   and	   it	   was	  
considered	   prudent	   to	   give	   an	   overview	   of	   the	   area	   of	   chemistry.	   The	   following	  





















1.2	  Activation	  of	  acid	  chlorides	  for	  acylation	  reactions	  
	  
The	   first	   area	   of	   homogeneous	   catalysis	   focused	   on	   in	   this	   introduction	   is	   the	  





Since	   the	   focus	   of	   this	   thesis	   is	   on	   the	   acylation	   of	   a	   sulfonamide	   it	   is	   worth	  
considering	  the	  basic	  chemistry	  of	  a	  sulfonamide.	  Please	  note	  however,	  that	  as	  will	  
be	  discussed	  in	  Chapter	  2,	  investigations	  were	  also	  made	  into	  the	  acylation	  of	  other	  





Sulfonamide Amide 	  
Scheme	  1.10	  
	  
The	   sulfonamide	   functional	   group	   is	   analogous	   to	   the	  amide	   functional	   group.	  The	  
lone	  pair	  of	  electrons	  on	  nitrogen	  in	  both	  functional	  groups	  can	  donate	  into	  the	  π*	  
orbital	   on	   the	   adjacent	   atom,	   in	   the	   case	   of	   an	   amide	   the	   π*	   orbital	   of	   the	   (C=O)	  
carbonyl	  carbon	  and	  in	  the	  sulfonamide	  the	  π*	  orbital	  of	  the	  (O=S=O)	  sulfonyl	  sulfur.	  
It	   is	   this	  delocalization	  of	  electron	  density	   that	  explains	   the	  stability	  of	  amides	  and	  
sulfonamides.	   The	   delocalization	   of	   the	   lone	   pair	   of	   electrons	   also	   explains	   the	  
reduced	  nucleophilicity	  of	  the	  nitrogen,	  which	  will	  be	  shown	  to	  be	  very	  important	  to	  
the	  work	  discussed	  in	  this	  thesis.	  
	  
Typically	   sulfonamides	   are	   derived	   from	   the	   reaction	   of	   sulfonic	   acid	   or	   sulfonyl	  













Interestingly	   this	  method	   is	   the	   basis	   of	   the	   Hinsberg	   test.	   The	   Hinsberg	   test	   was	  
used	  to	  characterize	  a	  primary,	  secondary	  or	  tertiary	  amine.	  To	  conduct	  the	  test	  the	  
amine	   is	   added	   to	   benzenesulfonyl	   chloride.	   If	   no	   product	   (precipitate)	   is	   formed	  
then	   the	   amine	   is	   tertiary	   since	   no	   reaction	   can	   occur	   between	   the	   two.	   If	   the	  
product	  formed	  dissolves	  in	  aqueous	  sodium	  hydroxide	  then	  the	  amine	  is	  a	  primary	  
one	  because	  the	  acidic	  proton	  on	  the	  nitrogen	  makes	   it	  soluble	   in	  aqueous	  sodium	  
hydroxide.	   So	   finally	   if	   the	   product	   is	   formed	   but	   is	   insoluble	   in	   aqueous	   sodium	  
hydroxide	  then	  the	  amine	  is	  secondary.19	  	  
	  
The	   pKa	   of	   a	   proton	   on	   the	   nitrogen	   is	   significantly	   affected	   by	   the	   electron	  
withdrawing	   or	   donating	   properties	   of	   the	   other	   substituent	   on	   the	   nitrogen.	  





A	   large	   portion	   of	   research	   into	   pharmaceuticals	   focuses	   on	   surrogate	   functional	  
groups	  that	  can	  be	  used,20	  for	  example	  β-­‐amino	  acids	  and	  the	  peptides	  derived	  from	  
them.21	   In	   the	   same	  way	   sulfonamides	   are	   investigated	   for	   their	   biological	   activity	  







































































































Why	   investigate	   acylating	   sulfonamides?	   N-­‐Acylsulfonamides	   are	   an	   important	  
functional	   group	   found	   in	   an	   array	   of	   molecules.	   They	   have	   a	   wide	   range	   of	  
applications	  illustrated	  by	  the	  molecules	  shown	  below	  in	  Scheme	  1.14.	  Molecules	  1	  
and	  2	  are	  herbicides,	  3	  is	  an	  anti-­‐proliferative	  agent,23	  4	  is	  a	  tRNA	  inhibitor	  24	  and	  5	  is	  





As	  shown	  in	  Scheme	  1.12	  the	  N-­‐acylsulfonamide	  moiety	  has	  a	  pKa	  of	  approximately	  
4-­‐5,	  making	  the	   functional	  group	  a	  suitable	  surrogate	   for	  carboxylic	  acid	   functional	  
groups.	   N-­‐Acylsulfonamides	   have	   been	   shown	   to	   have	   a	   variety	   of	   therapeutic	  
benefits.26	   Acylsulfonamides	   are	   also	   used	   as	   therapeutic	   agents	   for	   Alzeheimer’s	  
disease,27	   treatments	   of	   osteoporosis,28	   antagonists	   for	   angiotensin	   II29	   and	   find	  
applications	   as	   precursors	   for	   a	   variety	   of	   drug	   molecules,	   click	   chemistry	  
intermediates	  and	  enzyme	  inhibitors.30	  	  
Chapter	  1	  
20	  
Therefore	  there	  is	  demand	  for	  an	  industrially	  relevant	  method	  that	  doesn’t	  use	  toxic	  
catalysts	   or	   reagents	   and	   that	   doesn’t	   require	   a	   large	   use	   of	   solvents	   in	   the	  
purification	   process.	   It	   is	   also	   important	   that	   the	  method	   doesn’t	   produce	   a	   large	  
amount	   of	   waste	   by-­‐products,	   and	   use	   relatively	   mild	   conditions	   in	   the	   form	   of	  
ambient	  temperatures.	  
	  
1.2.3	  Synthesis	  using	  coupling	  agents	  
	  
The	   focus	   of	   this	   part	   of	   the	   introduction,	   Section	   1.2,	   is	   on	   the	   N-­‐acylation	   of	  
sulfonamides	  and	  so	  the	  examples	  of	  coupling	  agents	  for	  the	  activation	  of	  carboxylic	  
acids	  and	  acid	  chlorides	  shown	  here	  reflect	  that.	  	  
	  
The	   synthesis	   of	  N-­‐acetylbenzenesulfonamide	   was	   first	   reported	   in	   1945	   and	   was	  
carried	  out	  by	  addition	  of	  acetic	  anhydride	  to	  benzenesulfonamide	   in	  the	  presence	  
of	  potassium	  acetate.31	  This	  was	  one	  of	   the	   first	  examples	  of	  activating	  a	   carbonyl	  
group	  to	  make	  it	  more	  susceptible	  to	  nucleophilic	  attack	  from	  a	  sulfonamide.	  	  
	  
The	   alternative	   approach	   to	   their	   synthesis	   is	   to	   use	   a	   base	   to	   deprotonate	   the	  






The	  most	   common	  examples	   of	   coupling	   in	   the	   literature	   start	  with	   the	   carboxylic	  
acid	   and	   use	   an	   activating	   agent	   as	   shown	   in	   Scheme	   1.15.	   DMAP	   and	   DCC	   are	  



































The	  mechanism	   shows	  DCC	   deprotonating	   a	   carboxylic	   acid,	   allowing	   the	   negative	  
charge	   on	   the	   oxygen	   to	   attack	   the	   carbodiimide	   component.	   This	   activates	   the	  
carbonyl	   making	   it	   susceptible	   to	   nucleophilic	   attack	   from	   DMAP.	   This	   in	   turn	  
increases	   the	   carbonyl	   susceptibility	   to	   nucleophilic	   attack	   and	   the	   process	  
regenerates	  DMAP,	  which	  can	  therefore	  be	  used	  in	  a	  catalytic	  amount.	  This	  process	  
does,	  unfortunately	  generate	  an	  equivalent	  of	  urea	  product	  that	  requires	  removal.	  
	  
EDC.HCl	  has	  also	  been	  used	  as	  a	  coupling	  agent	  in	  a	  manner	  similar	  to	  DCC,	  with	  one	  
equivalent	   of	   DMAP	   rather	   than	   a	   catalytic	   amount.	   EDC.HCL	   was	   used	   mainly	  
because	   it	   is	   water-­‐soluble	   and	   therefore	   this	   is	   beneficial	   in	   the	   synthesis	   of	  
acylsulfonamides	   for	   biological	   applications,	   the	   reported	   yields	   were	   not	   as	  
impressive	  as	  with	  DCC.28,	  33	  	  	  
	  
Other	   reagents	   such	   as	   CDI	   have	   been	   used	   to	   activate	   carboxylic	   acids,	   this	  
procedure	   has	   become	   known	   as	   the,	   ‘Drummond	   protocol,’	   for	   synthesizing	   N-­‐
acylsulfonamides.34	   In	   1988	   Drummond	  was	   investigating	   pharmacologically	   active	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amino	  acid	  analogues	  and	  reasoned	  that	   the	  N-­‐acylsulfonamide	  group	  would	  be	  of	  
interest	   to	   synthesize.	   The	   synthesis	   involves	   the	   use	   of	   CDI	   in	   THF	   at	   reflux	   to	  
activate	  the	  carboxylic	  acid	  followed	  by	  the	  addition	  of	  a	  sulfonamide.	  
	  
In	   1980	   another	   method	   was	   reported	   which	   coupled	   an	   acid	   anhydride	   and	   a	  
sulfonamide	  under	  acidic	  conditions	  to	  afford	  the	  N-­‐acyl	  product.35	  This	  work	  didn’t	  
receive	  any	  further	  attention	  until	  2003	  when	  Martin	  et	  al.	  investigated	  the	  potential	  
of	   the	   acid-­‐catalysed	   addition	   of	   acid	   anhydride	   to	   sulfonamide	   to	   afford	   the	  





As	   shown	   in	  Scheme	  1.17	  a	   large	  excess	   (three	  equivalents)	  of	  acid	  anhydride	  was	  
used,	   however	   the	   isolated	   yields	   for	   the	   product	   shown	   above	   and	   other	   similar	  
aromatic	  sulfonamide	  derivatives	  were	  in	  excess	  of	  90%.	  The	  major	  limitation	  of	  the	  
method	   is	   the	   lack	   of	   diversity	   of	   acid	   anhydride	   substrates	   that	   produced	   good	  
yields.	  For	  example	  when	  benzoic	  anhydride	  was	  coupled	  to	  benzenesulfonamide	  a	  
yield	   of	   only	   44%	   was	   achieved.	   Furthermore	   when	   the	   anhydride	   has	   electron	  
withdrawing	  or	  electron	  donating	  groups	  on	  the	  phenyl	  ring	  no	  acylation	  occurred.	  
However,	  the	  steric	  bulk	  and	  electronic	  properties	  of	  the	  sulfonamide	  were	  seen	  to	  
have	  little	  effect	  on	  isolated	  yields.	  	  
	  
There	  are	  two	  other	  examples	  of	  acid	  catalysed	  N-­‐acylations	  of	  sulfonamides,	  one	  is	  
covered	  in	  the	  Lewis	  acid	  activated	  reactions	  in	  Section	  1.2.3,	  the	  other	  is	  a	  method	  
developed	  by	  Massah	  et	  al.	   in	  2008,	  who	  used	  a	  modified	   silica	   support	   to	   couple	  
acid	  anhydrides	  and	  acid	   chlorides	   to	   sulfonamides	  via	   the	  acylium	   intermediate.37	  
The	  procedure	  involves	  the	  reaction	  of	  thionyl	  chloride	  with	  silica,	  over	  48	  hours,	  at	  
120	  ˚C,	  followed	  by	  addition	  of	  the	  sulfonamide	  and	  either	  the	  acid	  anhydride	  or	  acid	  
chloride.	  The	  major	  drawback	  of	  this	  procedure	   is	   the	  two-­‐day	  preparation	  time	  of	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the	   silica	   gel	   support	   and	   the	   large	  waste	  of	   silica	   chloride	   that	   is	   synthesized	  and	  
then	  filtered	  off	  from	  the	  reaction	  mixture.	  
	  
In	  2004	  Katritzky	  et	  al.	  published	  work	  showing	  that	  N-­‐acylbenzotriazones	  could	  be	  






This	   reaction	   produces	   isolated	   yields	   of	   74-­‐98%,	  which	   is	   excellent.	  However,	   the	  
drawbacks	   of	   this	   reaction	   are	   clear	   from	   the	   scheme.	   Firstly,	   the	   N-­‐
acylbenzotriazone	   has	   to	   be	   synthesised	   and	   this	   takes	   two	   steps.	   The	   second	  
problem	   is	   the	   acylation	   of	   the	   sulfonamide	   step	   takes	   24	   hours	   with	   simple	  
unhindered	   sulfonamides	   and	   takes	  many	   days	   for	   sulfonamides	  with	   sterically	   or	  
electronically	  demanding	  R-­‐groups.	  
	  
2-­‐Chloro-­‐1-­‐methyl-­‐pyridinium	  iodide,	  CMPI,	  also	  known	  as	  Mukaiyama’s	  reagent,	  has	  
been	   shown	   to	   activate	   carboxylic	   acids	   for	   a	   wide	   variety	   of	   acylations.40	   The	  







All	   of	   the	   coupling	  methods	   have	   had	   one	   problem	   in	   common.	   The	   problem	  was	  
that	  they	  all	  produce	  a	  stoichiometric	  amount	  of	  waste	  that	  has	  to	  be	  removed	  from	  
the	  reaction.	  With	  that	  in	  mind,	  another	  coupling	  agent	  that	  has	  more	  recently	  been	  
investigated	  is	  cyanuric	  chloride	  the	  mechanism	  for	  the	  reaction	  is	  shown	  in	  Scheme	  




The	  carboxylic	  acid	  was	  activated	  and	  subsequently	  used	  to	  acylate	  the	  sulfonamide	  
by	   improving	   its	   electrophilicity.	   In	   this	   instance	   the	   cyanuric	   chloride	   can	   activate	  
three	  equivalents	  of	  carboxylic	  acid	  this	  generates	  three	  equivalents	  of	  HCl	  and	  Et3N	  
is	  used	  to	  remove	  the	  HCl.42	  This	  method	  produced	  one	  third	  of	  the	  amount	  of	  waste	  




Another	  way	  to	  approach	  the	  activation	  of	  carboxylic	  acids	  was	  to	  convert	  them	  into	  
the	  corresponding	  acid	  halides	  and	  subsequently	  use	  them	  to	  acylate	  sulfonamides.	  





PyBroP	   is	   a	   coupling	   agent	   specifically	   designed	   to	   generate	   an	   acid	   halide,	   it	  was	  
originally	  conceived	  to	  acylate	  amines	  to	  form	  amides	  and	  there	  are	  other	  analogues	  
that	  have	  also	  been	  exploited	  for	  this	  coupling.43	  However,	  with	  respect	  to	  acylating	  
sulfonamides	   there	   are	   two	   notable	   examples	   involving	   this	   reagent.	   The	   first	   is	  
synthesis	  of	   safety	   linkers	   in	   the	  acylation	  of	  polymer	  bound	  sulfonamides,	  PyBroP	  
was	   shown	   to	   acylate	   successfully	   but	   produced	   a	   racemic	  mixture.30c	   The	   second	  
example	   also	   used	   in	   the	   acylation	   of	   polymer	   bound	   sulfonamides,	   finds	   an	  
application	   in	  the	  treatment	  of	  pancreatic	  disorders.	  However,	  PyBroP	  was	  not	  the	  
most	  efficient	  reagent	  and	  in	  fact	  DCC	  and	  DMAP	  combination	  was	  shown	  to	  acylate	  
more	  readily.29b	  
	  






Scheme	  1.22	   shows	   the	  need	   for	   catalytic	  DMF	   to	  activate	   the	  oxalyl	   chloride,	   the	  









































Scheme	  1.23	  shows	  that	  DMF	  is	  regenerated	  in	  the	  mechanism	  hence	  it	  can	  be	  used	  
in	  a	  catalytic	  amount.	  The	  active	  intermediate	  is	  formed	  by	  the	  attack	  of	  DMF	  on	  the	  
oxalyl	   chloride,	   it	   is	   this	   intermediate	   that	   is	   responsible	   for	   the	   acid	   chloride	  
formation	  from	  the	  carboxylic	  acid.44	  	  	  
	  
Work	  carried	  out	  by	  Ishusuka	  et	  al.45	  used	  this	  method	  of	  acid	  chloride	  formation	  to	  
acylate	   sulfonamides.	   The	   group	   took	   a	   variety	   of	   acid	   chlorides	   and	   screened	   a	  
range	   of	   inorganic	   bases	   to	   determine	   the	   best	   method	   to	   retain	   chirality	   of	   a	  
starting	  carboxylic	  acid	  through	  to	  the	  chiral	  N-­‐acylsulfonamide	  product.	  Powdered	  
KOH,	   NaOH	   and	   LiOH	   all	   gave	   similarly	   impressive	   enantioselectivity	   and	   isolated	  
yields	  (>95%,	  >90%,	  respectively).	  
	  
Another	  method	  historically	  employed	  is	  the	  addition	  of	  NaH	  in	  THF	  to	  a	  sulfonamide	  
to	  deprotonate	  the	  sulfonamide	  followed	  by	  addition	  of	  an	  excess	  of	  acid	  chloride.46	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The	  final	  method	  in	  this	  coupling	  section	  approaches	  the	  challenge	  of	  synthesizing	  N-­‐





























Scheme	  1.24	  above	  shows	  that	  sulfonyl	  chlorides	  can	  be	  used	  to	  produce	  alkylated	  
secondary	  sulfonamides,	  which	  are	  subsequently	  oxidized	  with	  oxygen	  and	  sodium	  
ethoxide.	  	  
	  
In	  summary,	  there	  are	  drawbacks	  to	  existing	  coupling	  reagents,	  which	  often	  produce	  
a	   stoichiometric	   amount	   of	   waste	   products	   that	   have	   to	   be	   removed	   from	   the	  
reaction.	  
	  
1.2.3	  Synthesis	  using	  Lewis	  acid	  activation	  
	  
Bismuth(III)	   has	   been	   investigated	   as	   a	   potential	   catalyst	   for	   the	   N-­‐acylation	   of	  
sulfonamides.48	   Massah	   et	   al.	   reported	   that	   bismuth(III)	   chloride	   and	   bismuth(III)	  





The	   proposed	  mechanism	   is	   shown	   in	   Scheme	   1.26,	   the	   group	   proposed	   that	   the	  
acylium	   ion	   is	   formed	  and	   that	   it	  was	   this	   that	  undergoes	  nucleophilic	  attack	   from	  

























The	   evidence	   for	   the	   mechanism	   is	   provided	   by	   the	   lack	   of	   the	   nitro-­‐substituted	  
product,	  indicating	  that	  the	  acylium	  intermediate	  is	  formed	  and	  made	  unfavourable	  
with	   a	   strongly	   electron	   withdrawing	   group	   present	   on	   the	   aromatic	   ring.	   The	  
bismuth(III)	  acts	  as	  a	  Lewis	  acid	  in	  this	  reaction	  and	  it	  is	  this	  that	  leads	  on	  to	  the	  next	  
development	  in	  acylations.	  
	  
Fu	  et	  al.	   published	  a	  paper	  detailing	  a	   screening	  of	  possible	   Lewis	  acids	   for	   the	  N-­‐
acylation	   of	   sulfonamides	   with	   carboxylic	   esters.49	   Titanium(IV)	   chloride	   was	   the	  
most	  active	  Lewis	  acid.	  However,	  when	  1.5	  equivalents	  were	  used	  the	  test	  reaction	  
only	  produced	  an	  isolated	  yield	  of	  53%.	  	  Other	  Lewis	  acids	  showed	  no	  reaction	  so	  the	  
group	   investigated	   further	   and	   showed	   that	   sulfonamides	   could	   be	   acylated	   and	  
isolated	   yields	   for	   various	   substrates	   ranged	   from	  34-­‐76%.	  Although	   the	   yields	   are	  
not	   as	   high	   as	   other	  methods	   this	   procedure	   does	   have	   the	   advantage	   of	   starting	  









Recently	   Ton	   et	   al.	   reported	   an	   iron	   catalysed	   acylation	   of	   sulfonamides.50	   Shown	  
below	   in	   Scheme	   1.27	   is	   the	   general	   reaction	   pathway	   for	   this	   transformation.	  
Iron(II)	   chloride	   reacts	  with	  pyridine	   to	   form	   the	   catalyst	   in	   situ.	   The	   iron	   complex	  
then	  activates	  an	  aldehyde	  and	   then	   reacts	  with	  N-­‐tosyliminoiodinane	   to	   form	   the	  
corresponding	  acylsulfonamide,	  this	  type	  of	  mechanism	  will	  be	  discussed	  in	  further	  
























1.3	  Transfer	  hydrogenation	  
	  
Transfer	   hydrogenation	   is	   the	   second	   area	   of	   homogeneous	   catalysis	   that	   will	   be	  
discussed	  as	  part	  of	   this	   thesis.	   The	   focus	  of	   the	  work	  described	   in	   this	   thesis	  was	  
again	  the	  acylation	  of	  a	  sulfonamide,	  however,	  using	  alcohols	  as	  the	  acylating	  agent	  
with	   catalytic	   transfer	   hydrogenation.	   Here,	   therefore,	   other	   metal	   catalysed	  
methods	   for	   acylating	   sulfonamides	   are	   considered,	   before	   considering	   existing	  
transfer	  hydrogenation	  reactions	  that	  would	  be	  relevant	  to	  the	  work	  that	  was	  to	  be	  
undertaken.	  
	  
1.3.1	  Existing	  catalytic	  methods	  of	  acylating	  sulfonamides	  
	  
In	   the	   last	   decade	   the	   search	   for	   a	   more	   atom	   efficient	   method	   to	   acylate	  
sulfonamides	  has	  begun	  to	  focus	  on	  metal	  catalysed	  reactions.	  The	  earliest	  example	  
of	   heterogeneous	   catalysis	   for	   the	  N-­‐acylation	   of	   sulfonamides	  was	   in	   reported	   in	  
2004.51	  The	  catalyst	  is	  an	  iron	  exchanged	  montmorillonite	  K10,	  FeO-­‐K10.	  The	  catalyst	  
is	  prepared	  by	  heating	  montmorillonite	  K10	  clay	  with	  iron(III)	  chloride	  in	  acetonitrile	  
at	   120	   ˚C	   for	   5	  hours	  prior	   to	   reacting	  with	   the	   substrates.	   Sulfonamides	   are	   then	  
coupled	   to	   acid	   anhydrides	   in	   the	   presence	   of	   the	   catalyst.	   Good	   yields	   were	  
recorded	  for	  various	  substrates,	  this	  was	  a	  good	  example	  of	  acid-­‐catalysed	  acylation	  
of	  sulfonamides.	  However,	  the	  process	  required	  to	  prepare	  the	  catalyst	  is	  extremely	  
lengthy	  and	  consumes	  a	  vast	  amount	  of	  energy.	  The	  fact	  that	  this	  process	  is	  required	  
before	  any	  acylations	  can	  take	  place	  is	  far	  from	  ideal.	  	  
	  
In	  2005	  Cho	  et	  al.	  looked	  at	  using	  copper	  iodide	  with	  alkynes,	  water	  and	  tosyl	  azides	  

















The	   mechanism	   for	   this	   reaction	   is	   not	   known	   but	   the	   group	   proposed	   that	   the	  
copper	   catalyst	   forms	   the	   copper	   acetylide	   and	   that	   this	   under	   goes	   amination	   to	  
form	   the	   N-­‐sulfonyl	   ynamide.	   Subsequent	   addition	   of	   water	   to	   the	   allenamide	  
tautomer	   gives	   the	   N-­‐acylsulfonamide	   product,	   with	   the	   formation	   of	   N2	   as	   the	  
driving	   force	   for	   the	   overall	   reaction.	   However,	   there	   are	   several	   fundamental	  
problems	  with	  this	  method	  as	  an	  alternative	  synthetic	  route,	  the	  sulfonyl	  azides	  are	  
not	  commercially	  available	  and	  will	  require	  prior	  synthesis.	  	  
	  
In	  2007	  rhodium(II)	  was	  investigated	  in	  the	  oxidative	  coupling	  between	  sulfonamides	  
and	  aldehydes.53	  The	  method	  requires	  an	  excess	  of	  aldehyde	  and	  one	  equivalent	  of	  
an	  oxidant	  to	  be	  present,	  in	  this	  case	  the	  oxidant	  used	  is	  (diacetoxyiodo)benzene	  and	  
the	  rhodium	  catalyst	   is	  Rh2(esp)2.	  The	  proposed	  pathway	   is	  shown	  in	  Scheme	  1.29.	  
There	  are	  some	  obvious	  disadvantages	  to	  this	  process,	  the	  main	  one	  being	  the	  cost,	  
1	  g	  of	  the	  rhodium	  catalyst	  costs	  £260,	  and	  although	  this	  is	  used	  at	  10	  mol%	  it	  is	  not	  
an	   industrially	   viable	   method	   of	   acylating	   sulfonamides.	   However,	   this	   cannot	  
overshadow	   the	   large	   turnover	   numbers	   that	   this	   catalyst	   can	   achieve.	   Excellent	  
yields	   are	   achieved	   and	   reported	   for	   some	   very	   challenging	   substrates,	   such	   as	  








The	  development	  continued	  and	  in	  2008	  whilst	  searching	  for	  an	  efficient	  catalyst	  to	  
synthesise	   amides	   Chan	   et	   al.	   developed	   a	   ruthenium(II)	   porphyrin	   catalyst	   that	  
could	   successfully	   form	  N-­‐acylsulfonamides	   in	   good	   yields.54	   This	  method	   involves	  
the	   prior	   synthesis	   of,	   in	   their	  model	   reaction,	  N-­‐tosyliminoiodinane.	   The	   reaction	  
between	   the	   oxidising	   agent,	   PhI(OAc)2,	   with	   a	   sulfonamide	   affords	   the	  
corresponding	   iminoiodinane.55	   The	   N-­‐tosyliminoiodinane	   is	   subsequently	   reacted	  






Despite	  reported	  yields	  of	  60-­‐99%	  for	  a	  variety	  of	  aldehydes	  this	  method	  has	  some	  
crucial	  drawbacks.	  Firstly	   the	  N-­‐tosyliminoiodinane	  has	   to	  be	  synthesized	  and	   then	  
two	  to	  four	  equivalents	  of	  it	  are	  required.	  Secondly	  the	  ruthenium	  catalyst	  also	  has	  
to	  be	  prepared	  prior	   to	  use.	  However	   this	   is	   a	   good	  example	  of	   a	  metal	   catalysed	  
reaction	  where	  the	  sulfonamide	  is	  activated	  by	  an	  oxidizing	  agent	  and	  results	  in	  good	  
isolated	  yields.	  
	  
In	   2009	   Wang	   et	   al.	   investigated	   the	   potential	   of	   iron	   catalysed,	   NBS	   mediated	  
coupling	   of	   sulfonamides	   and	   thioesters	   to	   form	   N-­‐acylsulfonamides	   as	   well	   as	  





The	   amount	   of	   NBS	   required	   to	   achieve	   a	   good	   isolated	   yield	   varies	   from	   0.4-­‐1	  
equivalent,	   reaction	   times	   are	   typically	   8-­‐12	   hours	   and	   yields	   were	   almost	   always	  
>90%.	  This	  method	  showed	  that	  acylation	  of	  secondary	  sulfonamides	  could	  also	  be	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achieved,	  although	  the	   isolated	  yield	  was	  45%.	  No	  mechanism	  was	  put	  forward	  for	  
how	   the	   coupling	   occurs,	   however	   in	   work	   carried	   out	   by	  Wang	   et	   al.	   a	   possible	  
mechanism	  was	   proposed	   for	   the	   alkylation	  of	   sulfonamides	   using	   iron(II)	   chloride	  
and	  NBS.57	  NBS,	  a	  good	  source	  of	  electrophilic	  bromine,	  was	  used	  to	  brominate	  the	  
sulfonamide,	   the	   sulfonamide	   is	   then	   further	   activated	  by	   the	   iron(II)	   chloride	   and	  
forms	   an	   iron-­‐nitrene	   complex	   with	   the	   production	   of	   HCl	   or	   HBr.	   C-­‐H	   bond	  
activation	  occurs	  and	  the	   iron	  salt,	   the	  driving	  force	  of	  this	  reaction,	   is	   formed	  and	  
recycles	  back	  to	  activate	  another	  halogenated	  sulfonamide.	  The	  full	  catalytic	  cycle	  is	  





It	   is	   therefore	   plausible	   that	   the	   bromination	   of	   the	   sulfonamide	   and	   subsequent	  
formation	  of	  the	  iron-­‐nitrene	  complex	  occurs	  in	  the	  acylation	  reaction	  and	  that	  the	  
intermediate	  step	  involving	  the	  thioester	  results	  in	  the	  N-­‐acyl	  product.	  
	  
1.3.2	  Transfer	  hydrogenation	  catalysts	  
	  
The	   following	   section	  will	   show	   examples	   of	   transfer	   hydrogenation	   catalysts	   and,	  
where	  appropriate,	  how	  they	  have	  been	  used	  to	  catalyse	  similar	  reactions	  to	  the	  N-­‐
acylation	  of	  sulfonamides.	  The	  definition	  of	  transfer	  hydrogenation	  is	  the	  addition	  of	  
H2	  to	  a	  molecule	  from	  a	  source	  other	  than	  hydrogen	  gas.	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Meerwein-­‐Ponndorf-­‐Verley	  (MPV)	  reduction	  was	  an	  early	  example	  of	  metal	  catalysed	  
transfer	   hydrogenation.58	  Oppenauer	   oxidation	   is	   the	   reverse	   of	  MPV,59	   hence	   the	  
whole	   process	   is	   usually	   referred	   to	   as	   MPVO,	   where	   a	   substrate	   is	   oxidized	   or	  
reduced	  and	  a	  sacrificial	  reagent	   is	  used	  as	  the	  corresponding	  reductant	  or	  oxidant	  












R1 = alkyl, aryl, alkenyl; R2 = H, alkyl, aryl, alkenyl 	  
Scheme	  1.33	  
	  
The	   currently	   accepted	   mechanism	   involves	   a	   chair-­‐like	   six-­‐membered	   transition	  























The	  main	  problem	  with	  MPVO	  reactions	  is	  the	  reversibility	  of	  the	  process	  as	  shown	  
in	  Scheme	  1.34,	  this	  issue	  is	  in	  fact	  an	  equilibrium	  problem.	  Historically	  this	  has	  been	  
overcome	  by	  using	  a	   large	  excess	  of	  alcohol	   to	  produce	  a	   low	  boiling	  point	  ketone	  
that	  can	  easily	  be	  removed.	  This	  is	  why	  IPA	  is	  typically	  used	  as	  the	  alcohol,	  producing	  
low	  boiling	   acetone	   that	   is	   easily	   removed	   from	   the	   reaction	  mixture.	   Kinetic	   data	  
can	   provide	   greater	   insight	   into	   this	   problem,61	   by	   comparison	   of	   the	   oxidation	  
potentials	   of	   ketones	   (product	   and	   starting	   ketones)	   one	   can	   determine	   an	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approximate	   equilibrium	   position	   using	   equations	   for	   Gibbs	   free	   energy	   and	   the	  
equilibrium	  constant.	  This	  can	  inform	  the	  choice	  of	  oxidant	  or	  reductant	  for	  a	  given	  
substrate.	  
	  
MPVO	   has	   been	   studied	   and	   modified	   over	   the	   past	   90	   years.	   One	   of	   the	   most	  
significant	   modifications	   was	   to	   use	   TFA	   to	   enhance	   the	   rate	   of	   MPV	   and	   was	  
presented	   in	   1977	   by	  Rathke	   et	   al.62	   The	   reaction	   is	   shown	   below	   in	   Scheme	  1.34	  
shows	   that	   in	   the	   absence	   of	   TFA	   an	   aldehyde	   is	   slowly	   reduced	   to	   an	   alcohol,	  




H OHAl(OR)3, 0 ˚C
Benzene
                                       3 h = 50% conversion 
5 mins (adding 0.5 eq. TFA) = 90% conversion 	  
Scheme	  1.35	  
	  
Kagan	   et	   al.	   showed	   in	   1984	   the	   use	   of	   rare-­‐earth	   metal	   salts	   for	   transfer	  
hydrogenation	   reactions.63	  These	  catalysts	  were	  pre-­‐prepared	  as	   shown	   in	  Scheme	  
1.36.	  
	  
LnI3 + iPrOM LnOiPrI2 + MI






The	  synthesized	  catalyst	  was	  then	  shown	  to	  successfully	  oxidize	  alcohols	  to	  ketones	  
in	   yields	   around	   90%.	   The	   reverse	   reductions	   could	   be	   achieved	  with	   comparable	  
yields.	  A	   comprehensive	   review	  of	   lanthanide	   isopropoxides	  as	   catalysts	   for	  MPVO	  
reactions	  was	  presented	  in	  1987	  by	  Kiji	  et	  al.64	  the	  complexes	  were	  tested	  for	  their	  
catalytic	  activity.	  The	  results	  showed	  that	  Nd,	  Eu,	  Gd,	  Dy,	  Er,	  Tm	  and	  Yb	  isopropoxide	  
were	  able	  to	  catalyse	  MPV	  reactions,	  with	  Gd(iPrO)3	  proving	  103	  times	  more	  active	  
than	  the	  analogous	  aluminium	  catalyst.	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In	   1986	   Ishii	   et	   al	   presented	   two	   papers	   on	   the	   use	   of	   zirconocene	   dihydride	   to	  
address	   one	   of	   the	   limitations	   of	   MPVO	   using	   traditional	   aluminium	   catalysts.65	  







+ +Cp2ZrH2 (4 mol%)150 ˚C, 8 h
70% yield 	  
Scheme	  1.37	  
	  
The	   example	   shown	   in	   Scheme	   1.37	   uses	   cyclohexanone	   as	   a	   hydrogen	   acceptor	  
instead	  of	  acetone.	  Further	  selectivity	  was	  shown	  by	   Ishii	  et	  al.	   in	  1987	  when	  they	  
showed	   the	   conversion	   of	   allylic	   alcohols	   into	   the	   corresponding	  α,β–unsaturated	  
ketones	  and	  aldehydes	  using	  zirconocene	  dihydride.66	  
	  
During	   the	   1990s	   and	   early	   2000s	   modifications	   to	   the	   alkoxide	   component	   of	  






+ Me3Al (5 mol%)(10 mol%)




91% yield 	  
Scheme	  1.38	  
	  
One	  of	   the	  modifications	   is	   shown	   in	   Scheme	  1.38,	  bidentate	  oxygen	   ligands	  were	  
used	  to	  form	  aluminium	  pre-­‐catalysts	   in	  this	  manner.67b	  They	  showed	  the	  ability	  to	  
successfully	  oxidize	  a	  variety	  of	  alcohols.	  
	  
Since	  then	  work	  has	  been	  reported	  using	  a	  variety	  of	  metals	   to	  carry	  out	  modified	  
MPVO	  reactions:	  Fe,68	  Pu,69	  B,70	  Mo,71	  Ni,72	  Sn73	  and	  Ti.74	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Rhodium,75	  ruthenium76	  and	  iridium77	  have	  been	  investigated	  extensively	  in	  transfer	  
hydrogenation	  reactions	  that	  do	  not	  proceed	  by	  the	  MPVO	  mechanism.	  Early	  work	  in	  
the	  1970s	   focused	  on	   the	  model	   reaction	   shown	   in	   Scheme	  1.39	  and	   investigating	  











During	   the	  1980s	   the	   focus	   switched	   to	  asymmetric	   transfer	  hydrogenation,	  which	  
will	   be	   discussed	   in	   a	   later	   section	   of	   this	   introduction.	   Catalytic	   transfer	  
hydrogenation,	   that	  was	   not	  MPVO,	  was	   not	   seriously	   investigated	   again	   until	   the	  
mid-­‐2000s	   when	   ‘borrowing	   hydrogen’	   methodology	   was	   investigated	   more	  
heavily.78	  	  
	  
R OH R NH
R'
R O N R'R
oxidation
   (-H2)
reduction





Scheme	   1.40	   shows	   a	   general	   ‘borrowing	   hydrogen’	  methodology,	   in	   this	   instance	  
the	   reaction	   is	   the	  N-­‐alkylation	   of	   an	   amine	   using	   benign	   alcohol	   as	   the	   alkylating	  
agent,	  please	  see	  the	  review	  for	  the	  various	  catalysts	  using	  ruthenium	  and	  iridium.78	  
The	  principle	  being	  that	  if	  one	  wished	  to	  alkylate	  an	  amine,	  traditionally	  one	  would	  
require	  an	  alkyl	  halide	  reagent	  that	  are	  generally	  toxic	  and	  therefore	  using	  an	  alcohol	  




This	   naturally	   led	   to	   the	   consideration	   of	   other	   substrates	   that	   could	   be	   alkylated	  
and	  whether	  alcohol	  could	  be	  used	  as	  the	  alkylating	  agent.	  Amides	  were	  considered	  
as	  early	  as	  1983	  by	  Watanabe	  et	  al.79	  The	  reaction	  is	  shown	  in	  Scheme	  1.41.	  
NH2
O









However,	   if	  the	  hydrogen	  wasn’t	  ‘borrowed’	  and	  was	  merely	  ‘taken’	  by	  a	  hydrogen	  
acceptor,	   then	   transfer	   hydrogenation	   would	   be	   performed.	   Unlike	   the	   previous	  
investigations	  in	  the	  1970s	  and	  1980s	  though,	  the	  transformations	  investigated	  were	  
on	  substrates	  of	  greater	  interest.	  
	  
The	   first	   example	   of	   secondary	   amide	   formation	   from	   the	   coupling	   of	   amines	   and	  













































Then	  in	  2008	  Madsen	  et	  al.	   investigated	  the	  same	  transformation,	  coupling	  amines	  
and	   alcohols	   to	   form	   amides,	   using	   an	   alternative	   catalytic	   system,	   via	   the	   same	  
proposed	  mechanism.81	  
	  





L 5 mol%, KOtBu 20 mol%
PCyp3.HBF4 5 mol%




In	   2009	  Ghosh	   et	   al.	   looked	   at	   the	   coupling	   of	   alcohols	   and	   amines	   to	   form	   the	  









toluene, reflux 	  
Scheme	  1.44	  
	  
All	  these	  examples	  proceed	  through	  a	  hemiaminal	  intermediate	  that	  is	  thought	  to	  be	  















1.4	  Asymmetric	  transfer	  hydrogenation	  
	  
With	   transfer	   hydrogenation	   in	   mind	   from	   the	   previous	   section,	   it	   is	   prudent	   to	  
discuss	  the	  final	  area	  of	  homogeneous	  catalysis	  in	  this	  introduction,	  which	  is	  catalytic	  
asymmetric	  transfer	  hydrogenation	  (ATH).	  
	  
1.4.1	  Asymmetric	  MPV	  reduction	  	  
	  
Initially	   modifications	   to	   the	   existing	   MPV	   protocol	   were	   used	   to	   try	   to	   perform	  




O La(OtBu)3 (10 mol%)Ligand (10 mol%)
IPA (10 eq.) THF, 60 ˚C, 6 d
Me
OH
10% conversion, 32% e.e.







The	  reaction,	  shown	  in	  Scheme	  1.45,	  was	  carried	  out	  by	  van	  Bekkum	  et	  al.	  and	  gave	  
a	  poor	  conversion	  and	  poor	  enantioselectivity	  using	  a	   lanthanum	  alkoxide	  complex	  
with	   a	   1,2-­‐diol	   ligand	   system	   in	   an	   excess	   of	   IPA.84	   Improvements	   were	  made	   by	  
Kellogg	  et	  al.	  who	  used	  erbium	  alkoxides	  with	  a	  prochiral	  1,3-­‐diol	   in	   IPA,	   shown	   in	  
Scheme	  1.46.85	  Both	  systems	  had	  lengthy	  reaction	  times	  though.	  
Me
O Er(OiPr)3 (10 mol%)Ligand (10 mol%)
IPA/PhMe (1:1), r.t., 3 d
Me
OH
62% conversion, 46% e.e.
Ligand =




Significant	  improvements	  were	  made	  by	  Knaueur	  et	  al.	   in	  1995,	  they	  used	  an	  initial	  
incubation	   period	   of	   six	   hours	   to	   preform	   the	   zirconium	   catalyst	   in	   situ	   before	  





















Scheme	  1.48	  shows	  how	  Evans	  et	  al.	   synthesized	  their	  samarium	  chiral	  catalyst	   for	  
MPV	  asymmetric	  reductions	  of	  aromatic	  ketones.	  The	  reaction	  conditions	  are	  shown	  





















The	   enantioselectivity	   achieved	   represents	   the	   best	   that	   has	   so	   far	   been	   achieved	  





IPA (25 eq.), 24 h, r.t., THF
X X
X = Cl, 96% conversion, 97% e.e.
X = H, 74% conversion, 96% e.e.
X = OMe, 95% conversion, 96% e.e. 	  
Scheme	  1.49	  
	  
1.4.2	  Noyori’s	  ATH	  catalyst	  	  
	  
The	  main	  focus	  of	  research	  into	  asymmetric	  transfer	  hydrogenation	  has	  been	  on	  the	  
Noyori	  system.	  Scheme	  1.50	  shows	  the	  general	  reaction	  scheme	  taken	  from	  a	  review	  

























The	  most	  utilized	  derivative	  of	  the	  chiral	  catalyst	  shown	  in	  Scheme	  1.50	  is	  formed	  in	  
situ	   from	   the	   reaction	   of	   dichlororuthenium(II)p-­‐cymene	   dimer	   and	   TsDpen	   in	   the	  
presence	   of	   a	   base,	   usually	   potassium	   hydroxide.	   Undergraduates	   study	   the	  












































The	  chirality	  and	  steric	  bulk	  of	  the	  in	  situ	  catalyst	  dictates	  the	  direction	  of	  association	  
of	  the	  substrate	  ketone,	  resulting	  in	  a	  chiral	  alcohol	  product.	  
	  
There	  are	  many	  variations	  to	  the	  system	  described	  here.	  Scheme	  1.52	  shows	  some	  



































1.4.3	  Wills	  modification	  to	  Noyori	  ATH	  system	  
	  
In	  2004	  Wills	  et	  al.	  presented	  a	  new	  class	  of	  tethered	  ruthenium	  systems	  that	  were	  
based	   on	   the	   successful	   Noyori	   catalyst	   system	   described	   above.92	   Wills	   had	  
previously	   been	   investigating	   modifications	   to	   the	   Noyori	   system	   and	   provides	   a	  
comprehensive	  summary	  of	  progress	  up	  to	  1999	   in	  his	   review.93	  The	  group’s	   initial	  
work	  focused	  on	  stabilizing	  the	  active	  catalyst	  species	  by	  locking	  the	  aryl	  system	  on	  
the	   ruthenium	   centre	   to	   the	   ligand	   providing	   greater	   enantiomeric	   control	   over	  
asymmetric	  reductions.	  The	  ligands	  that	  were	  investigated	  were	  monotosylated	  1,2-­‐




















The	   catalysts	   shown	   in	   Scheme	   1.53	   showed	   excellent	   activity	   achieving	   high	  
conversions	   with	   high	   enantiomeric	   excess.	   Analogous	   rhodium(III)	   catalysts	   were	  
also	   shown	   to	   have	   good	   activity.94	   In	   2005	   another	   form	  of	   the	   tethered	   catalyst	  
had	   been	   synthesized	   and	   was	   shown	   to	   be	   significantly	   more	   active	   than	   the	  













Scheme	  1.54	  shows	  the	  tethered	  catalyst	   that	  has	  since	  become	  Wills	  catalyst,	   the	  





Wills Catalyst (0.5 mol%)
HCOOH/Et3N (5:2)
100% conversion
96% e.e. 	  
Scheme	  1.55	  
	  
In	  the	  final	  part	  of	  this	  introduction	  it	  is	  worth	  noting	  some	  of	  the	  different	  hydride	  
or	  hydrogen	  sources	  that	  are	  used	  for	  asymmetric	  transfer	  hydrogenation	  as	  well	  as	  
transfer	  hydrogenation.	  Shown	  in	  Scheme	  1.55	  is	  probably	  the	  most	  effective	  source	  
of	   hydrogen	   other	   than	   the	   gas	   itself,	  which	   is	   an	   azeotrope	   of	   5:2	   formic	   acid	   to	  
triethylamine,	  which	  is	  generally	  used	  as	  a	  solvent	  and	  avoids	  the	  need	  with	  IPA	  to	  
have	  a	  very	  large	  excess	  to	  overcome	  the	  reversibility	  issue.96	  
	  
Finally,	   Hantzsch	   esters	   are	   another	   source	   of	   hydrogen,	   the	  mechanism	   is	   shown	  






































Homogeneous	  catalysis	   is	  extremely	   important	  to	  both	   industrial	  and	  fine	  chemical	  
synthesis.	  Research	  into	  new	  catalysts	  and	  catalytic	  systems	  is	  ongoing	  and	  receives	  
significant	   attention	   throughout	   the	   literature.	   This	   introduction	   was	   to	   give	   the	  
reader	  an	  overview	  of	  the	  various	  applications	  of	  homogeneous	  catalysis.	  
	  
Existing	  methods	  to	  synthesize	  N-­‐acylsulfonamides	  were	  summarized	  here	  and	  show	  
that	   there	   is	   a	   need	   for	   a	  more	   atom	  efficient	  method	   of	   synthesis.	  Whether	   it	   is	  
based	  on	   activating	   carboxylic	   acid	   derivatives	   or	   transfer	   hydrogenation	   reactions	  
with	  alcohols.	  	  
	  
Improvements	   to	   the	   activation	   of	   carboxylic	   acid	   derivatives	   would	   be	   desirable	  
since	  this	  route	  usually	  involves	  stoichiometric	  amounts	  of	  waste	  and	  toxic	  coupling	  
reagents.	  This	  would	  be	  of	  significant	  benefit	   to	   industrial	  synthesis	  as	  a	  significant	  
amount	  of	  their	  synthetic	  pathways	  involve	  this	  type	  of	  activation.	  
	  
Transfer	  hydrogenation	  reactions	  are	  also	  extremely	  desirable	  since	  hydrogen	  can	  be	  
introduced	   to	   the	   product	   from	   a	   source	   other	   than	   hydrogen	   gas.	   Therefore	   the	  
reaction	  does	  not	  need	  to	  be	  run	  under	  an	  atmosphere	  of	  hydrogen.	  
	  
1.6	  Project	  aims	  
	  
The	   research	   presented	   in	   this	   thesis	   aims	   to	   address	   some	   of	   the	   problems	  with	  
current	  N-­‐acylsulfonamide	   synthesis	   outlined	   in	   previous	   sections.	   Specifically,	   the	  
activation	  of	  carboxylic	  acid	  derivatives	  and	  also	  the	  acylation	  of	  sulfonamides	  using	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Iodide	  as	  an	  Activating	  Agent	  
Chapter	  2:	  Results	  and	  Discussion	  I	  
2.1	  Aims	  
The	  aim	  of	  this	  work	  is	  to	  investigate	  whether	  acid	  chlorides	  can	  be	  activated,	  using	  
an	   iodide	   source,	   towards	   nucleophilic	   attack	   from	   relatively	   poor	   nucleophiles.	  
Sulfonamides	  are	  initially	  investigated	  but	  other	  nucleophiles	  are	  also	  considered.	  
	  
Previous	   work	   in	   the	   group	   focused	   on	   DBN	   catalysed	   acylation	   using	   acid	  
chlorides.98	  It	  was	  considered	  that	  acid	  chlorides	  form	  a	  complex	  with	  DBN	  and	  that	  
























While	   screening	   additives	   that	   might	   enhance	   the	   yield	   and	   scope	   of	   the	   above	  
reaction,	   lithium	   iodide	   was	   seen	   to	   enhance	   the	   reactivity	   of	   the	   DBN	   reaction,	  
furthermore	   in	   the	   absence	   of	   DBN,	   with	   one	   equivalent	   of	   iodide	   the	   reaction	  











+ LiI (1 eq.)





The	   aim	   of	   this	   work	   is	   therefore	   to	   investigate	   the	   potential	   scope	   for	   iodide	  
activation	   and	   to	   probe	   the	   reaction	   further	   to	   determine	   any	   mechanistic	  




2.2	  Initial	  work	  
2.2.1	  Sulfonamides	  
Sulfonamides	   are	   relatively	   poor	   nucleophiles	   owing	   to	   the	   electron-­‐withdrawing	  
nature	  of	   the	   adjacent	   -­‐SO2	   group	   to	   the	   -­‐NH2	   thereby	   acting	   to	   stabilize	   the	   lone	  
pair	  on	  the	  nitrogen.	  	  
	  
To	   begin	   with	   it	   was	   investigated	   whether	   the	   following	   reaction	   would	   proceed	  
















The	  percentage	  conversion	  of	  reactants	  into	  N-­‐acylsulfonamide	  2.1	  is	  determined	  by	  
analysis	   of	   relative	   integration	   of	   the	   peaks	   corresponding	   to	   the	   methyl	   CH3	   of	  
methanesulfonamide,	   at	   δ	   3.15	   ppm	   and	   the	   methyl	   CH3	   of	   N-­‐
acetylmethansulfonamide	  at	  δ	  3.25	  ppm	  in	  the	  1H	  NMR.	  The	  initial	  amount	  of	  lithium	  
iodide,	  20	  mol%,	  was	  chosen	  arbitrarily	  and	  a	   series	  of	  dry	   solvents	  was	   screened,	  










+ LiI (20 mol%)
solvent, r.t.,18 h
2.1 	  
Entry	   Solventa	   N-­‐Acylsulfonamide	  2.1	  conversionb	  
(%)	  
1	   PhMe	  (anhydrous)	   46	  
2	   MeCN	  (anhydrous)	   94	  
3	   DCM	  (anhydrous)	   57	  
4	   Et2O	  (anhydrous)	   93	  
5	   EtOAc	  (4	  Å	  MS)	   89	  
Table	  2.1.	  a	  Reactions	  were	  performed	  on	  a	  2	  mmol	  scale	  in	  2	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra. 
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Although	  similar	  results	  are	  observed	  for	  Et2O	  (Table	  2.1,	  entry	  4)	  and	  MeCN	  Table	  
2.1,	  entry	  2),	  MeCN	  is	  chosen	  as	  the	  solvent	  because	  of	  its	  higher	  boiling	  point	  82	  ˚C.	  
	  
The	   amount	   of	   lithium	   iodide	   was	   varied	   to	   determine	   whether	   a	   lower	   amount	  
would	  still	  form	  the	  N-­‐acylated	  product.	  It	  was	  pleasing	  that	  0.1	  mol%	  lithium	  iodide	  
(Table	  2.2,	  entry	  2)	  gave	  86%	  conversion	   into	  compound	  2.1.	  However,	   it	  was	  also	  
noted	  that	  in	  the	  absence	  of	  lithium	  iodide,	  73%	  conversion	  into	  compound	  2.1	  was	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Entry	   LiIa	  (mol%)	   N-­‐Acylsulfonamide	  2.1	  conversionb	  (%)	  
1	   0	   73	  
2	   0.1	   	   86	   	  
3	   1	   84	  
4	   2	   88	  
5	   5	   83	  
6	   10	   86	  
7	   20	   94	  
Table	  2.2.	  a	  Reactions	  were	  performed	  on	  a	  5	  mmol	  scale	  in	  5	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  
	  
Whilst	  it	  was	  apparent	  that	  the	  presence	  of	  lithium	  iodide	  does	  alter	  the	  conversion,	  
the	   background	   rate	   is	   very	   high.	   It	   is	   known	   that	   acetyl	   chloride	   is	   extremely	  
reactive	  to	  nucleophilic	  attack,	   this	   is	  because	  the	  δ+	  on	  the	  carbonyl	  carbon	  has	  a	  
readily	   accessible	   π*	   (C=O)	   orbital	   to	   an	   incoming	   nucleophile	   and	   the	   inductive	  
effect	   of	   a	   single	   methyl	   group	   would	   not	   affect	   this	   significantly,	   either	  
electronically	   or	   sterically.	   Hence	   a	  more	   challenging	   electrophile	   was	   required	   to	  
provide	  a	  greater	  contrast	  between	  the	  presence	  and	  absence	  of	  an	  activating	  agent.	  
Benzoyl	  chloride	  was	  chosen	  since	  it	  is	  less	  reactive	  than	  acetyl	  chloride.	  This	  can	  be	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The	   delocalization	   around	   the	   phenyl	   ring	   results	   in	   stabilization	   of	   the	   positive	  
charge,	  therefore	  unlike	  in	  acetyl	  chloride,	  the	  positive	  charge	  is	  not	  concentrated	  on	  
the	  carbonyl	  carbon	  and	  benzoyl	  chloride	   is	   therefore	   less	  electrophilic	   than	  acetyl	  
chloride.	  
	  
However,	   acylation	   of	   methanesulfonamide	   using	   benzoyl	   chloride	   to	   form	  

















Entry	   LiIa	  (mol%)	   N-­‐Acylsulfonamide	  2.2	  conversionb	  (%)	  
1	   20	   <5	  
2	   100	   36	  
3	   100	   38c	  
Table	  2.3.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  1	  mL	  MeCN.	  b	  Conversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  cReaction	  carried	  out	  at	  40	  ˚C	  on	  a	  2	  mmol	  scale	  in	  2	  mL	  MeCN.	  
	  
Increasing	  the	  amount	  of	  lithium	  iodide	  to	  one	  equivalent	  was	  an	  improvement	  but	  
insufficient	  because	  the	  conversion	  into	  compound	  2.2	   is	  only	  36%	  (Table	  2.3,	  entry	  





























This	  showed	  that	  N-­‐acylsulfonamide	  2.1	  is	  produced	  exclusively,	  with	  a	  conversion	  of	  
79%.	  This	  confirms	  the	  lower	  electrophilicity	  of	  benzoyl	  chloride	  and	  the	  preference	  
of	  a	  sulfonamide	  nucleophile	  for	  acetyl	  chloride.	  
	  
Returning	  to	  the	  reaction	  of	  benzoyl	  chloride	  with	  methanesulfonamide,	   increasing	  
the	  temperature	  to	  40	  ˚C	  only	  increased	  the	  conversion	  to	  38%	  (Table	  2.3,	  entry	  3),	  
however	  upon	  heating	  to	  reflux	  and	  extending	  the	  reaction	  time,	  higher	  conversions	  
could	  be	  obtained	  (Table	  2.4).	  When	  the	  amount	  of	   lithium	  iodide	  is	  again	  reduced	  
to	   catalytic	   levels	   conversion	   into	   N-­‐acylsulfonamide	   2.2	   improves	   over	   the	  
background	  rate	  with	  excellent	  turnover	  observed	  at	  20	  mol%	  catalyst	  loading	  (Table	  
2.4,	   entry	   6)	   and	   quantitative	   conversion	   is	   achievable	   with	   an	   excess	   of	   lithium	  















Entry	   LiIa	  (mol%)	   N-­‐Acylsulfonamide	  2	  conversionb	  (%)	  
1	   0	   16	  
2	   1	   64	  
3	   2	   79	  
4	   5	   84	  
5	   10	   89	  
6	   20	   91	  
7	   100	   95	  
8	   150	   100	  
Table	  2.4.	  a	  Reactions	  were	  performed	  on	  a	  2	  mmol	  scale	  in	  2	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	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Extending	  the	  reaction	  time	  to	  24	  hours	  and	  increasing	  the	  amount	  of	  acid	  chloride	  
to	   1.2	   equivalents	   of	   the	   nucleophile	   provided	   the	   optimized	   conditions.	   The	  
substrate	  scope	  was	   investigated	  and	  the	  sulfonamide	  nucleophile	  was	  varied	  with	  



































































































Table	   2.5.	   aReactions	   were	   performed	   on	   a	   5	   mmol	   scale,	   using	   6	   mmol	   of	   acid	   chloride	   in	   2	   mL	  
solvent.	   bIsolated	  yields,	  products	  purified	  by	  column	  chromatography,	  conversions,	   in	  parentheses,	  
determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	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Table	  2.5	  shows	  that	  the	  nature	  of	  the	  sulfonamide	  nucleophile	  has	  very	  little	  impact	  
on	   the	   yield	   of	   N-­‐acylsulfonamide,	   reinforcing	   the	   reactivity	   of	   the	   electrophile,	  
acetyl	  chloride.	  	  
	  
Aliphatic	  sulfonamides	  would	  be	  expected	  to	  give	  higher	  yields	  based	  on	  electronic	  
arguments.	  The	  inductive	  effect	  of	  an	  alkyl	  group	  donates	  electron	  density	  to	  the	  π*	  
(S=O)	   orbital	   on	   the	   sulfonyl	   sulfur	   reducing	   the	   stabilization	   of	   the	   nitrogen	   lone	  
pair,	   hence	   they	   are	   better	   nucleophiles.	   However,	   methanesulfonamide	   gave	   a	  
lower	  than	  expected	  yield	  for	  the	  reaction	  (Table	  2.5,	  entry	  1).	  The	  experiment	  was	  
repeated	   several	   times	   and	   always	   yields	   the	   same	   19%	   isolated	   yield	   despite	   the	  
observed	  conversion	  of	  94%.	  The	  reason	  for	  this	  could	  be	  attributed	  to	  the	  method	  
of	  purification.	  Methyl	   esters	   are	   susceptible	   to	   acid	   catalysed	  hydrolysis	  on	  acidic	  
silica,	  the	  analogous	  N-­‐acetylmethanesulfonamide	  is	  also	  susceptible.	  
	  
Aromatic	   sulfonamides	   behave	   as	   expected	   with	   the	   more	   electron	   rich	  
sulfonamides,	  such	  as	  4-­‐methoxybenzene	  sulfonamide	  (Table	  2.5,	  entry	  6),	  giving	  the	  
highest	   isolated	   yield,	   conversely	   the	   most	   electron	   withdrawing	   aromatic	  
sustituents,	   4-­‐nitro	   and	   4-­‐chloro	   benzene	   sulfonamide	   (Table	   2.5,	   entries	   7	   &	   8)	  
respectively)	  are	  produced	  in	  slightly	  lower	  yields.	  
	  
However,	   it	   is	   important	   to	   note	   that	   the	   reactivity	   of	   acetyl	   chloride	   is	   the	  
predominant	  factor	  for	  the	  results	  in	  Table	  2.5.	  	  
	  
In	  Table	  2.6	  the	  acid	  chloride	  is	  varied	  and	  the	  nucleophile,	  p-­‐toluenesulfonamide,	  is	  
fixed.	   The	   results	   raise	   a	   problem:	   aliphatic	   acid	   chlorides	   (considerably	   more	  
reactive)	   showed	   excellent	   coupling	   to	   p-­‐toluenesulfonamide;	   however,	   aromatic	  
acid	   chlorides	   (relatively	   less	   reactive),	   such	   as	   benzoyl	   chloride,	   showed	   poor	  
reactivity	  with	  a	  conversion	  into	  the	  N-­‐acylsulfonamide	  2.10	  of	  13%	  (Table	  2.6,	  entry	  
1).	   This	   is	   attributed	   to	   the	   difference	   between	   the	   nucleophilicity	   of	  
methanesulfonamide	   and	   p-­‐toluenesulfonamide	   (N-­‐acylsulfonamide	   2.2	   &	   2.10,	  





















































































Table	   2.6.	   aReactions	  were	  performed	  on	  a	  5	  mmol	   scale,	   using	  6	  mmol	  of	   acid	   chloride	   in	  2	  mL	  
solvent.	  bConversions	  determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  
	  
Aliphatic	   acid	   chlorides	   give	   high	   conversions,	   consistent	  with	   their	   reactivity.	   The	  
relatively	   lower	   conversion	   for	   trimethylacetyl	   chloride	   (Table	   2.6,	   entry	   3)	   can	   be	  
attributed	  to	  the	  steric	  hindrance	  around	  the	  carbonyl	  carbon	  hindering	  attack	  from	  
the	  nucleophile	  and	   inductive	  effects	   from	  three	  methyl	  groups	  reducing	  δ+	  on	  the	  
carbonyl	  carbon.	  	  Further	  optimization	  would	  be	  required	  to	  obtain	  high	  conversions	  
for	  the	  less	  reactive	  acid	  chlorides.	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2.2.2	  Secondary	  Sulfonamides	  
Secondary	  sulfonamide	  starting	  materials	  were	  synthesized	  so	  that	  the	  acylation	  of	  a	  
secondary	   sulfonamide	   could	   be	   investigated.	   Below	   in	   Scheme	   2.6	   is	   the	   general	  








R Et3N (1.5 eq.)
DCM, r.t., 3 h




Scheme	  2.6	  	  
	  
Using	   the	  optimized	   reaction	   conditions,	   acetyl	   and	  benzoyl	   chloride	  were	   reacted	  
with	  secondary	  sulfonamides	  2.17	  &	  2.18.	  The	  experiments	  were	  also	  carried	  out	  in	  
the	  absence	  of	  lithium	  iodide	  to	  give	  a	  background	  rate	  for	  this	  reaction.	  The	  results	  










R' = Ph or Me
MeCN 82 ˚C
24 h


























































Table	   2.7.	   aReactions	  were	  performed	  on	  a	  5	  mmol	   scale,	   using	  5	  mmol	  of	   acid	   chloride	   in	  2	  mL	  
solvent.	   bConversions	   determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra,	   figures	   in	   parentheses	   are	  
reactions	  performed	  in	  the	  absence	  of	  lithium	  iodide.	  
	  
No	  reaction	  between	  benzoyl	  chloride	  and	  either	  of	  the	  secondary	  sulfonamides	  was	  
observed	   (Table	   2.7,	   entries	   3	  &	  4).	  Given	   the	  poor	   reaction	  between	   the	  primary	  
sulfonamide	  and	  benzoyl	  chloride	  this	  was	  expected.	  Since	  secondary	  sulfonamides	  
are	  more	  hindered	  nucleophiles	  than	  primary	  ones	  they	  are	  less	  nucleophilic.	  	  
	  
The	  reaction	  between	  acetyl	  chloride	  and	  compounds	  2.17	  &	  2.18	  (Table	  2.7,	  entries	  
1	  &	  2)	  succeeded	  and	  it	  was	  pleasing	  that	  there	  is	  a	  marked	  improvement	  over	  the	  
background	  rate.	  
	  













Most reactive Least reactive 	  
Scheme	  2.7	  
	  
Lithium	  iodide	  was	  tested	  to	  determine	  if	  others	  in	  the	  acid	  series	  are	  activated	  in	  a	  
similar	  manner	  to	  the	  most	  reactive,	  acid	  chloride.	  The	  trend	  is	  shown	  in	  Scheme	  2.7.	  
	  
Acetyl	  chloride	  and	  acetic	  anhydride	  were	  the	  only	  members	  of	   the	  acid	  derivative	  
series	  to	  show	  activity	  under	  these	  conditions.	  Ester	  and	  caboxylic	  acid	  groups	  were	  
not	   activated	  by	   lithium	   iodide	   (Table	  2.8,	   entries	  2	  &	  3)	   and	   therefore	  no	   further	  
investigations	  were	   carried	   out	   into	   them.	   Acetic	   anhydride	   is	   sufficiently	   reactive	  
that	  in	  the	  presence	  and	  absence	  of	  lithium	  iodide	  81%	  conversion	  was	  observed	  for	  
both	   (Table	   2.8,	   entry	   1).	  However	   further	   investigations	   into	   anhydride	   activation	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Table	  2.8.	  aReactions	  were	  performed	  on	  a	  2	  mmol	  scale,	  using	  2.4	  mmol	  of	  acid	  chloride	  in	  2	  mL	  
solvent.	   bConversions	   determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra,	   figures	   in	   parentheses	   are	  



















2.3	  Potassium	  iodide	  
2.3.1	  Sulfonamides	  
At	   this	   stage	   the	   low	   conversion	   observed	   with	   benzoyl	   chloride	   and	   p-­‐
toluenesulfonamide	   (Table	  2.6,	  entry	  1)	  needed	   to	  be	   revisited.	  A	   screen	  of	   iodide	  
sources	  was	  undertaken	  to	  determine	  if	  lithium	  iodide	  is	  the	  best	  source.	  Initially	  the	  
reaction	  between	  valeroyl	  chloride	  and	  p-­‐toluenesulfonamide	  was	   investigated	  and	  

















Entry	   Iodide	  sourcea	  	   N-­‐Acylsulfonamide	  2.11	  conversionb	  (%)	  
1	   No	  Iodide	   91	  
2	   LiI	   86	  
3	   NaI	   97	  
4	   KI	   100	  
5	   NH4I	   97	  
6	   CuI2	   87	  
7	   FeI2	   52	  
8	   ZnI2	   94	  
9	   I2	   66	  
Table	  2.9.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	  bConversions	  determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  
	  
Other	   salts	   were	   considered	   to	   see	   if	   iodide	   is	   just	   a	   counter-­‐ion	   or	  whether	   it	   is	  






















Entry	   Salta	  	   N-­‐Acylsulfonamide	  2.11	  conversionb	  (%)	  
1	   No	  salt	   91	  
2	   KBr	   100	  
3	   KCl	   97	  
4	   AlCl3	   96	  
Table	  2.10.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	  bConversions	  determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  
	  
Lithium	   iodide	   shows	   decreased	   activity	   (Table	   2.9,	   entry	   2)	   compared	   to	   the	  
absence	  of	  an	   iodide	  source	   (Table	  2.9,	  entry	  1).	  However,	  quantitative	  conversion	  
into	   the	  N-­‐acylsulfonamide	   is	  achieved	  using	  potassium	   iodide	   (Table	  2.9,	  entry	  4).	  
Tables	  2.9	  &	  2.10	  highlight	  that	  the	  contrast	  between	  the	  background	  rate	  and	  the	  
catalysed	   rate	   is	   too	   close	   to	   properly	   assess	   the	   relative	   activities	   and	   therefore	  






























Entry	   Iodide	  sourcea	  	   N-­‐Acylsulfonamide	  2.10	  conversionb	  (%)	  
1	   No	  Iodide	   7	  
2	   LiI	   13	  
3	   NaI	   78	  
4	   KI	   69	  
5	   RbI	   46	  
6	   CsI	   18	  
7	   NH4I	   61	  
8	   n-­‐Bu4NI	   10	  
Table	  2.11.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
The	   results	   show	   that	   there	   is	   a	   large	   contrast	   between	   the	   absence	   of	   an	   iodide	  
source	   (Table	  2.11,	  entry	  1)	   and	   the	  presence	  of	  either	   sodium	   iodide	   (Table	  2.11,	  
entry	   3)	   or	   potassium	   iodide	   (Table	   2.11,	   entry	   4).	   The	   conversion	   achieved	   with	  
lithium	   iodide	   is	   consistent	   with	   those	   remarked	   on	   earlier	   (Table	   2.11,	   entry	   2).	  
Although	   lithium	   iodide	   showed	   some	   promise	   as	   an	   activating	   agent	   for	   acid	  
chlorides	   in	  some	  situations,	   sodium	  and	  potassium	   iodide	  performed	  much	  better	  
under	  the	  conditions	  shown	  in	  Table	  2.11.	  	  
	  
Potassium	  iodide	  was	  optimized,	  given	  the	  cheaper	  cost	  relative	  to	  sodium	  iodide	  at	  
the	  time	  of	  conducting	  these	  experiments.	  However,	  sodium	  iodide	  appears	  to	  work	  
just	   as	   well	   and	   sometimes	   better	   and	   therefore	   they	   could	   be	   interchanged	   if	  
required.	  
	  
The	   amount	   of	   potassium	   iodide	  was	   investigated,	   60	  mol%	   provided	   quantitative	  














82 ˚C, 24 h
KI, MeCN
2.10 	  
Entry	   KI	  (mol%)a	  	   N-­‐Acylsulfonamide	  2.10	  conversionb	  (%)	  
1	   0	   12	  
2	   1	   20	  
3	   2	   25	  
4	   5	   36	  
5	   10	   30	  
6	   20	   67	  
7	   30	   63	  
8	   40	   62	  
9	   50	   80	  
10	   60	   100	  
11	   70	   70	  
12	   80	   87	  
13	   90	   84	  
14	   100	   57	  
15	   150	   68	  
16	   200	   65	  
Table	  2.12.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
Increasing	   the	   amount	   of	   potassium	   iodide	   did	   not	   improve	   the	   conversion	   and	  
actually	  inhibited	  it.	  There	  is	  no	  obvious	  explanation	  for	  this	  at	  this	  stage.	  	  
	  
A	  solvent	  screen	  was	  carried	  out	  to	  establish	  the	  best	  solvent	  for	  potassium	  iodide.	  
Interestingly	  the	  results	  are	  very	  different	  to	  Table	  2.1,	  only	  MeCN	  and	  EtOAc	  (Table	  

















Entry	   Solventa	  	   N-­‐Acylsulfonamide	  2.10	  conversionb	  (%)	  
1	   PhMe	   0	  
2	   MeCN	   46	  
3	   Hexane	   0	  
4	   THF	   0	  
5	   Et2O	   0	  
6	   DCM	   0	  
7	   EtOAc	   14	  
8	   DMSO	   0	  
9	   DMF	   0	  
Table	  2.13.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
The	  substrate	  scope	  was	   investigated	  using	  the	  optimized	  conditions	  for	  potassium	  
iodide.	   Table	   2.14	   shows	   the	   results	   for	   the	   addition	   of	   p-­‐toluenesulfonamide	   to	  
various	   acid	   chlorides.	   Table	   2.15	   shows	   the	   results	   for	   the	   addition	   of	   various	  
















































































































Table	  2.14.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale,	  using	  3.6	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
































































Table	  2.15.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale,	  using	  3.6	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
solvent.	  bIsolated	  yields,	  products	  purified	  by	  column	  chromatography.	  cIsolated	  after	  recrystallisation	  
(EtOH/H2O).	  
	  
Tables	  2.14	  &	  2.15	  show	  that	  both	  aliphatic	  and	  aromatic	  acid	  chlorides	  were	  found	  
to	   be	   suitable	   substrates,	   as	   were	   aromatic	   and	   aliphatic	   sulfonamides.	   Electron	  
withdrawing	  and	  electron	  donating	  aromatic	  acid	  chlorides	  and	  sulfonamides	  were	  
also	   tolerated.	   Excellent	   yields	  were	   obtained	  with	   steric	   bulk	   on	   the	   sulfonamide	  
and	   acid	   chloride.	   There	   was	   partial	   racemization	   in	   the	   formation	   of	   the	   chiral	  
product	  (Table	  2.14,	  entry	  9).	  However,	  as	  the	  product	  was	  not	  racemic	  this	  suggests	  
that	  the	  reaction	  did	  not	  proceed	  wholly	  via	  a	  ketene	   intermediate.	  Although	  large	  
amounts	   of	   iodide	   were	   needed	   in	   order	   to	   achieve	   a	   significant	   beneficial	   rate	  




The	  method	   could	   now	  be	   incorporated	   into	   the	   synthesis	   of	   a	  molecule	   that	   has	  



















2.38 2.39 	  
Scheme	  2.8	  
	  
The	  existing	  method	  relies	  on	  the	  use	  of	  catalytic	  DMAP	  to	  couple	  the	  acid	  chloride	  
to	   the	   corresponding	   sulfonamide.	   It	   was	   therefore	   of	   interest	   to	   investigate	  
whether	  one	  could	  couple	  the	  sulfonamide	  and	  acid	  chloride	  using	  the	  cheaper	  and	  
significantly	  less	  toxic	  potassium	  iodide.	  
	  
Initially	   the	   sulfonamide	   was	   synthesized	   starting	   from	   2-­‐bromothiophene,	   the	  























2.37 2.38 	  
Scheme	  2.9	  
	  
The	   final	   step	   of	   the	   synthesis	   is	   the	   coupling	   of	   the	   acid	   chloride	   and	   the	  
sulfonamide	   as	   shown	   in	   Scheme	   2.8.	   The	   isolated	   yield	   for	   this	   step	   is	   a	  








The	   acylation	   of	   amides	   using	   acid	   chlorides	   is	   another	   reaction	   that	   generally	  
requires	   an	   activating	   agent.	   Since	   the	   previous	   effort	   with	   lithium	   iodide	   only	  
worked	  for	  acetyl	  chloride,	  an	  iodide	  source	  screen	  was	  carried	  out	  on	  the	  reaction	  
between	   p-­‐toluamide	   and	   benzoyl	   chloride.	   Amides	   are	   less	   nucleophilic	   than	  
sulfonamides	  owing	   to	   the	  better	  overlap	  of	  orbitals	  between	  the	   lone	  pair	  on	   the	  
nitrogen	  and	  π*	  (C=O)	  carbonyl	  carbon	  orbital.	  This	  orbital	  overlap	  stabilizes	  the	  lone	  














Entry	   Iodide	  sourcea	  	   Imide	  2.40	  conversionb	  (%)	  
1	   No	  Iodide	   4	  
2	   LiI	   10	  
3	   NaI	   18	  
4	   KI	   27	  
5	   RbI	   14	  
6	   CsI	   7	  
7	   NH4I	   19	  
8	   n-­‐Bu4NI	   10	  
Table	  2.16.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
Potassium	  iodide	  (Table	  2.16,	  entry	  4)	  showed	  the	  best	  activity,	  however,	  at	  50	  mol%	  
the	  conversion	   into	   imide	  2.40	   is	  only	  27%.	  The	  concentration	  of	  potassium	   iodide	  















Entry	   KI	  (mol%)a	  	   Imide	  2.40	  conversionb	  (%)	  
1	   0	   15	  
2	   1	   11	  
3	   2	   11	  
4	   5	   16	  
5	   10	   17	  
6	   20	   14	  
7	   30	   24	  
8	   40	   16	  
9	   50	   22	  
10	   60	   48	  
11	   70	   39	  
12	   80	   40	  
13	   90	   42	  
14	   100	   34	  
15	   150	   51	  
16	   200	   49	  
Table	  2.17.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
In	   a	   similar	   manner	   to	   sulfonamides	   the	   lowest	   mol%	   of	   potassium	   iodide	   that	  
achieves	   the	   best	   conversion	   into	   imide	   2.40	   is	   60	   mol%	   (Table	   2.17,	   entry	   10).	  
However,	   in	   contrast	   to	   sulfonamides	   an	   increase	   in	   potassium	   iodide	   is	   not	  
detrimental	  to	  the	  conversion	  into	  imide,	  although	  there	  is	  no	  significant	  increase	  in	  
conversion	   either.	   It	   was	   therefore	   necessary	   to	   look	   at	   other	   variables	   to	   try	   to	  




Increasing	  the	  temperature	  to	  115	  ˚C	  using	  butyronitrile	  as	  the	  solvent	  reduced	  the	  
conversion	  to	  18%,	  probably	  owing	  to	  either	  the	  dryness	  of	  solvent	  or	  the	  solubility	  
of	  potassium	  iodide.	  Having	  seen	  from	  the	  solvent	  screen	  in	  Table	  2.9	  that	  solubility	  
appears	  to	  be	  crucial	  to	  the	  iodide	  activation.	  
	  
Next	   the	   amount	   of	   acid	   chloride	  was	   increased,	   the	   aim	  being	   to	   try	   to	   generate	  
more	   of	   the	   suspected	   acid	   iodide	   intermediate,	   thereby	   increasing	   the	  












2.4 eq. 	  
Entry	   KIa	  (mol%)	  	   Imide	  2.40	  conversionb	  (%)	  
1	   0	   12	  
2	   60	   50	  
3	   120	   87	  
Table	  2.18.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  2.4	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
Although	   increasing	   the	  concentration	  of	  benzoyl	  chloride	   in	   itself	  did	  not	   increase	  
the	   conversion	   into	   imide	   2.40,	   when	   the	   concentration	   of	   potassium	   iodide	   is	  
doubled	  as	  well	   the	  conversion	   is	  87%	  (Table	  2.18,	  entry	  3).	   It	  was	  noted	  from	  the	  
results	   gathered	   so	   far	   that	   the	   best	   conversions,	   irrespective	   of	   nucleophile,	   are	  
obtained	  when	  the	  acid	  chloride	  to	  potassium	  iodide	  ratio	  is	  2:1.	  	  
	  
However,	  quantitative	  conversion	  could	  not	  be	  obtained	  for	  the	  acylation	  of	  amides.	  
In	  the	  1H	  NMR	  a	  side	  product	  was	  observed,	  upon	  careful	  analysis	  it	  was	  deduced	  to	  
be	  N-­‐acetylbenzamide	   (compound	  2.41).	   It	   is	   possible	   that	   the	   solvent	  MeCN	  was	  
Chapter	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acting	   as	   nucleophile	   that	   competes	   with	   p-­‐toluamide	   in	   this	   reaction	   in	   a	   ‘Ritter	  




















It	  was	  hypothesized	  that	  the	  nitrile	  attacks	  the	  extremely	  electrophilic	  benzoyl	  iodide	  
and	  that	  the	  workup	  procedure	  used	  might	  hydrolyze	  the	  intermediate	  and	  form	  N-­‐

















To	  confirm	  if	  Scheme	  2.11	  was	  a	  competing	  pathway	  in	  the	  acylation	  of	  amides,	  the	  






O Oi) KI (50 mol%),
   82 ˚C, 24 h
ii) H2O
2.411 eq. 1 eq. 	  
Scheme	  2.12	  
	  
After	  an	  aqueous	  workup,	  5%	  conversion	  into	  compound	  2.41	  is	  observed.	  This	  was	  
potentially	   sufficient	   to	   prevent	   quantitative	   acylation	   of	   amides.	   However,	   in	   the	  
presence	   of	   a	   better	   nucleophile,	   such	   as	   a	   sulfonamide,	   the	   competing	   pathway	  
appears	  to	  not	  be	  so	  much	  of	  a	  factor.	  Optimized	  conditions	  for	  potassium	  iodide	  are	  
1.2	   equivalents	   of	   potassium	   iodide	   and	   2.4	   equivalents	   of	   acid	   chloride,	  which	   is	  
required	   to	   push	   the	   acylation	   near	   to	   completion.	   The	   scope	   of	   the	   reaction	   is	  



















































































































Table	  2.19.	  aReactions	  were	  performed	  on	  a	  5	  mmol	  scale,	  using	  12	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
Table	  2.19	  shows	  that	  quantitative	  conversions	  can	  be	  obtained	  with	  most	  aromatic	  
acid	  chlorides,	  however,	   the	   factors	   that	  affect	  electrophilicity	  directly	   correlate	   to	  
the	   %	   conversion	   observed,	   for	   example	   the	   4-­‐methoxybenzoyl	   chloride	   is	   an	  
electron	  rich	  aromatic	  acid	  chloride	  and	  the	  electron	  density	   reduces	  the	  δ+	  on	  the	  
carbonyl	   carbon,	   hence	   reducing	   electrophilicity	   and	   the	  observed	  %	   conversion	   is	  
58%	   (Table	   2.19,	   entry	   5).	   Table	   2.20	   shows	   the	   varying	   the	   electronic	   and	   steric	  
nature	   of	   the	   nucleophile,	   the	   structure	   of	   the	   imide	   product	   means	   that	   either	  





















































































Table	  2.20.	  aReactions	  were	  performed	  on	  a	  5	  mmol	  scale,	  using	  12	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
Table	  2.19	  &	  2.20	  taken	  together	  show	  that	  the	  electrophilicity	  of	  the	  acid	  chloride	  is	  
seen	  to	  determine	  the	  %	  conversion	  that	  can	  be	  achieved.	  Table	  2.20	  shows	  that	  the	  
electronic	  and	  steric	  nature	  of	  the	  nucleophile	  has	  little	  effect	  on	  the	  %	  conversion	  
observed.	  The	  range	  of	  %	  conversions	  is	  only	  66-­‐80%.	  Whereas	  in	  contrast	  when	  the	  
electrophile	   is	   varied	   a	   range	   of	  %	   conversions	   of	   48-­‐100%	   is	   observed.	   This	   is	   an	  
indicator	   that	   the	   nature	   of	   the	   electrophile	   is	   possibly	   important	   to	   the	   rate-­‐
determining	   step	   in	   the	   reaction.	   This	  might	   indicate	   that	   if	   the	   formation	   of	   acid	  
iodide	  is	  in	  the	  reaction	  pathway	  then	  the	  formation	  of	  acid	  iodide	  might	  be	  the	  rate	  




2.3.3	  Other	  nucleophiles	  
Other	  nucleophiles	  are	  now	  considered	  using	  the	  optimized	  conditions	  for	  potassium	  
iodide.	   BHT	   is	   added	   to	   various	   acid	   chlorides	   and	   the	   results	   are	   summarized	   in	  
Table	  2.21.	  2.4	  equivalents	  of	  acid	  chloride	  and	  1.2	  equivalents	  of	  potassium	  iodide	  
are	  required	  to	  achieve	  the	  isolated	  yields,	  this	  probably	  owing,	  as	  discussed	  in	  the	  
amide	   section,	   to	   the	   increased	   amount	   of	   in	   situ	   acid	   iodide	   generated	   providing	  




















































Table	  2.21.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale,	  using	  7.2	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
solvent.	  bIsolated	  yields,	  products	  purified	  by	  column	  chromatography.	  	  
Chapter	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Benzoyl	  chloride	  (Table	  2.21,	  entry	  3)	  and	  pivaloyl	  chloride	  (Table	  2.21,	  entry	  4)	  are	  
poorer	  electrophiles	  than	  the	  simple	  aliphatic	  acid	  chlorides	  and	  as	  such	  the	  isolated	  
yields	  shown	  in	  Table	  2.21	  follow	  the	  expected	  trend	  of	  reactivity.	  
	  
Friedel-­‐Crafts	   C-­‐acylation	   of	   aromatic	   compounds	   was	   also	   investigated	   and	   the	  
results	  are	  shown	  in	  Table	  2.22.	  Electron	  rich	  aromatic	  compounds	  are	  necessary	  for	  
acylation	  to	  occur,	  however	  there	  is	  evidence	  of	  potassium	  iodide	  activation	  over	  the	  
background	  rate	  as	  shown	  here	  (Table	  2.22,	  entry	  4).	  
	  
EDG+ MeCN 82 ˚C
24 h

















































Table	  2.22.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale,	  using	  7.2	  mmol	  of	  acid	  chloride	  in	  3	  mL	  
solvent.	   bIsolated	   yields,	   products	   purified	   by	   column	   chromatography.	   cConversion	   determined	   by	  





2.4	  Mechanistic	  investigations	  
	  
13C	   NMR	   experiments	   were	   carried	   out	   to	   provide	   insight	   into	   the	   mechanism	   of	  
potassium	  and	  lithium	  iodide	  activation	  of	  acid	  chlorides.	  
	  
O








The	  reaction	  between	  p-­‐toluenesulfonamide	  and	  benzoyl	  chloride	  with	  and	  without	  
potassium	  iodide	  was	  followed	  by	  NMR	  analysis	  using	  CD3CN	  as	  the	  solvent,	  Scheme	  
2.13.	  The	  reaction	  was	  run	  at	  a	  temperature	  of	  70	  ˚C	  because	  heating	  the	  solvent	  to	  
reflux	  could	  be	  damaging	  to	  the	  NMR	  machine.	  Therefore	  the	  following	  data	  are	  not	  
truly	  representative	  of	  the	  experimental	  observations	  that	  would	  be	  obtained	  at	  82	  
˚C.	  However,	  the	  13C	  NMR	  experiments	  allow	  us	  to	  follow	  the	  course	  of	  the	  reaction	  
and	  potentially	  observe	  any	  intermediates	  in	  the	  process.	  
	  
Initially	  potassium	  iodide	  was	  added	  to	  an	  NMR	  tube	  and	  dissolved	  in	  CD3CN	  and	  the	  
NMR	  probe	  pre-­‐warmed	  to	  70	  ˚C.	  Benzoyl	  chloride	  is	  then	  added	  and	  the	  NMR	  tube	  
quickly	  returned	  to	  the	  NMR	  machine	  and	  spectra	  were	  taken	  every	  20	  minutes	  for	  
the	  next	  24	  hours.	  This	  experiment	  is	  designed	  to	  see	  if	  benzoyl	  iodide	  is	  formed	   in	  
situ	   in	   the	   absence	   of	   a	   nucleophile.	   From	   the	   literature	   it	   is	   known	   that	   the	   13C	  
carbonyl	  shift	  in	  benzoyl	  iodide	  occurs	  at	  159.6	  ppm,	  which	  compares	  with	  a	  shift	  of	  
168.6	  ppm	  for	  benzoyl	  chloride.100	  	  
	  
It	   was	   pleasing	   that	   a	   peak	   at	   159.6	   ppm	   appeared	   during	   the	   course	   of	   the	  
experiment.	  Since	  the	  amount	  of	  material	  in	  the	  NMR	  tube	  is	  finite	  it	  is	  possible	  that	  
a	  relative	  integration	  of	  the	  13C	  NMR	  spectrum	  could	  be	  used	  to	  estimate	  the	  relative	  




The	   following	   graph	   shows	   the	  progress	   of	   the	   reaction	  described	   and	  depicts	   the	  
formation	  of	  benzoyl	  iodide	  with	  time.	  Given	  the	  apparent	  error	  with	  %	  conversions	  
only	  qualitative	   information	  can	   reliably	  be	   taken	   from	   the	  graph,	  however,	   it	  was	  
approximated	   that	   an	   equilibrium	  between	   benzoyl	   iodide	   and	   benzoyl	   chloride	   is	  
established	   within	   the	   first	   few	   hours	   of	   the	   reaction	   and	   that	   ~20%	   is	   the	  






Figure	   2.2	   shows	   the	   initial	   and	   final	   13C	  NMR	   spectra	   for	   the	   reaction	   detailed	   in	  
Scheme	  2.13,	  they	  correspond	  to	  the	  first	  and	  last	  point	  on	  the	  graph	  in	  Figure	  2.1.	  
The	   spectra	   clearly	   demonstrate	   the	   absence	   and	   presence	   of	   the	   benzoyl	   iodide	  
carbonyl	   carbon	   peak	   at	   159.6	   ppm.	   Spectrum	   2	   is	   the	   initial	   13C	   NMR	   at	   t	   =	   0,	  





Figure	  2.2	  	  
	  
The	   appearance	   of	   the	   peak	   at	   159.6	   ppm	   in	   the	   13C	  NMR	   spectrum	   supports	   the	  
idea	  that	  the	  acid	  iodide	  is	  the	  intermediate	  in	  the	  reaction.	  	  
	  
In	  order	  to	  determine	  if	  the	  formation	  of	  acid	  iodide	  caused	  the	  increase	  in	  reactivity	  
a	  further	  13C	  NMR	  experiment	  was	  carried	  out,	  using	  tetrabutylammonium	  iodide	  as	  
the	   iodide	   source.	  Analysis	  of	   the	   13C	  NMR	  spectra	   showed	   that	  no	  benzoyl	   iodide	  
formed	   in	   situ,	  with	   only	   benzoyl	   chloride	  being	  detected.	   It	  was	   seen	   earlier	   that	  
tetrabutylammonium	   iodide	  gave	  10%	  conversion	   (Table	  2.11,	  entry	  8)	   into	   the	  N-­‐
acylsulfonamide	   product,	   compared	   with	   potassium	   iodide,	   which	   gave	   69%	  
conversion	   (Table	   2.11,	   entry	   4).	   It	   was	   therefore	   assumed	   that	   potassium	   is	  







Other	  potassium	  and	  sodium	  salts	  are	  considered	  to	  see	   if	  acid	   iodide	  formation	   is	  

















Entry	   Salta	  	   N-­‐Acylsulfonamide	  2.10	  conversionb	  (%)	  
1	   No	  salt	   7	  
2	   KI	   72	  
3	   KBr	   44	  
4	   KCl	   8	  
5	   NaCl	   41	  
Table	  2.23.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  
	  
The	  trend	  down	  the	  halogen	  series	  shows	  that	  the	  halogen	  component	  is	  important	  
in	   the	  mechanism	  of	   this	   reaction.	   This	   suggests	   that	   the	   reaction	   is	   not	  occurring	  
purely	  by	  a	  Lewis	  acid	  mechanism.	  	  
	  
To	   reinforce	   that	   the	   reaction	   is	   not	   proceeding	   via	   a	   Lewis	   acid	   mechanism,	   p-­‐
toluenesulfonamide	  and	  benzoyl	  chloride	  were	  reacted	  using	  potassium	  iodide	  in	  the	  
presence	  of	  crown	  ethers	  known	  to	  sequester	  the	  potassium	  ion,	  thereby	  eliminating	  
the	  Lewis	  acid	  mechanism	  pathway.101	  	  
	  
The	  results	  show	  that	  potassium	  is	  successfully	  sequestered	  by	  both	  15-­‐crown-­‐5	  and	  
18-­‐crown-­‐6	  ether.	  A	   13C	  NMR	  experiment	  using	  benzoyl	   chloride,	  potassium	   iodide	  
and	  the	  crown	  ethers	  was	  also	  carried	  out	  and	  in	  the	  absence	  of	  a	  nucleophile	  only	  
benzoyl	   chloride	   could	   be	   observed,	   no	   benzoyl	   iodide	  was	   formed.	   This	   indicates	  
that	   potassium	   is	   important	   in	   the	   formation	   of	   the	   acid	   iodide	   and	   in	   turn	   the	  














Entry	   Conditionsa	  	   N-­‐Acylsulfonamide	  2.10	  
conversionb	  (%)	  
1	   No	  salt	   13	  
2	   KI	  (60	  mol%)	   100	  
3	   KI	  (60	  mol%)	  &	  15-­‐Crown-­‐5	  	  etherc	   8	  
4	   KI	  (60	  mol%)	  &	  18-­‐Crown-­‐6	  	  etherc	   7	  
Table	  2.24.	  a	  Reactions	  were	  performed	  on	  a	  1	  mmol	  scale,	  using	  1.2	  mmol	  of	  acid	  chloride	  in	  1	  mL	  
solvent.	   bConversions	   determined	  by	   analysis	   of	   the	   1H	  NMR	   spectra	   using	   2,5-­‐dimethylfuran	   as	   an	  
internal	  standard.	  c2.2	  equivalents	  of	  crown	  ether	  are	  used	  relative	  to	  KI,	  therefore	  1.32	  mmol.	  
	  
The	   formation	   of	   acid	   iodide	   would	   enhance	   reactivity	   since	   acid	   iodides	   are	  
considerably	  more	   reactive	   than	  acid	  chlorides.	  Given	   the	  greater	  electronegativity	  
of	  chlorine	  over	  iodine	  it	  is	  not	  necessarily	  obvious	  why	  the	  acid	  iodide	  is	  inherently	  
more	  reactive.	  It	  is	  reasonable	  to	  suggest	  that	  the	  acid	  iodide	  is	  more	  reactive	  owing	  
to	  its	  greater	  polarizability	  and	  the	  fact	  that	  the	  lone	  pairs	  on	  the	  iodine	  are	  less	  able	  
to	  overlap	  with	  π*	  (C=O).	  
	  
In	  order	  to	  confirm	  the	  increased	  reactivity	  of	  an	  acid	  iodide	  over	  the	  acid	  chloride	  a	  
competition	   experiment	   was	   carried	   out	   in	   an	   NMR	   machine.	   First	   the	   reaction	  
shown	   in	   Scheme	   2.13	  was	   repeated.	   The	   acid	   chloride	   to	   acid	   iodide	   equilibrium	  
was	  established,	  by	  heating	  the	  mixture	  for	  three	  hours,	  13C	  NMR	  spectra	  are	  taken	  
to	  confirm	  the	  presence	  of	  benzoyl	  iodide,	  ~20%.	  	  
	  
Secondly	   the	   NMR	   tube	   was	   removed	   from	   the	   NMR	   machine	   and	   20	   mol%	  
benzylamine,	  a	  relatively	  good	  nucleophile,	  was	  added.	  The	  tube	  was	  returned	  to	  the	  
machine	  and	  a	  spectrum	  taken	   immediately.	  The	  spectrum	  showed	  that	   there	  was	  
no	  benzoyl	  iodide	  present,	  only	  benzoyl	  chloride,	  it	  also	  confirmed	  the	  formation	  of	  
N-­‐benzylbenzamide	   as	   expected.	   This	   implies	   that	   benzoyl	   iodide	   reacts	  
preferentially	  with	  nucleophilic	  benzylamine.	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The	   final	   13C	   NMR	   experiment	   carried	   out	   was	   to	   see	   if	   benzoyl	   iodide	   could	   be	  


















For	   the	   first	   24	   hours	   of	   the	   reaction,	   Scheme	   2.14,	   no	   benzoyl	   iodide	   peak	   was	  
observed,	   however	   the	   reaction	   was	   followed	   for	   several	   hours	   after	   all	   the	  
sulfonamide	  had	  been	  acylated.	  Given	  that	  an	  excess	  of	  benzoyl	  chloride	   is	  used	  in	  
the	  reaction	  (1.2	  eq.)	  it	  was	  no	  surprise	  that	  after	  three	  hours	  benzoyl	  iodide	  could	  
be	   observed	   in	   the	  NMR	   spectra.	   This	   implied	   that	   as	   soon	   as	   benzoyl	   iodide	  was	  
formed	  it	  underwent	  nucleophilic	  attack	  from	  the	  sulfonamide.	  	  
	  
It	  seems	  reasonable	  to	  conclude	  that	  the	  rate	  determining	  step	  is	  the	  slow	  formation	  
of	  acid	  iodide	  by	  reaction	  of	  acid	  chloride	  with	  potassium	  iodide.	  Although	  iodide	  is	  
an	   excellent	   nucleophile	   in	   SN2	   reactions,	   this	   is	   not	   the	   case	   for	   addition	   to	   the	  
carbonyl	   group.	   The	   difference	   has	   been	   attributed	   to	   the	   hard	   nature	   of	   a	   sp2	  
carbonyl	   carbon	   compared	   with	   the	   relatively	   soft	   nature	   of	   the	   sp3	   carbon,	  















A	  synthetically	  useful	  approach	  to	  activating	  acid	  chlorides	  via	  a	  proposed	  in	  situ	  acid	  
iodide	   intermediate	   has	   been	   developed,	   using	   readily	   available	   sodium	   or	  
potassium	   iodide.	   This	   has	   allowed	   poor	   nucleophiles	   to	   be	   acylated	   in	   good	   to	  
excellent	  yields,	  sometimes	  using	  a	  substoichiometric	  amount	  of	  a	  group	  I	  iodide.	  
	  
The	  mechanism	  of	   iodide	  activated	  acylations	  has	  been	  investigated	  using	  13C	  NMR	  
experiments.	  It	  has	  bee	  demonstrated	  that	  the	  acid	  iodide	  formation	  is	  probably	  the	  
rate	  determining	  step	  and	  that	  potassium	  is	  essential	  for	  the	  formation	  of	  acid	  iodide	  
























2.6	  Future	  work	  
	  
Many	   other	   nucleophiles	   could	   be	   considered.	   Hindered	   anilines	   should	   be	  
investigated,	  owing	  to	  the	  industrial	  importance	  of	  the	  amide	  products.	  Two	  further	  
reactions	  were	  investigated	  in	  this	  work,	  however	  insufficient	  work	  has	  been	  carried	  






















Phosphoramidates	   are	   relatively	   poor	   nitrogen	   nucleophiles,	   for	   similar	   reasons	   to	  
sulfonamides,	  therefore	  the	  difference	  between	  the	  potassium	  iodide	  activated	  and	  
the	  unactivated	  conversion	  into	  compound	  2.62	  warrants	  further	  investigation.	  
	  
The	  nickel	  catalyzed,	  cross	  coupling	  of	  acid	  chloride	  and	  benzyl	  chloride	  has	  recently	  
been	   investigated	   by	   the	   Reisman	   group.103	   It	   is	   proposed	   that	   the	   use	   of	   the	  
Reisman	  group’s	  conditions	  with	  the	  addition	  of	  potassium	  iodide	  might	  enhance	  the	  
rate	   of	   this	   reaction.	   The	   existing	   method	   takes	   24	   hours	   to	   achieve	   quantitative	  
conversion.	   The	   addition	   of	   potassium	   iodide	   reduced	   the	   reaction	   time	   to	   just	   1	  
hour.	   It	   was	   assumed	   that	   the	   rate	   enhancement	   came	   from	   the	   SN2	   reaction	   of	  
iodide	  with	   benzyl	   chloride	   thereby	   improving	   the	   oxidative	   addition	   to	   the	   nickel	  
complex	  in	  the	  cross	  coupling	  mechanism.	  However,	  further	  investigations	  could	  be	  
carried	   out	   to	   determine	   if	   this	   is	   indeed	   the	   case	   or	   if	   benzoyl	   iodide	   is	   actually	  







Mn(0) (3 eq,), 3 Å M.S.
DMA, r.t., 1 h
2.62











Results	  and	  Discussion	  II	  
	  
Asymmetric	  Transfer	  
Hydrogenation	  (ATH)	  using	  1,4-­‐
butanediol	  or	  cis-­‐1,4-­‐butenediol	  as	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Asymmetric	  Transfer	  Hydrogenation	  (ATH)	  using	  1,4-­‐butanediol	  or	  cis-­‐1,4-­‐
butenediol	  as	  a	  Hydrogen	  Source	  
Chapter	  3:	  Results	  and	  Discussion	  II	  
3.1	  Aims	  
The	  aim	  of	  this	  work	  was	  to	  investigate	  the	  use	  of	  alternative	  hydrogen	  sources	  for	  





r.t. 15 h 	  
Scheme	  3.1104	  
	  
The	   reaction	  shown	   in	  Scheme	  3.1	  was	  part	  of	  Noyori’s	  earliest	  work	   into	  catalytic	  
asymmetric	  transfer	  hydrogenation.	  This	  reaction	  used	  IPA	  as	  the	  hydrogen	  source.	  
However,	   for	   every	   molecule	   of	   IPA	   that	   was	   oxidized	   to	   acetone,	   a	   ketone	   was	  
produced	   that	   more	   easily	   reduced	   by	   the	   catalyst	   than	   the	   substrate	   ketone.	  
Therefore	  a	   large	  excess	  of	   IPA	  was	  used	  to	  drive	   the	  reaction	  near	  completion.	   In	  
the	  reaction	  shown	  in	  Scheme	  3.1	  the	  ruthenium	  pre-­‐catalyst,	   ligand	  ((S,S)-­‐TsDpen)	  
and	  IPA	  were	  initially	  heated	  to	  80	  ˚C	  to	  form	  the	  active	  catalyst	  before	  the	  substrate	  
ketone	  was	  added	  diluted	  in	  IPA.	  	  
	  
Previous	  work	   in	   the	   group	  has	   shown	  1,4-­‐butanediol	   to	  be	   an	  effective	  hydrogen	  
source,105	   the	  mechanism	   for	   this	  will	   be	   discussed	   later	   in	   the	   chapter.	  However,	  
optimizing	   the	   reaction	   for	   the	   asymmetric	   reduction	   of	   ketones	   had	   not	   been	  
possible.	  Previously	  only	  high	  yield	  with	   low	  enantiomeric	  excess	  or	   low	  yield	  with	  
high	  enantiomeric	  excess,	  has	  been	  achieved.	  
	  
O OH[Ru(p-cymene)Cl2]2 (1 mol%)
1,4-butanediol (1 eq.)
(S,S)-TsDpen (4 mol%)
KOH (8 mol%), 72 h, r.t.
24% conversion




Further	  investigations	  into	  this	  reaction	  were	  undertaken	  and	  form	  the	  basis	  of	  this	  
work.	  
	  
3.2	  Initial	  work	  
	  
Initially	   similar	   conditions	   to	   those	   shown	   in	   Scheme	   3.2	   were	   taken.	   It	   was	   of	  
interest	  to	  determine	  if	  the	  use	  of	  solvent	  would	  increase	  the	  conversion	  and	  retain	  
the	  selectivity	  previously	  observed.	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen  (5 mol%)
Cs2CO3 (10 mol%)
Solvent, 24 h, 30 ˚C 3.1 	  
Entry	   Solventa	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   DCM	   45(91)	  
2	   THF	   38(>99)	  
3	   Et2O	   49(89)	  
4	   PhMe	   52(>99)	  
5	   MeCN	   46(90)	  
6	   Hexane	   31(89)	  
7	   tBuOH	   17(97)	  
Table	  3.1.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  1	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	   the	   1H	  NMR	  spectra.	   cEnantiomeric	  excess	   calculated	  using	  HPLC	  after	  purification	  by	  
column	  chromatography.	  
	  
It	  was	  found	  that	  PhMe	  provided	  the	  best	  result	  under	  these	  conditions	  (Table	  3.1,	  
entry	   4).	   The	   catalyst	   and	   ligand	   loading	   were	   considered,	   using	   toluene	   as	   the	  
solvent,	   with	   the	   intention	   of	   increasing	   the	   %	   conversion	   into	   alcohol	   3.1	   whilst	  










PhMe, 24 h, 30 ˚C 3.1 	  
Entry	   Catalysta	  (mol%)	   Ligandb	  (mol%)	   Alcohol	  3.1	  %	  conversionc	  (%	  e.e.)d	  
1	   1	   1	   58(92)	  
2	   1	   2	   43(92)	  
3	   2	   2	   61(81)	  
4	   2	   4	   41(93)	  
5	   3	   3	   44(89)	  
6	   3	   6	   53(89)	  
7	   4	   4	   39(91)	  
8	   4	   8	   56(84)	  
9	   5	   5	   27(95)	  
10	   5	   10	   32(94)	  
Table	   3.2.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   1	   mL	   solvent,	   catalyst	   is	   [Ru(p-­‐
cymene)Cl2]2.	  
bLigand	   is	   (S,S)-­‐TsDpen	  .	   cConversions	   determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	  
dEnantiomeric	  excess	  calculated	  using	  HPLC	  after	  purification	  by	  column	  chromatography.	  
	  
The	   results	   in	   Table	   3.2	   showed	   that	   the	   amount	   of	   catalyst	   and	   ligand	   has	   little	  
effect	   on	   the	   overall	   conversion	   and	   enantioselectivity.	   This	   was	   counter-­‐intuitive	  
and	  indicated	  that	  there	  might	  have	  been	  an	  issue	  with	  obtaining	  consistent	  results.	  
	  
Further	   inconsistencies	   were	   observed	   when	   the	   reaction	   time	   and	   temperature	  
were	  varied.	  When	  the	  temperature	  was	  reduced	  to	  30	  ˚C	  the	  conversion	  over	  72	  h	  
was	  56%	   in	  0.25	  mL	  of	   solvent	  and	  58%	   in	  1	  mL	  solvent	   (Table	  3.3,	  entries	  6	  &	  7).	  
Two	  other	  experiments	  were	  also	   run	  with	  0.5	  &	  0.75	  mL	  of	   solvent	  however	  <5%	  
conversion	  was	  obtained.	  It	  was	  deduced	  that	  the	  careful	  mixing	  of	  the	  reagents	  was	  
necessary	  for	  the	  reaction	  to	  proceed	  and	  as	  such	  the	  conversions	  obtained	  thus	  far	  
were	  unreliable.	  Table	  3.3	  also	  shows	  that	  after	  24	  h	  at	  40	  ˚C	  the	  reaction	  proceeds	  
to	   72%	   conversion	  however	   the	   enantioselectivity	  was	   reduced	   to	   72%	  e.e.	   (Table	  
3.3,	  entry	  5)	  indicating	  that	  extended	  reaction	  times	  led	  to	  reduced	  e.e.	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O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen (5 mol%)
Cs2CO3 (10 mol%), PhMe
3.1 	  
Entry	   Timea	  (h)	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   1	   32(>99)	  
2	   1d	   41(>99)	  
3	   2	   48(>99)	  
4	   4	   29(95)	  
5	   24	   72(72)	  
6	   72e	   58(>99)	  
7	   72e,f	   56(>99)	  
Table	   3.3.	   aReactions	  were	   performed	  on	   a	   1	  mmol	   scale	   in	   1	  mL	   solvent	   at	   40	   ˚C.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	  
purification	  by	  column	  chromatography.	  dReaction	  performed	  at	  50	  ˚C.	  eReaction	  performed	  at	  30	  ˚C.	  
fReaction	  perfomed	  on	  a	  1	  mmol	  scale	  in	  0.25	  mL	  solvent.	  
	  
The	  erratic	  results	  obtained	  were	  attributed	  to	  mixing	  issues	  possibly	  caused	  by	  the	  
viscosity	  of	  1,4-­‐butanediol.	  The	  careful	  addition	  of	  reagents	  and	  the	  use	  of	  identical	  
stirrer	  bars,	   that	  were	  tested	  to	  check	  that	  mixing	  of	   the	  reagents	  was	  good,	  were	  
used	  in	  subsequent	  experiments.	  
	  
Next	  the	  choice	  of	  base	  was	  investigated,	  the	  role	  of	  base	  is	  to	  activate	  the	  catalyst	  
as	  shown	  in	  Scheme	  3.3.	  The	  pre-­‐catalyst	  3.2	  is	  activated	  to	  the	  true	  catalyst	  3.3	  by	  












Focusing	  on	  the	  %	  conversion,	  DBU	  gave	  a	  conversion	  of	  21%	  and	  KOtBu	  gave	  29%	  so	  
they	   showed	   no	   improvement	   over	   Cs2CO3.	   Next	   the	   use	   of	   sodium	   hydride	   was	  
tested	   and	   the	   pre-­‐catalyst	   formation	   before	   addition	   of	   the	   substrates	   was	  
attempted	  but	  this	  resulted	  in	  no	  conversion.	  
	  
It	  was	  hypothesized	  that	  the	  solubility	  of	  base	  in	  toluene	  might	  be	  causing	  an	  issue	  
with	  the	  activation	  of	  the	  catalyst,	  which,	  in	  turn	  resulted	  in	  lower	  conversions.	  Since	  
it	  had	  previously	  been	  seen	  that	  THF	  could	  be	  a	  good	  alternative	  to	  toluene	  (Table	  
3.1,	   entry	   2)	   THF	   was	   investigated	   further.	   The	   main	   advantage	   of	   THF	   was	   its	  
miscibility	   with	   water,	   which	   allowed	   the	   base	   to	   dissolve	   in	   a	   THF	   water	   mix,	  
resulting	   in	   a	   homogeneous	   solution.	   A	   screen	   bases	   was	   carried	   out	   in	   the	   9:1	  
THF/H2O	  solvent,	  shown	  in	  Table	  3.4.	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen (5 mol%)
Base (10 mol%), 30 ˚C, 1 h
THF/H2O (9:1) 3.1 	  
Entry	   Basea	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   K2CO3	   26(95)	  
2	   LiOH	   21(>99)	  
3	   NaOH	   49(89)	  
4	   KOH	   36(>99)	  
Table	   3.4.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	  
purification	  by	  column	  chromatography.	  	  
	  
It	   was	   hoped	   that	   the	   homogeneous	   solution,	   careful	   addition	   of	   reagents	   and	  
careful	   selection	   of	   stirrer	   bar	   would	   provide	  more	   consistent	   results.	   The	   results	  
show	  that	  the	  best	  base	  for	  activation	  of	  the	  catalyst	  was	  KOH	  (Table	  3.4,	  entry	  4).	  
However,	   when	   it	   was	   carried	   out	   three	   similtaneous	   reactions	   with	   identical	  




O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen (5 mol%)
KOH (10 mol%), 30 ˚C
THF/H2O (9:1), 1 h 3.1 	  
Entrya	   Alcohol	  3.1	  %	  conversionb	  	  
1	   22(32)	  
2	   13(29)	  
3	   11(5)	  
Table	   3.5.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra	   from	   a	   sample	   of	   the	   reaction	   mixture,	   figures	   in	  
parenthesis	  are	  conversions	  determined	  after	  2	  h	  reaction	  time.	  	  
	  
The	  results	  showed	  that	  unless	  the	  mixing	  of	  reagents	  is	  perfect	  then	  the	  reduction	  
can	  fail	  to	  start	  as	  in	  the	  case	  of	  entry	  3,	  Table	  3.5.	  	  
	  
The	   amount	   of	   base	   to	   optimize	   the	   reaction	   further	   was	   investigated.	   Noyori’s	  
system	  required	  5	  equivalents	  of	  base	  to	  ruthenium.	  It	  was	  observed	  that	  30	  mol%	  















O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen (5 mol%)
KOH (10 mol%), 30 ˚C
THF/H2O (9:1), 1 h 3.1 	  
Entry	   KOHa	  (mol%)	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   5	   7(-­‐)	  
2	   10	   32(94)	  
3	   20	   28(>99)	  
4	   30	   37(>99)	  
5	   40	   38(92)	  
6	   50	   27(>99)	  
7	   110	   31(>99)	  
Table	   3.6.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	  
purification	  by	  column	  chromatography.	  	  
	  
Raising	   the	   amount	   of	   1,4-­‐butanediol	   was	   investigated	   to	   increase	   the	   amount	   of	  
available	   hydrogen	   to	   try	   to	   increase	   the	   reduction	   of	   the	   acetophenone	   into	   1-­‐
phenylethanol	  3.1.	  	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol
(S,S)-TsDpen (5 mol%)
KOH (30 mol%), 30 ˚C
THF/H2O (9:1), 1 h 3.1 	  
Entry	   1,4-­‐butanediola	  (eq.)	   Alcohol	  3.1	  %	  conversionb	  	  
1	   2	   46	  
2	   3	   52	  
3	   4	   53	  
4	   5	   53	  
5	   10	   49	  
Table	   3.7.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  




The	   results	   in	   Table	   3.7	   show	   that	   increasing	   the	   amount	   of	   hydrogen	   source	  
available	   does	  not	   alter	   the	   rate	  of	   reduction	  of	   ketone.	   Below	   in	   Scheme	  3.4	   the	  









3.4 3.5 3.6 	  
Scheme	  3.4	  
	  
The	  advantage	  of	  using	  1,4-­‐butanediol	  over	   IPA	  should	  be	  the	  final	   irrevesible	  step	  
which	   means	   that	   the	   γ-­‐butyrolactone	   product	   3.6	   is	   stable	   with	   respect	   to	   the	  
reverse	  reduction	  step.	  This	  eliminates	  the	  equilibrium	  problem	  associated	  with	  IPA.	  
However,	  from	  the	  results	  it	  was	  seen	  that	  the	  use	  of	  0.5	  equivalents	  1,4-­‐butanediol	  
has	   not	   resulted	   in	   quantitative	   conversion	   as	   the	   theory	   suggests	   it	   should.	  
Therefore	  the	  reduction	  of	  acetophenone	  in	  the	  presence	  of	  half	  an	  equivalent	  of	  γ-­‐
butyrolactone	  was	  tested.	  The	  conversion	  of	  acetophenone	  into	  alcohol	  3.1	  was	  shut	  
down	   in	  the	  presence	  of	  the	   lactone.	  Therefore	  the	   lactone	  product	  3.6	   formed	  by	  
the	  oxidation	  of	  1,4-­‐butanediol	  and	  subsequent	  oxidation	  of	  lactol	  3.5	  poisoned	  the	  
catalyst.	   Therefore	   as	   the	   reaction	   progressed	   the	   turnover	   of	   the	   catalyst	   was	  
retarded	  and	  full	  reduction	  of	  acetophenone	  was	  not	  possible.	  
	  
Interestingly	  because	  KOH	  was	  used	  as	  the	  base	  to	  activate	  the	  ruthenium	  catalyst	  
3.2,	   the	   hydroxide	   ion	   would	   be	   able	   to	   ring	   open	   γ-­‐butyrolactone	   to	   form	   the	  
corresponding	  4-­‐hydroxybutyric	  acid.	  Therefore	  the	  reaction	  was	  carried	  out	   in	  the	  
presence	  of	  a	  greater	  amount	  of	  KOH	  to	  try	  to	  prevent	  the	  lactone	  product	  poisoning	  
the	  catalyst.	  However,	  this	  did	  not	  improve	  the	  conversion	  into	  alcohol	  3.1.	  	  
	  
Therefore	  different	  ligands	  were	  looked	  at	  to	  see	  the	  effect	  they	  had	  on	  the	  reaction	  
and	   to	   try	   to	   form	   an	   active	   catalyst	   that	  was	   less	   suceptible	   to	   poisoning	   by	   the	  
lactone	  product	  formed.	  The	  results	  are	  summarized	  in	  Table	  3.7.	  At	  this	  stage	  only	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%	  conversion	  was	  considered	   to	   try	   to	   focus	  on	  optimizing	   the	   reaction	   to	  achieve	  




















The	   diamine,	   bisoxazoline	   and	   aminoalcohol	   ligands	   were	   considered,	   phosphine	  
based	  ligands	  were	  not	  investigated	  and	  this	  may	  be	  an	  area	  for	  future	  work.	  	  
	  
O OH[Ru(p-cymene)Cl2]2 (15 mol%)
1,4-butanediol (0.5 eq.)
Ligand (15 mol%)
KOH (1.1 eq.), 30 ˚C
THF/H2O (9:1), 1 h 3.1 	  
Entry	   Liganda	  	   Alcohol	  3.1	  %	  conversionb	  	  
1	   L1	   5	  
2	   L2	   35	  
3	   L3	   76	  
4	   L4	   10	  
Table	   3.8.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  
determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
The	  aminoindanol	  ligand	  showed	  the	  best	  reduction	  of	  the	  ketone	  (Table	  3.8,	  entry	  




The	   effect	   of	   increasing	   the	   amount	   of	   base	   further	  was	   investigated,	   using	  more	  
than	  1.1	  equivalents	  to	  see	  what	  effect	  that	  had	  on	  the	  reduction	  of	  the	  ketone.	  
	  
O OH[Ru(p-cymene)Cl2]2 (15 mol%)
1,4-butanediol (0.5 eq.)
L3 (15 mol%), KOH, 30 ˚C
THF/H2O (9:1), 1 h
3.1 	  
Entry	   KOHa	  (eq.)	   Alcohol	  3.1	  %	  conversionb	  
1	   1.2	   73	  
2	   1.3	   69	  
3	   1.4	   70	  
4	   1.5	   76	  
5	   1.6	   69	  
6	   1.7	   71	  
7	   1.8	   70	  
Table	   3.9.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.5	   mL	   solvent.	   bConversions	  
determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
The	  results	  in	  Table	  3.9	  show	  that	  the	  amount	  of	  KOH	  above	  1.1	  equivalents	  has	  no	  
effect	  on	  the	  reduction	  of	  ketone	  to	  alcohol	  3.1.	  Therefore	  increasing	  the	  amount	  of	  
1,4-­‐butanediol	  was	  considered.	  When	  1	  equivalent	  of	  1,4	  butanediol	  was	  used	  and	  
the	   temperature	   was	   raised	   to	   50	   ˚C,	   94%	   conversion	   into	   3.1	  was	   observed.	   15	  
mol%	   ruthenium	   was	   used,	   which	   was	   a	   large	   amount	   of	   ruthenium	   to	   use	   and	  
reactions	  on	  any	  scale	  bigger	  than	  a	  few	  mmol	  would	  be	  very	  expensive.	  However,	  it	  




L3, KOH (1.1 eq.), 30 ˚C
THF/H2O (9:1), 1 h
3.1
Conversion into 3.1
5 mol% Ru, L3   = 31% 






However,	  as	  shown	  in	  Scheme	  3.6	  lowering	  the	  temperature	  reduced	  the	  conversion	  
from	   94%	   to	   76%	   and	   lowering	   the	   amount	   of	   catalyst	   and	   ligand	   reduced	   the	  
conversion	  further	  still	  to	  31%.	  	  
	  
Next	   a	   small	   changes	   in	   the	   amount	   of	   ligand,	   L3	   was	   considered,	   with	   5	   mol%	  
ruthenium	  and	  in	  the	  absence	  of	  solvent.	  It	  was	  observed	  that	  6.25	  mol%	  L3	  (Table	  
3.10,	  entry	  5)	  showed	  the	  best	  %	  conversion	  obtained	  so	  far.	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (1.1 eq.)
L3, KOH (1.1 eq.), 50 ˚C, 1 h
3.1 	  
Entry	   L3a	  (mol%)	   Alcohol	  3.1	  %	  conversionb	  
1	   1.25	   47	  
2	   2.50	   58	  
3	   3.75	   43	  
4	   5.00	   92	  
5	   6.25	   95	  
6	   7.50	   92	  
Table	  3.10.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale.	  bConversions	  determined	  by	  analysis	  of	  
the	  1H	  NMR	  spectra.	  	  
	  
With	  hindsight	  however,	  it	  was	  not	  sensible	  to	  only	  focus	  on	  the	  %	  conversion	  since	  
when	  the	  enantiomeric	  excess	  of	  entry	  5,	  Table	  3.10	  was	  determined	   it	  was	   found	  
the	  alcohol	  product	  3.1	  was	  racemic.	  	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
1,4-butanediol (1.1 eq.)
(S,S)-TsDpen (6.25 mol%)
KOH (1.1 eq.), 50 ˚C, 1 h
3.1
Neat:                 conversion = 72%, e.e.= 69%




Scheme	   3.7	   represents	   the	   best	   compromise	   of	   conversion	   and	   e.e.	   that	   could	   be	  
achieved	  with	  dichlororuthenium(II)p-­‐cymene	  dimer	  as	  the	  catalyst,	  (S,S)-­‐TsDPEN	  as	  
the	  ligand	  and	  1,4-­‐butanediol	  as	  the	  hydrogen	  source.	  
	  
3.3	  Other	  catalysts	  
	  
It	   was	   hypothesized	   that	   the	   stability	   of	   the	   catalyst	   was	   affecting	   turnover	   and	  
enantioselectivity,	  therefore	  other	  catalysts	  were	  screened	  to	  test	  their	  viability.	  
	  
O OHCatalyst (5 mol%)
1,4-butanediol (0.5 eq.)
(S,S)-TsDpen  (5 mol%)
KOH (10 mol%), 30 ˚C
THF/H2O (9:1), 1 h 3.1 	  
Entry	   Catalysta	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   Ru(PPh3)3H2CO	   0(-­‐)	  
2	   [IrCp*Cl2]2	   0(-­‐)	  
3	   H2IrCl6.4H2O	   0(-­‐)	  
4	   Ru(PPh3)3Cl2	   0(-­‐)	  
5	   Ru(PPh3)3ClH(CO)	   0(-­‐)	  
6	   [Ir(COD)Cl]2	   12(90)	  
7	   Ir4(CO)12	   0(-­‐)	  
8	   [Ru(C6H6)Cl2]2	   0(-­‐)	  
9	   [Ru(C6Me6)Cl2]2	   46(0)	  
Table	  3.11.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  1	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	   the	   1H	  NMR	  spectra.	   cEnantiomeric	  excess	   calculated	  using	  HPLC	  after	  purification	  by	  
column	  chromatography.	  
	  
The	   results	   shown	   in	   Table	   3.11	   show	   that	   most	   transfer	   hydrogenation	   catalysts	  
were	   ineffective	  under	   these	   conditions.	   The	   stability	   of	   the	  η6-­‐aromatic	   group	  on	  
the	  ruthenium	  catalyst	  is	  important	  for	  the	  stability	  of	  the	  catalyst88	  and	  this	  increase	  
in	   stability	   results	   in	   better	   conversions.	   When	   hexamethylbenzene	   ruthenium	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catatlyst	   (Table	   3.11,	   entry	   9)	   was	   used	   with	   L3	   instead	   of	   (S,S)-­‐TsDPEN,	   100%	  
conversion	  in	  one	  hour	  was	  observed,	  the	  alcohol	  was	  again	  racemic.	  
	  
Now	   the	   ability	   to	   reduce	  acetophenone	   fully	   to	   1-­‐phenylethanol	   in	  one	  hour	  was	  
possible,	  however,	  with	  no	  stereochemical	  control.	  A	  catalyst	   that	  had	  the	  stability	  
and	   chirality	   combined	   in	   one	   structure	   was	   desired.	   The	   tethered	  Wills	   catalyst,	  








The	  first	  step	  was	  to	  consider	  the	  effect	  of	  base	  on	  the	  activity	  of	  the	  Wills	  catalyst.	  
Table	  3.12	  shows	  that	  the	  stability	  of	  the	  catalyst	  resulted	  in	  a	  high	  conversion	  and	  
that	  base	  was	  necessary	  to	  activate	  the	  catalyst,	  10	  mol%	  was	  required	  (Table	  3.12,	  
entry	  2).	  
	  
O OHWills Catalyst (5 mol%)
1,4-butanediol (1.1 eq.)
KOH, 50 ˚C, 1 h
3.1 	  
Entry	   KOHa	  (mol%)	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   0	   <5(-­‐)	  
2	   10	   91(0)	  
3	   110	   90(0)	  
Table	  3.12.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale.	  bConversions	  determined	  by	  analysis	  of	  





The	  lack	  of	  stereochemical	  control	  was	  disappointing.	  Therefore	  running	  the	  reaction	  
in	   THF	   was	   considered,	   since	   this	   had	   previously	   provided	   greater	   enantiomeric	  
selectivity.	  Also,	  the	  temperature	  was	  lowered	  to	  try	  to	  improve	  selectivity	  further.	  
Other	  solvents	  were	  shown	  to	  not	  improve	  the	  e.e.	  above	  what	  could	  be	  achieved	  in	  
THF.	  
O OHWills Catalyst (5 mol%)
1,4-butanediol (1.1 eq.)
KOH (10 mol%)
30 ˚C, 1 h
3.1 	  
Entry	   THFa	  (mL)	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   0.25	   68(91)	  
2	   0.50	   78(76)	  
3	   1.00	   69(70)	  
Table	  3.13.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale.	  bConversions	  determined	  by	  analysis	  of	  
the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	   purification	   by	   column	  
chromatography.	  
	  
Table	   3.13	   shows	   that	   higher	   conversions	   were	   obtained	   with	   higher	  
enantioselectivity.	   It	  was	  necessary	  to	   improve	  the	  figures	  further	  and	  so	  extended	  
the	  reaction	   time	  and	   investigated	   increasing	   the	  amount	  of	  1,4-­‐butanediol.	   It	  was	  
hypothesized	   that	   the	   enantioselectivity	   was	   affected	   by	   temperature	   and	  
proceeded	  to	  cool	  the	  reaction	  to	  0	  ˚C	  to	  confirm	  this.	  
	  
Shown	  in	  Scheme	  3.9	  is	  the	  transition	  state	  for	  a	  ketone	  bound	  to	  the	  Wills	  catalyst.	  
It	  is	  widely	  accepted	  that	  there	  is	  an	  electrostatic	  C(sp2)H/π-­‐interaction	  between	  the	  
δ+	   of	   the	   electron	   poor	   hydrogen	   on	   the	   ruthenium	   aromatic	   and	   the	   δ-­‐	   of	   the	  
electron	   rich	   phenyl	   ring	   on	   the	   substrate	   ketone.	   This	   gives	   the	   catalyst	   its	  














It	  is	  this	  interaction	  that	  helps	  explain	  why	  the	  (S,S)	  enantiomer	  of	  the	  Wills	  catalyst	  
gives	  (S)-­‐1-­‐phenylethanol	  in	  the	  reduction	  of	  acetophenone.	  
	  
O OHWills Catalyst (5 mol%)
1,4-butanediol
KOH (10 mol%)
0 ˚C, 4 h
3.1 	  
Entry	   1,4-­‐butanediola	  (eq.)	   Alcohol	  3.1	  %	  conversionb	  (%	  e.e.)c	  
1	   1.1d	   73(79)	  
2	   1.1	   53(89)	  
3	   2.0d	   96(62)	  
4	   2.0	   67(86)	  
5	   4.0	   67(86)	  
Table	   3.14.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.25	   mL	   solvent.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	  
purification	  by	  column	  chromatography.	  dReaction	  performed	  at	  30	  ˚C.	  
	  
Although	  67%	  conversion	  and	  86%	  e.e.	  had	  been	  achieved	  with	  two	  equivalents	  of	  




At	   this	   stage	   an	   alternative	   hydrogen	   source	  was	   considered.	   cis-­‐1,4-­‐Butenediol	   is	  
synthesized	   on	   an	   industrial	   scale	   from	   2-­‐butyne-­‐1,4-­‐diol.	   It	   is	   important	   in	   the	  
production	   of	   endosulfan,107	   Vitamins	   A	   &	   B108	   and	   is	   an	   additive	   in	   resin	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manufacturing.109	  2-­‐butyne-­‐1,4-­‐diol	   is	  synthesised	  from	  the	  Reppe	  carbonylation	  of	  
acetylene	   using	   formaldehyde	   as	   the	   carbonyl	   source,	   therefore	   it	   is	   cheaply	  
produced.110	   Lindlar’s	   catalyst111	   as	   well	   as	   many	   supported	   palladium108,	   112	   and	  
nickel	   catalysts113	   are	   able	   to	   hydrogenate	   butynediol	   to	   butenediol	   selectively.	  



















cis-­‐1,4-­‐Butenediol	  was	  chosen	  to	  be	  investigated	  given	  that	  the	  isomerisation	  of	  cis-­‐
1,4-­‐butenediol	   to	   4-­‐hydroxybutanal	   is	   catalysed	   by	   ruthenium	   transfer	  
hydrogentation	   catalysts.114	   Therefore	   if	   the	   catalyst	   could	   carry	   out	   the	   faster	  
isomerisation	  step	  and	  then	  subsequently	  oxidise	  the	   lactol	  to	  the	   lactone	   it	  would	  
demonstrate	   another	   irrevesible	   hydrogen	   source,	   as	   shown	   in	   Scheme	   3.10.	   It	   is	  
important	   to	   note	   that	   this	  would	   require	   twice	   as	  much	   diol	   than	   1,4-­‐butanediol	  
given	  that	  only	  two	  hydrogens	  are	  liberated	  in	  the	  oxidation	  of	  lactol.	  
	  
O OHWills Catalyst (5 mol%)
cis-1,4-butenediol (1 eq.)
KOH (10 mol%)
0 ˚C, 2 h
3.1
88% conversion, 94% e.e. 	  
Scheme	  3.11	  
	  
Using	  the	  optimisation	  carried	  out	  so	  far,	  it	  was	  possible	  to	  use	  cis-­‐1,4-­‐butenediol	  to	  




Lowering	  the	  temperature	  to	  -­‐10	  ˚C	  to	  try	  to	  improve	  the	  e.e.,	  with	  two	  equivalents	  
of	   cis-­‐1,4-­‐butenediol	   and	   extended	   the	   reaction	   time.	   Good	   conversion	   and	  
enantiomeric	  excess	  were	  achieved	  as	  shown	  in	  Scheme	  3.12.	  
	  
O OHWills Catalyst (5 mol%)
cis-1,4-butenediol (2 eq.)
KOH (10 mol%)
-10 ˚C, 6 h
3.1
90% conversion, 96% e.e. 	  
Scheme	  3.12	  
	  
It	  was	  noted	  from	  all	  the	  previous	  investigations	  into	  this	  transformation	  that	  longer	  
reaction	  times	  usually	  resulted	  in	  a	  reduction	  in	  enantiomeric	  excess.	  An	  experiment	  
was	   conducted	   with	   the	   conditions	   shown	   in	   Scheme	   3.11	   starting	   from	   1-­‐
phenylethanol	   to	   measure	   the	   amount	   of	   racemization	   that	   occurs	   under	   these	  
conditions.	  The	  enantiomerically	  pure	   (S)-­‐1-­‐phenylethanol	  had	  an	  e.e.	  of	  >99%	  and	  
after	   1	   hour	   under	   the	   reaction	   conditions	   the	   e.e.	   was	   98%	   demonstrating	   that	  
racemization	  was	  occurring.	  
	  
Then	  the	  amount	  of	  KOH	  was	  increased	  to	  20	  mol%	  and	  reduced	  the	  reaction	  time	  to	  
finally	   achieve	   the	   optimal	   conditions.	   The	   scope	   of	   this	   reaction	   was	   then	  





OHWills Catalyst (5 mol%)cis-1,4-butenediol (2 eq.)
KOH (20 mol%)
-10 ˚C, 4 h 	  































































































Table	   3.15.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.25	   mL	   solvent.	   bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cEnantiomeric	   excess	   calculated	   using	   HPLC	   after	  
purification	  by	  column	  chromatography.	  dReaction	  time	  16	  h.	  eEnantiomeric	  excess	  calculated	  using	  1H	  




Table	  3.15	  shows	  that	   this	  method	  was	   tolerant	  of	  electron	  rich	  and	  electron	  poor	  
aromatic	  ketones,	  ortho	  and	  meta	  substituents	  were	  also	  tolerated.	  The	  method	  was	  
less	  effective	  with	  propiophenone	  (Table	  3.15,	  entry	  2)	  which	  required	  an	  extended	  
reaction	   time	   and	   resulted	   in	   a	   lower	   yield	   than	   for	   acetophenone.	   It	   is	   proposed	  
that	  this	  is	  because	  the	  ethyl	  group	  is	  sufficiently	  disruptive	  to	  the	  catalyst	  compared	  
with	  a	  methyl	  group	  that	  the	  turnover	  of	  the	  catalyst	  is	  affected	  by	  propiophenone.	  
	  
Lower	  yields	  obtained	  for	  entires	  8	  and	  6	  were	  attributed	  to	  solubility	   issues	  when	  
carrying	  out	  purification,	  since	  the	  conversion	  for	  both	  substrates	  was	  100%.	  
	  
3.5	  cis-­‐1,4-­‐Butenediol	  with	  [Ru(p-­‐cymene)Cl2]2	  
	  
After	  successfully	  optimizing	  the	  ATH	  using	  Wills	  catalyst	  and	  cis-­‐1,4-­‐butenediol	  the	  
investigations	  returned	  to	  the	  cheaper	  [Ru(p-­‐cymene)Cl2]2	  and	  (S,S)-­‐TsDPEN	  catalyst	  
system.	  
	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
cis-1,4-butenediol
KOH (10 mol%), 30 ˚C, 1 h, THF 
(S,S)-TsDPEN (6.25 mol%)
3.1 	  
Entry	   cis-­‐1,4-­‐butenediola	  (eq.)	   Alcohol	  3.1	  %	  conversionb	  
1	   1.1	   36	  
2	   2.0	   44	  
3	   4.0	   44	  
Table	   3.16.	   aReactions	   were	   performed	   on	   a	   1	   mmol	   scale	   in	   0.25	   mL	   solvent.	   bConversions	  
determined	  by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
Next	  the	  slow	  addition	  of	  cis-­‐1,4-­‐butenediol	  was	  investigated,	  to	  allow	  time	  for	  the	  




O OH[Ru(p-cymene)Cl2]2 (5 mol%)
cis-1,4-butenediol
KOH (10 mol%), 30 ˚C, 2 h, THF 
(S,S)-TsDPEN (6.25 mol%)
3.167% conversion, 90% e.e. 	  
Scheme	  3.13	  
	  
Scheme	  3.13	  shows	  that	  when	  cis-­‐1,4-­‐butenediol	  is	  added	  at	  a	  rate	  of	  1	  mmol	  per	  30	  
minutes,	   a	   reasonable	   conversion	   and	  enantioselectivity	   can	  be	   achieved	  with	   this	  
catalyst	  system.	  	  
	  
Finally,	  increasing	  the	  amount	  of	  catalyst	  and	  ligand	  and	  also	  increasing	  the	  amount	  
of	  base,	  using	  slow	  addition	  of	  cis-­‐1,4-­‐butenediol	  (one	  mmol	  per	  30	  minutes	  to	  total	  
four	  mmol	  over	  two	  hours)	  gave	  75%	  conversion	  and	  92%	  e.e.	  
	  
O OH[Ru(p-cymene)Cl2]2 (10 mol%)
cis-1,4-butenediol
KOH (1.1 eq.), 30 ˚C, 2 h, THF 
(S,S)-TsDPEN (12.5 mol%)
3.175% conversion, 92% e.e. 	  
Scheme	  3.14	  
	  
Therefore	  cis-­‐1,4-­‐butenediol	   is	  a	  more	  effective	  hydrogen	  source	  for	  ATH	  reactions	  
than	  1,4-­‐butanediol.	  
	  
3.6	  Mechanistic	  investigation	  
	  
1H	  NMR	  experiments	  were	  carried	  out	  to	  try	  to	  understand	  the	  mechanism	  by	  which	  





O OH[Ru(p-cymene)Cl2]2 (5 mol%)
cis-1,4-butenediol (1 eq.)
(S,S)-TsDPEN (6.25 mol%)
KOH (1.1 eq.), r.t., 2 h
THF-d8 3.1 	  
Scheme	  3.15	  
	  
Scheme	  3.15	  shows	   the	  conditions	   for	   the	   initial	   1H	  NMR	  experiment	  where	   in	   the	  
presence	   of	   the	   substrate	   ketone,	   the	   rapid	   reduction	   of	   acetophenone	   to	   1-­‐
phenylethanol	   and	   also	   the	   disappearance	   of	   the	   cis-­‐1,4-­‐butenediol	   peaks	   were	  
observed.	   However,	   it	   was	   not	   possible	   to	   determine	  what	   cis-­‐1,4-­‐butenediol	   had	  
been	   converted	   in	   to.	   It	  was	   expected	   that	   the	   formation	   of	   γ-­‐butyrolactone	  with	  
formation	   of	   1-­‐phenylethanol	   could	   be	   seen.	   However	   a	   significant	   amount	   of	  
lactone	  was	  not	  observed	  being	   formed.	  When	   the	   same	   1H	  NMR	  experiment	  was	  
conducted	   in	   the	   absence	  of	   acetopheone	   the	   disappearance	  of	   cis-­‐1,4-­‐butenediol	  
and	   the	   formation	   of	   a	   small	   amount	   of	   γ-­‐butyrolactone	   was	   still	   observed.	   The	  
largest	   peaks	   in	   the	   NMR	   spectrum	   were	   attributed	   to	   1,4-­‐butanediol.	   This	   was	  
confirmed	   by	   addition	   of	   0.5	   equivalents	   of	   1,4-­‐butanediol	   to	   the	   NMR	   tube	   and	  


























One	   possible	   pathway,	   shown	   in	   Scheme	   3.16,	   was	   that	   once	   isomerized	   to	   4-­‐
hydroxybutanal	   3.4	   the	   aldehyde	   could	   be	   reduced	   to	   an	   alcohol	   3.18	   before	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cyclisation	   to	   the	   lactol	   3.5.	   However,	   one	   would	   expect	   the	   intramolecular	  
cyclisation	  to	  proceed	  more	  quickly	  than	  the	  reduction.	  	  
	  
From	   the	   analysis	   of	   the	   1H	   NMR	   there	   was	   no	   evidence	   of	   any	   lactol	   3.5	   being	  
formed,	   there	   was	   no	   evidence	   of	   4-­‐hydroxybutanal	   3.4	   being	   formed.	   cis-­‐1,4-­‐
Butenediol	  3.17	  peaks	  were	  observed	  disappearing	  whilst	  1,4-­‐butanediol	  3.18	  peaks	  
appeared.	   Unfortunately	   sufficient	   Wills	   catalyst	   was	   not	   available	   to	   carry	   out	  
further	  1H	  NMR	  experiments	  to	  confirm	  that	  the	  same	  products	  were	  observed	  with	  



























It	  was	  demonstrated	  that	  1,4-­‐butanediol	  can	  be	  used	  as	  a	  hydrogen	  source	  for	  the	  
asymmetric	   transfer	   hydrogentaion	   of	   aromatic	   ketones.	   However,	   the	   conversion	  
and	   enantiomeric	   excess	   were	   lower	   than	   desired	   and	   since	  many	   other	   catalytic	  
systems	   exist	   that	   can	   perform	   this	   transformation	   more	   efficiently	   this	   outcome	  
was	  not	  especially	  satisfying.	  
	  
It	  is	  possible	  to	  use	  cis-­‐1,4-­‐butenediol	  as	  a	  hydrogen	  source	  that	  with	  the	  ruthenium	  
catalysts	   tested	   here,	   out	   performed	   1,4-­‐butanediol.	   With	   the	   use	   of	   a	   tethered	  
ruthenium	   catalyst,	  Wills	   catalyst	   it	   was	   possible	   to	   reduce	   a	   range	   of	   ketones	   in	  
good	  to	  excellent	  yields	  and	  with	  good	  to	  excellent	  enantioselectivity.	  
	  
Brief	  mechanistic	  insight	  was	  gained	  from	  the	  NMR	  experiments,	  however	  it	  was	  not	  
possible	   to	  determine	  an	  exact	  mechanism	   for	   the	   reduction	  of	  ketones.	   If	   it	  were	  
possible	   to	   determine	   exactly	   how	   cis-­‐1,4-­‐butenediol	   was	   acting	   as	   a	   hydrogen	  


















3.8	  Future	  work	  
	  
There	   is	   scope	   to	   search	   for	   a	   catalyst	   that	   is	   able	   to	   perform	   better	   than	   the	  
ruthenium	   catalysts	   investigated	   here.	   The	   concept	   of	   cis-­‐1,4-­‐butenediol	   and	   1,4-­‐
butanediol	   as	   a	   hydrogen	   source	   has	   been	   shown	   to	   have	   great	   potential	   for	   the	  
reduction	  of	  ketones.	  
	  
Other	   ligands	   could	   be	   investigated,	   phosphine	   based	   ligands,	   or	   bulkier	  
aminoethanol	  type	  ligands	  that	  showed	  good	  conversions	  but	  poor	  selectivity.	  
	  
The	   scope	  of	   substrates	  examined	  here	  was	   rather	   limited	  and	  could	  be	  expanded	  
upon,	  in	  particular	  aliphatic	  ketones.	  Imines	  could	  also	  be	  investigated,	  to	  synthesize	  

























Results	  and	  Discussion	  III	  
	  



















Alcohols	  as	  a	  benign	  source	  of	  acylating	  agent	  
Chapter	  4:	  Results	  and	  Discussion	  III	  
4.1	  Aims	  
Aim	   of	   this	   work	   was	   to	   discover	   a	   suitable	   catalyst	   to	   couple	   alcohols	   and	  
sulfonamides	  to	  form	  N-­‐acylsulfonamides	  using	  transfer	  hydrogenation.	  
	  
Previous	   work	   in	   the	   group	   considered	   the	   borrowing	   hydrogen	   transformation	  












K2CO3 (10 mol%), xylene
150 ˚C, 24 h 	  
Scheme	  4.1	  
	  
The	  N-­‐alkylation	  of	   sulfonamides	   complemented	   the	   group’s	  work	  on	  alkylation	  of	  
amines	   using	   alcohols.115	   However,	   whilst	   investigating	   the	   alkylation	   of	   amines	   a	  



















Optimization	  of	  the	  amide	  pathway	  was	  conducted	  and	  was	  subsequently	  reported	  
in	  the	  literature.80-­‐81,	  116	  Therefore	  it	  was	  considered	  that	  conditions	  could	  be	  found	  
for	   the	   formation	   of	  N-­‐acylsulfonamide	   from	   alcohol	   and	   sulfonamide	   coupling	   by	  





4.2	  Initial	  work	  
	  
Initially	  the	  conditions	  that	  had	  been	  seen	  to	  favour	  the	  pathway	  of	  the	  oxidation	  of	  









Cs2CO3 (10 mol%), tBuOH





The	  initial	  intention	  was	  to	  investigate	  whether	  the	  same	  conditions	  would	  result	  in	  
acylation	  of	   sulfonamide	  with	  an	  alcohol	   starting	  material.	   Scheme	  4.3	   shows	  how	  
the	  conditions	  were	  modified	   from	  alkylation	  to	  afford	  the	  oxidized	  amide	  product	  














Cs2CO3 (10 mol%), tBuOH
125 ˚C, 24 h
3-methyl-2-butanone (2.5 eq.) 	  
Scheme	  4.4	  
	  
Initially	  the	  reaction	  in	  Scheme	  4.4	  was	  investigated,	  which	  had	  identical	  conditions	  
to	  Scheme	  4.3.	  However,	  analysis	  of	  1H	  NMR	  spectra	  revealed	  that	  3-­‐phenylpropanol	  
had	   N-­‐alkylated	   methanesulfonamide	   to	   form	   compound	   4.1	   in	   43%	   conversion	  
rather	  than	  acylation.	  	  
	  
When	  the	  sulfonamide	  substrate	  was	  changed	  to	  p-­‐toluenesulfonamide	  a	  conversion	  
of	  79%	  into	  the	  N-­‐alkylated	  product	  was	  observed.	  1H	  NMR	  peaks	  that	  corresponded	  
to	  the	  N-­‐acylated	  product	  were	  not	  observed.	  The	  conditions	  using	  primary	  amides	  
and	   alcohols	   to	  determine	   if	   an	   imide	   could	  be	   formed	  were	   subsequently	   tested.	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However,	   the	  only	  observed	  product	  was	   the	  corresponding	  secondary	  amide.	  The	  










Cs2CO3 (10 mol%), tBuOH
125 ˚C, 24 h
3-methyl-2-butanone (2.5 eq.) NH
Z R
or
Z = C=O or SO2 	  

















































Table	  4.1.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale	  in	  3	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
It	  was	  necessary	  to	  test	  whether	  the	  hydrogen	  acceptor	  used	  had	  an	  effect	  on	  the	  
pathway	  preference.	  It	  was	  hypothesized	  that	  if	  a	  very	  good	  hydrogen	  acceptor	  was	  
















Cs2CO3 (10 mol%), tBuOH
125 ˚C, 24 h





Entry	   Hydrogen	  acceptora	   Alkylation	  (acylation)	  %	  conversionb	  
1	   3-­‐Methyl-­‐2-­‐butanone	   43(0)	  
2	   Benzophenone	  imine	   4(0)	  
3	   N-­‐Benzylidine	  methylamine	   29(0)	  
4	   1,3-­‐Cyclohexanedione	   0(0)	  
5	   Acetophenone	   41(0)	  
6	   Acetone	   43(0)	  
7	   Crotononitrile	   49(0)	  
Table	  4.2.	  aReactions	  were	  performed	  on	  a	  3	  mmol	  scale	  in	  3	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
It	  was	  disappointing	   to	  observe	   that	   only	   alkylation	  occurred	   and	   that	   3-­‐methyl-­‐2-­‐
butanone	   provided	   the	   best	   conversion	   for	   this	   small	   selection	   of	   hydrogen	  
acceptors.	  	  
	  
Subsequently	  sulfonimine	  4.6	  was	  synthesized	  to	  test	  if	  the	  imine	  intermediate	  that	  
was	   suspected	   was	   being	   reduced	   to	   the	   alkylated	   product	   could	   be	   used	   in	   a	  
sacrificial	  manner	  as	  the	  hydrogen	  acceptor.	  However,	  no	  acylation	  or	  alkylation	  was	  












Cs2CO3 (10 mol%), tBuOH












Next	  other	  catalysts	  were	  considered	  that	  were	  known	  from	  the	  literature	  to	  act	  as	  
transfer	   hydrogenation	   catalysts	   in	   the	   coupling	   of	   alcohols	   and	   amines	   to	   form	  
amides.82,	   117	   Initially	   the	   N-­‐heterocyclic	   carbene	   (NHC)	   precursor	   4.8	   was	  







i) PhMe, <40 ˚C
   10 Min





The	   reaction	   in	   Scheme	   4.7	   was	   investigated	   based	   on	   previous	   work	   in	   the	  
literature,82	   which	   had	   shown	   the	   formation	   of	   an	   amide	   from	   an	   alcohol	   and	   an	  
amine.	  Under	   these	   conditions	   the	   reaction	  of	  methanesulfonamide	  and	  3-­‐phenyl-­‐












NHC 4.8 (5 mol%)
NaH (20 mol%)
MeCN (5 mol%) 





0% conversion acylation 	  
Scheme	  4.7	  
	  
It	  was	  hypothesized	  that	  the	  hemiaminal	  was	  still	  eliminating	  to	  give	  the	  sulfonimine,	  
which	  was	   subsequently	   reduced	   to	   the	  N-­‐alkylsulfonamide.	   The	   next	   step	  was	   to	  
test	  these	  conditions	  on	  an	  amide	  substrate,	  however,	  no	  coupling	  was	  observed	  at	  
all.	  
	  
Then	   Milstein’s	   catalyst	   was	   investigated.	   In	   2007	   Milstein	   had	   shown	   the	   first	  
example	  of	  an	  amine	  and	  an	  alcohol	  coupling	  to	   form	  an	  amide	  using	  a	  ruthenium	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catalyst.80	   With	   the	   intention	   of	   testing	   whether	   the	   same	   conditions	   could	   be	  


















0% conversion acylation 	  
Scheme	  4.8	  
	  
The	   results	   shown	   in	  Scheme	  4.8	  show	  that	  no	  coupling	  between	  sulfonamide	  and	  
alcohol	  was	  observed.	  The	  procedure	  was	  repeated	  for	  the	  coupling	  of	  an	  amide	  and	  
an	  alcohol,	  however,	  no	  acylation	  or	  alkylation	  was	  observed.	  
	  
At	   this	   stage	   it	   was	   decided	   that	   a	   different	   approach	   should	   be	   taken	   and	   to	  
consider	   the	   other	   transfer	   hydrogenation	  mechanism,	  Meerwein-­‐Ponndorf-­‐Verley,	  


















4.3	  MPVO	  system	  
	  
The	  Meerwein-­‐Ponndorf-­‐Verley	   (MPV)	   reduction	  mechanism	   is	   detailed	   in	   Scheme	  
4.9,	   it	   relies	   on	   a	   6-­‐membered	   transition	   state	   with	   a	   hydride	   transfer	   shift.	   The	  
hydride	   shift	   is	   usually	   catalysed	   by	   an	   aluminium	   alkoxide	   catalyst.58a,	   62,	   119	   The	  















Initially	   the	  potential	   of	   using	   standard	  MPVO	   conditions	   to	   acylate	   a	   sulfonamide	  






















Initially	  aluminium	  alkoxide	  catalysts	  were	  considered	  and	  the	  effect	  of	  base	  on	  the	  


















Entry	   Al(OtBu)3a	  (mol%)	   KOtBu	  (mol%)	   N-­‐Acylsulfonamide	  %	  conversionb	  
1	   10	   10	   0	  
2	   10	   0	   0	  
3	   0	   10	   0	  
4	   0	   0	   0	  
5	   100	   10	   0	  
6	   100	   0	   0	  
Table	  4.3.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  3	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
The	  results	  in	  Table	  4.3	  were	  disappointing.	  Therefore	  the	  oxidant	  was	  changed.	  IPA	  
would	   have	   a	   greater	   affinity	   for	   the	   aluminium	   catalyst	   than	   3-­‐phenylpropanol,	  
which	  might	  have	  been	  the	  reason	  for	  no	  reaction	  occurring.	  The	  temperature	  and	  















Entry	   Oxidanta	  (1	  eq.)	   Catalyst	  (10	  mol%)	   N-­‐acylsulfonamide	  %	  conversionb	  
1	   Benzophenone	   Al(OtBu)3	   0	  
2	   Cyclohexanone	   Al(OtBu)3	   0	  
3	   Benzophenone	   Al(OiPr)3	   0	  
4	   Benzophenone	   AlMe2Cl	   0	  
5	   Cyclohexanone	   AlMe2Cl	   0	  
6	   Benzophenone	   AlMe2Clc	   0	  
7	   Benzophenone	   AlMe3d	   0	  
Table	  4.4.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  2	  mL	  solvent.	  bConversions	  determined	  
by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cReaction	   performed	   at	   110	   ˚C	   with	   1	   mmol	   KOtBu.	   dReaction	  
performed	  at	  110	  ˚C	  with	  1	  mmol	  K2CO3.	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Table	  4.4	   shows	  the	  results	  when	  the	  oxidant,	  catalyst	  and	  conditions	  were	  varied.	  	  
No	  coupling	  at	  all	  was	  observed	  and	  merely	  observed	  starting	  materials.	  
	  
4.4	  Methyl	  levulinate	  
	  
Previous	  work	  in	  the	  group	  had	  shown	  methyl	  levulinate	  to	  be	  an	  excellent	  hydrogen	  
acceptor.120	   Scheme	  4.11	   shows	   the	  equilibrium	  problem	   that	  occurs	  with	   transfer	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Scheme	  4.11	  
	  
The	  equilibrium	  lies	  to	  the	  left	  of	  the	  equation.	  This	   is	  a	  problem	  if	  one	  desires	  the	  
oxidation	   of	   cyclohexanol	   to	   proceed.	   Methyl	   levulinate	   performs	   as	   an	   excellent	  
hydrogen	  acceptor	  because	  lactonisation	  can	  occur	  after	  the	  initial	  reduction	  and	  the	  

































Base (10 mol%), tBuOH
125 ˚C, 24 h
Methyl levulinate (2 eq.) 	  
Entry	   Catalysta	  	   Base	   %	  conversionb	  
1	   Ru(PPh3)3(CO)H2	   Cs2CO3	   0	  
2	   Ru(PPh3)3(CO)H2	   KOtBu	   0	  
3	   [Ru(p-­‐cymene)Cl2]2	   Cs2CO3	   0	  
4	   [Ru(p-­‐cymene)Cl2]2	   KOtBu	   0	  
5	   Al(OiPr)3	   Cs2CO3	   0	  
6	   Al(OtBu)3	   Cs2CO3	   0	  
7	   AlMe3	   Cs2CO3	   0	  
8	   Al(OiPr)3	   KOtBu	   0	  
9	   Al(OtBu)3	   KOtBu	   0	  
10	   AlMe3	   KOtBu	   0	  
Table	  4.5.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  in	  2	  mL	  solvent.	  bConversions	  determined	  
by	  analysis	  of	  the	  1H	  NMR	  spectra.	  	  
	  
It	  was	   disappointing	   to	   discover	   that	  methyl	   levulinate	   did	   not	   show	   any	   coupling	  
between	  the	  sulfonamide	  and	  alcohol.	  	  
	  
A	   solution	  of	   SmI2	  in	  THF	  was	   then	   synthesized	  using	  a	   literature	  procedure121	   and	  
tested	  the	  SmI2	  catalyst.	  	  
	  
Sm(0) + I I
THF SmI2 + 	  
Scheme	  4.13	  
	  
Previous	  work	   in	   the	   literature	  had	  shown	   that	  SmI2	   in	  THF	  and	  SmI2(THF)2	   can	  be	  
effective	  MPVO	  catalysts	  using	   IPA	  as	   the	  hydrogen	  source.122	  Therefore	   it	   seemed	  
prudent	   to	   test	   whether	   these	   catalysts	   showed	   any	   activity	   in	   the	   acylation	   of	  












+ SmI2(THF)2 (5 mol%)
Hydrogen acceptor (100 eq.)
125 ˚C, 72 h 	  
Entry	   Hydrogen	  acceptora	  	   Alkyl,	  acyl	  or	  imine	  product	  %	  conversionb	  
1	   Cyclohexanone	   0,	  0,	  0	  
2	   4-­‐Nitroacetophenone	   0,	  0,	  0	  
3	   Acrylonitrile	   0,	  0,	  18	  
4	   Methyl	  levulinatec	   0,	  0,	  0	  
Table	   4.6.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale.	  bConversions	  determined	  by	  analysis	  of	  
the	  1H	  NMR	  spectra.	  cReaction	  performed	  with	  4	  mmol	  methyl	  levulinate.	  
	  
The	   disappointing	   results	   in	   Table	   4.6	   show	   that	   only	   acrylonitrile	   showed	   any	  
activity	   at	   all	   and	   that	   only	   a	   small	   conversion	   into	   the	   sulfonimine	   product	   was	  










+ SmI2 0.04 M in THF (5 mol%)
Hydrogen acceptor (100 eq.)
125 ˚C, 72 h 	  
Entry	   Hydrogen	  acceptora	  	   Alkyl,	  acyl	  or	  imine	  product	  %	  conversionb	  
1	   Cyclohexanone	   0,	  0,	  0	  
2	   4-­‐Nitroacetophenone	   0,	  0,	  0	  
3	   Acrylonitrile	   0,	  0,	  8	  
4	   Methyl	  levulinatec	   0,	  0,	  0	  
5	   Acetone	   0,	  0,	  0	  
6	   Crotononitrile	   0,	  0,	  0	  
Table	   4.7.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale.	  bConversions	  determined	  by	  analysis	  of	  
the	  1H	  NMR	  spectra.	  cReaction	  performed	  with	  4	  mmol	  methyl	  levulinate.	  
	  
It	  was	   disappointing	   again	   that	   only	   acrylonitrile	   showed	   any	   activity	   at	   all.	   It	  was	  
apparent	  that	  benzyl	  alcohol	  could	  be	  oxidized	  to	  benzaldehyde	  but	  that	  SmI2	  could	  





The	  final	  attempt	  to	  try	  to	  solve	  this	   issue	  involved	  using	  CuSO4	  as	  the	  oxidant	  and	  
testing	  whether	  another	  catalyst	  could	  carry	  out	  the	  coupling	  reaction	  between	  the	  
aldehyde	  generated	  and	  the	  sulfonamide.	  Initially	  a	  rhodium	  catalyst	  was	  used	  that	  
was	  known	  in	  the	  literature	  to	  couple	  aldehydes	  and	  sulfonamides	  in	  the	  presence	  of	  













150 ˚C, 24 h 	  
Entry	   Catalysta	  	   Alkyl,	  acyl	  or	  imine	  product	  %	  conversionb	  
1	   No	  catalyst	   46,	  	  0,	  <5	  
2	   Rh2(OAc)4	  (2	  mol%)	   <5,	  	  0,	  67	  
3	   Cu(OTf).MeCN	  (10	  mol%)	   67,	  	  0,	  20	  
4	   FeCl2/pyridinec	  	   	  	  0,	  	  0,	  <5	  
5	   Ru(p-­‐cymene)Cl2d	   	  	  0,	  	  0,	  	  	  8	  
Table	  4.8.	  aReactions	  were	  performed	  on	  a	  1	  mmol	  scale	  using	  4	  mmol	  benzyl	  alcohol.	  bConversions	  
determined	   by	   analysis	   of	   the	   1H	   NMR	   spectra.	   cReaction	   performed	   with	   0.1	  mmol	   FeCl2	   and	   0.4	  
mmol	  pyridine.	  dReaction	  performed	  with	  1.1	  mmol	  benzyl	  alcohol.	  
	  
The	  results	  shown	  in	  Table	  4.8	  were	  disappointing.	  Only	  alkylation	  and	  sulfonimine	  
formation	   could	   be	   achieved.	   Several	   side	   products	   were	   observed	   in	   these	  
reactions,	   the	   formation	   of	   the	   Tishchenko	   by-­‐product,	   benzyl	   benzoate	   was	  
observed	  and	  also	  the	  formation	  of	  benzaldehyde.	  This	   indicates	  that	  the	  oxidation	  
of	  benzyl	  alcohol	  to	  benzaldehyde	  occurs	  but	  that	  the	  addition	  of	  sulfonamide	  leads	  
only	  to	  formation	  of	  the	  hemiaminal	  that	  eliminates	  to	  give	  the	  sulfonimine,	  which	  is	  










The	   principle	   of	  N-­‐acylation	   of	   sulfonamides	   using	   benign	   alcohol	   as	   the	   acylating	  
agent	  is	  a	  good	  one.	  The	  analogous	  reaction	  can	  be	  performed	  on	  amides	  as	  shown	  
in	   the	   literature	   and	   by	   previous	   work	   in	   the	   group.	   However,	   using	   the	   catalytic	  
systems	   presented	   here,	   the	   sulfonamide	   reaction	   could	   not	   be	   achieved.	   All	  
attempts	  either	  returned	  starting	  materials	  or	  resulted	  in	  sulfonimine	  formation	  and	  
subsequent	  reduction	  to	  the	  N-­‐alkyl	  product.	  The	  results	  were	  very	  disappointing.	  It	  
is	   still	   possible	   that	   there	   is	   a	   catalyst	   or	   catalyst	   system	   that	   will	   perform	   this	  










































The	   final	   experiments	   that	  were	   conducted	   on	   this	   project	   involved	   attempting	   to	  
synthesize	   2,2-­‐dichloro-­‐3-­‐phenyl-­‐propanol	   from	   commercially	   available	   3-­‐phenyl-­‐
propanol	  with	  the	  aim	  to	  test	  whether	  the	  presence	  of	  α-­‐chlorines	  adjacent	  to	  the	  
hemiaminal	   would	   stabilize	   it	   enough	   to	   allow	   oxidation	   to	   occur	   prior	   to	   the	  
elimination	   reaction	   that	   occurs	   when	   the	  α	   atoms	   are	   hydrogen.	   However,	   time	  
constraints	  meant	  that	  it	  has	  not	  yet	  been	  tested	  whether	  stabilizing	  the	  hemiaminal	  
in	   this	  manner	  will	   in	   fact	   lead	   to	  preventing	   elimination.	   This	  would	   therefore	  be	  
suitable	   for	   future	  work,	   in	  conjunction	  with	   the	  ongoing	  search	   for	  a	  catalyst	   that	  













































Chapter	  5:	  Experimental	  
5.1	  General	  Experimental	  Methods	  
	  
All	   reactions	   requiring	   an	   anhydrous,	   inert	   atmosphere	  were	   carried	   out	   under	   an	  
argon	  atmosphere	  using	  evacuated	  carousel	  or	  ampules.	  Unless	  preparative	  details	  
are	   provided,	   all	   reagents	   were	   purchased	   from	   commercial	   suppliers	   Acros	  
Organics,	  Aldrich,	  Alfa	  Aesar,	  Fluka,	  Lancaster,	  Maybridge,	  Strem	  or	  TCI	  UK	  and	  used	  
without	   further	   purification.	   Thin	   layer	   chromatography	   was	   carried	   out	   on	  
aluminium	  or	  plastic	  backed	   silica	  plates,	   purchased	   from	  Aldrich.	   The	  plates	  were	  
visualised	  under	  UV	  (254	  nm)	  light,	  followed	  by	  staining	  with	  phosphomolybdic	  acid	  
dip	  or	  potassium	  permanganate	  and	  gentle	  heating.	  During	  compound	  separations,	  
column	  chromatography	  was	  carried	  out	  using	  60	  micron	  dry	  silica	  purchased	  from	  
Aldrich.	   Organic	   layers	   were	   routinely	   dried	   with	   anhydrous	   MgSO4	   and	  
concentrated	  using	  a	  Büchi	  rotary	  evaporator.	  
1H	  NMR	  /	  13C	  NMR	  spectra	  were	  run	  in	  deuterated	  (≥99.5%)	  solvents	  purchased	  from	  
Fluorochem	  unless	  stated	  otherwise,	  on	  a	  Bruker	  Avance	  300	  (300	  MHz	  1H,	  75	  MHz	  
13C)	  or	  Bruker	  Avance	  250	   (250	  MHz	  1H,	  62.5	  MHz	  13C).	  Any	  chemical	   shifts	   (δ)	  are	  
reported	  as	  parts	  per	  million	  (ppm)	  with	  reference	  to	  tetramethylsilane	  (TMS)	  (δH	  =	  
0.00	  ppm)	  unless	  otherwise	  stated.	  The	  coupling	  constants	  (J)	  are	  reported	  in	  Hz	  and	  
signal	   multiplicities	   are	   reported	   as	   singlet	   (s),	   doublet	   (d),	   triplet	   (t),	   quartet	   (q),	  
quintet	  (qu),	  doublet	  of	  doublets	  (dd),	  doublet	  of	  triplets	  (dt),	  triplet	  of	  triplets	  (tt),	  
multiplet	  (m),	  or	  broad	  singlet	  (br.	  s).	  
For	  mass	  spectrometry	  data	  acquisition	  a	  micrOTOF	  electrospray	  time-­‐of-­‐flight	  (ESI-­‐
TOF)	  mass	  spectrometer	  (Bruker	  Daltonik,	  GmbH,	  Bremen,	  Germany)	  was	  used;	  this	  
was	   coupled	   to	   an	   Agilent	   1200	   LC	   system	   (Agilent	   Technologies,	   Waldbronn,	  
Germany).	   The	   LC	   system	  was	  used	  as	  an	  auto	   sampler	  only.	  10	  μL	  of	   sample	  was	  
injected	   into	   a	   30:70	   flow	   of	   water:acetonitrile	   at	   0.3	   mL/min	   to	   the	   mass	  
spectrometer.	  For	  each	  acquisition	  10	  μL	  of	  a	  calibrant	  of	  5	  mM	  sodium	  formate	  was	  
injected	   after	   the	   sample.	   The	   observed	   mass	   and	   isotope	   pattern	   matched	   the	  
corresponding	  theoretical	  values	  as	  calculated	  from	  the	  expected	  elemental	  formula.	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Infrared	  spectra	  were	  recorded	  on	  a	  Perkin	  Elmer	  Spectrum	  100	  FT-­‐IR	  spectrometer,	  
using	  a	  Universal	  ATR	  accessory	  for	  sampling,	  with	  relevant	  absorbance	  quoted	  as	  ν	  
in	  cm-­‐1.	  Optical	  rotations	  were	  measured	  on	  an	  AA-­‐10	  Automatic	  Polarimeter.	  HPLC	  
traces	  were	  measured	  using	   a	   Perkin	   Elmer	   200	   Series	  HPLC	   system.	   Enantiomeric	  
excess	  measurements	  were	  carried	  out	  using	  a	  Chiracel	  column	  as	  specified	  for	  each	  
compound,	   eluting	  with	   HPLC	   grade	   hexane	   and	   isopropyl	   alcohol.	   All	   other	   HLPC	  
experiments	   were	   carried	   out	   using	   a	   Phenomenex	   Prodigy	   5	   μm	   column	   and	   an	  
acetonitrile	  (0.05%	  TFA):	  water	  (0.05%	  TFA)	  gradient	  elution	  system.	  Melting	  points	  
were	   determined	   using	   Stuart	   SMP10	   melting	   point	   equipment	   using	   closed	   end	  
glass	  capillary	  tubes	  and	  are	  uncorrected.	  Specific	  rotations	  were	  determined	  on	  an	  
Optical	  Activity	  LTD:	  AA-­‐10	  automatic	  polarimeter.	  
5.2	  Chapter	  2	  Experimental	  Methods	  
	  










+ LiI (20 mol%)
solvent, r.t.,18 h
	  
To	  oven	  dried	  Radleys	  carousel	  tubes	  lithium	  iodide	  and	  methanesulfonamide	  were	  
added,	  the	  appropriate	  anhydrous	  solvent	  dissolved	  the	  reagents,	  acid	  chloride	  was	  
added	   to	   the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	  
reaction	   mixture	   was	   immediately	   heated	   to	   the	   appropriate	   temperature	   and	  
stirred	  for	  the	  appropriate	  amount	  of	  time.	  The	  resulting	  reaction	  mixture	  was	  then	  
washed	  with	  DCM	  and	   sodium	   thiosulfate	   solution.	   The	  organic	   components	  were	  
then	  dried	  and	  concentrated	  in	  vacuo.	  The	  resulting	  products	  were	  analysed	  by	  their	  
1H	  NMR	  spectra.	  
	  
Solvent	  Screen	  
(Table	  2.1	  –	  Chapter	  2,	  Section	  2.2.1)	  
Following	  representative	  procedure	  I,	  the	  appropriate	  anhydrous	  solvent	  (2	  mL)	  was	  
used	   according	   to	   Table	   2.1.	   Lithium	   iodide	   (54	   mg,	   0.4	   mmol,	   20	   mol%),	  
methanesulfonamide	  (190	  mg,	  2	  mmol)	  and	  acetyl	  chloride	  (142	  µL,	  2	  mmol)	  were	  
used,	  the	  reaction	  was	  performed	  at	  room	  temperature	  for	  18	  hours.	  The	  1H	  NMR	  of	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the	  crude	  reaction	  mixture	  showed	  %	  conversion	  by	  comparison	  of	  the	  peaks	  at	  3.25	  
(3H,	   s,	   CH3,	  2.1)	   and	   3.15	   (3H,	   s,	   CH2,	  methanesulfonamide).	   1H	   NMR:	   (CDCl3,	   300	  
MHz)	  δ	  8.69	  (1H,	  br.s,	  NH),	  3.25	  (3H,	  s,	  CH3),	  2.09	  (3H,	  s,	  CH3).	  
	  






Following	  representative	  procedure	  I,	  the	  title	  compound	  was	  recovered	  and	  the	  1H	  
NMR	  of	  the	  crude	  product	  analysed.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.69	  (1H,	  br.s,	  NH),	  
3.25	  (3H,	  s,	  CH3),	  2.09	  (3H,	  s,	  CH3).	  	  
	  
Variation	  of	  lithium	  iodide	  loading	  
(Table	  2.2,	  Chapter	  2,	  Section	  2.2.1)	  
Following	  representative	  procedure	  I,	  the	  appropriate	  amount	  of	  lithium	  iodide	  was	  
used	  according	  to	  Table	  2.2.	  Methanesulfonamide	  (476	  mg,	  5	  mmol),	  acetyl	  chloride	  
(356	   µL,	   5	   mmol)	   and	   anhydrous	   MeCN	   (5	   mL)	   were	   used	   the	   reaction	   was	  
performed	   at	   room	   temperature	   for	   18	   hours.	   The	   1H	  NMR	   of	   the	   crude	   reaction	  
mixture	  showed	  %	  conversion	  by	  comparison	  of	   the	  peaks	  at	  3.25	   (3H,	  s,	  CH3,	  2.1)	  
and	  3.15	   (3H,	   s,	  CH2,	  methanesulfonamide).	   1H	  NMR:	   (CDCl3,	  300	  MHz)	  δ	  8.69	   (1H,	  
br.s,	  NH),	  3.25	  (3H,	  s,	  CH3),	  2.09	  (3H,	  s,	  CH3).	  
	  
Variation	  of	  acid	  chloride	  
(Table	  2.3,	  Chapter	  2,	  Section	  2.2.1)	  
Following	   representative	   procedure	   I,	   the	   appropriate	   acid	   chloride	   (1	  mmol)	   was	  
used	  according	  to	  Table	  2.3.	  Lithium	  iodide	  (134	  mg,	  1	  mmol),	  methanesulfonamide	  
(95	  mg,	  1	  mmol)	  and	  anhydrous	  MeCN	  (1	  mL)	  were	  used	  the	  reaction	  was	  performed	  
at	   room	   temperature	   for	   18	   hours.	   Where	   appropriate	   the	   reaction	   mixture	   was	  
heated	   to	  40	   ˚C	  and	  after	   the	  18	  hour	   reaction	   time,	   cooled	   to	   room	  temperature	  
before	   extraction.	   The	   1H	   NMR:	   (CDCl3,	   300	   MHz)	   of	   the	   crude	   reaction	   mixture	  
showed	  %	  conversion	  by	  comparison	  of	  the	  peaks	  at	  3.48	  (3H,	  s,	  CH3,	  2.2),	  3.25	  (3H,	  




(Scheme	  2.5,	  Chapter	  2,	  Section	  2.2.1)	  
Following	   representative	   procedure	   I,	   benzoyl	   chloride	   (116	   µL,	   1	   mmol),	   acetyl	  
chloride	  (72	  µL,	  1	  mmol),	  lithium	  iodide	  (134	  mg,	  1	  mmol),	  methanesulfonamide	  (95	  
mg,	  1	  mmol)	  and	  anhydrous	  MeCN	  (1	  mL)	  were	  used,	  the	  reaction	  was	  performed	  at	  
room	  temperature	  for	  18	  hours.	  The	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  of	  the	  crude	  reaction	  
mixture	  showed	  %	  conversion	  by	  comparison	  of	  the	  peaks	  at	  3.48	  (3H,	  s,	  CH3,	  2.2),	  
3.25	  (3H,	  s,	  CH3,	  2.1)	  and	  3.15	  (3H,	  s,	  CH2,	  methanesulfonamide).	  	  
	  
Changing	  the	  acid	  chloride	  with	  variation	  of	  lithium	  iodide	  loading	  
(Table	  2.4,	  Chapter	  2,	  Section	  2.2.1)	  
Following	  representative	  procedure	  I,	  the	  appropriate	  amount	  of	  lithium	  iodide	  was	  
used	   according	   to	   Table	   2.4.	   Methanesulfonamide	   (190	   mg,	   2	   mmol),	   benzoyl	  
chloride	  (232	  µL,	  2	  mmol)	  and	  anhydrous	  MeCN	  (2	  mL)	  were	  used,	  the	  reaction	  was	  
performed	  at	  82	  ˚C	  for	  20	  hours.	  The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  
mixture	  showed	  %	  conversion	  by	  comparison	  of	   the	  peaks	  at	  3.48	   (3H,	  s,	  CH3,	  2.2)	  
and	  3.15	  (3H,	  s,	  CH2,	  methanesulfonamide).	  
	  






Following	  representative	  procedure	  I,	  the	  title	  compound	  was	  recovered	  and	  the	  1H	  
NMR	  of	  the	  crude	  product	  analysed.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.93	  (1H,	  br.s,	  NH),	  










Representative	  Procedure	  II	  















To	  oven	  dried	  Radleys	  carousel	  tubes	  lithium	  iodide	  (134	  mg,	  1	  mmol,	  20	  mol%)	  and	  
sulfonamide	  were	  added,	  anhydrous	  MeCN	   (2	  mL)	  dissolved	   the	   reagents	  and	  acid	  
chloride	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  
and	  the	  reaction	  mixture	  was	  heated	  to	  82	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  resulting	  
reaction	  mixture	  was	   then	  washed	  with	  DCM	  and	  sodium	  thiosulfate	   solution.	  The	  
organic	  components	  were	  then	  dried	  and	  concentrated	  in	  vacuo.	  The	  crude	  product	  
was	   then	   purified	   using	   column	   chromatography	   using	   EtOAc/hexane	   1:2,	   unless	  
otherwise	   stated.	   The	   resulting	   products	   were	   analysed	   by	   their	   1H	   and	   13C	   NMR	  
spectra	  and	  mass	  spectrometry	  data.	  
	  






Following	   representative	  procedure	   II,	  methanesulfonamide	   (476	  mg,	  5	  mmol)	  was	  
used	  as	   the	  sulfonamide	  species	  and	  acetyl	  chloride	   (427	  μL,	  6	  mmol)	  was	  used	  as	  
the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (0.130	  
g,	  19%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.69	  (1H,	  br.s,	  NH),	  3.25	  (3H,	  s,	  CH3),	  2.09	  (3H,	  
s,	   CH3).	   13C	   NMR:	   (CDCl3,	   75.5	   MHz)	   δ	   171.8,	   43.4,	   23.5.	   ESI-­‐MS	   of	   [C3H7NO3S];	  







Following	   representative	  procedure	   II,	   benzenesulfonamide	   (786	  mg,	   5	  mmol)	  was	  
used	  as	   the	  sulfonamide	  species	  and	  acetyl	  chloride	   (427	  μL,	  6	  mmol)	  was	  used	  as	  
the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (0.839	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g,	  84%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.67	  (1H,	  br.s,	  NH),	  8.10	  	  (2H,	  d,	  J	  =	  8.1	  Hz,	  Ar),	  
7.77	  –	  7.52	  (3H,	  m,	  Ar),	  2.11	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  168.7,	  138.5,	  
134.1,	   129.1,	   128.2,	   23.5.	   ESI-­‐MS	   of	   [C8H9NO3S];	   theoretical	   m/z	   of	   [M+H]+	   =	  
200.0381,	  measured	  m/z	  of	  [M+H]+	  =	  200.0378.	  
	  





Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	   the	  sulfonamide	  species	  and	  acetyl	  chloride	   (427	  μL,	  6	  mmol)	  was	  used	  as	  
the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (0.999	  
g,	  94%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.73	  (1H,	  br.s,	  NH),	  7.81	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  
7.22	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  2.32	  (3H,	  s,	  CH3),	  1.94	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	   δ	   168.2,	   145.3,	   135.5,	   129.7,	   128.3,	   23.5,	   21.7.	   ESI-­‐MS	   of	   [C9H11NO3S];	  
theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  212.0381,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  212.0384.	  
	  





Following	   representative	  procedure	   II,	   naphthalene	   sulfonamide	   (1.036	  g,	   5	  mmol)	  
was	  used	  as	  the	  sulfonamide	  species	  and	  acetyl	  chloride	  (427	  μL,	  6	  mmol)	  was	  used	  
as	   the	   acid	   chloride	   species.	   The	   title	   compound	   was	   recovered	   as	   a	   yellow	   solid	  
(1.016	  g,	  90%).	  	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.94	  (1H,	  br.s,	  NH),	  8.68	  (1H,	  s,	  Ar),	  8.06	  
–	  7.87	  (2H,	  m,	  Ar),	  7.74	  –	  7.59	  (4H,	  m,	  Ar),	  2.09	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	  δ	  168.3,	  135.5,	  135.2,	  131.9,	  130.5,	  129.6,	  129.5,	  129.4,	  128.0,	  127.8,	  122.6,	  
23.6.	  ESI-­‐MS	  of	  [C12H11NO3S];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  248.0381,	  measured	  m/z	  of	  












Following	   representative	   procedure	   II,	   4-­‐methoxybenzene	   sulfonamide	   (936	  mg,	   5	  
mmol)	  was	   used	   as	   the	   sulfonamide	   species	   and	   acetyl	   chloride	   (427	   μL,	   6	  mmol)	  
was	  used	  as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  
solid	  (1.027	  g,	  90%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.81	  (1H,	  br.s,	  NH),	  7.92	  (2H,	  d,	  J	  =	  
9.1	  Hz,	  Ar),	  6.93	  (2H,	  d,	  J	  =	  9.1	  Hz,	  Ar),	  3.81	  (3H,	  s,	  CH3),	  1.99	  (3H,	  s,	  CH3).	  13C	  NMR:	  
(CDCl3,	   75.5	   MHz)	   δ	   168.3,	   164.0,	   130.7,	   129.8,	   114.2,	   55.8,	   23.5.	   ESI-­‐MS	   of	  
[C9H11NO4S];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   228.0331,	   measured	   m/z	   of	   [M-­‐H]-­‐	   =	  
228.0330.	  
	  






Following	   representative	   procedure	   II,	   4-­‐nitrobenzene	   sulfonamide	   (1.011	   g,	   5	  
mmol)	  was	   used	   as	   the	   sulfonamide	   species	   and	   acetyl	   chloride	   (427	   μL,	   6	  mmol)	  
was	  used	   as	   the	   acid	   chloride	   species.	   The	   title	   compound	  was	   recrystallised	   from	  
hot	   ethanol	   and	   distilled	   water,	   the	   product	   was	   isolated	   by	   filtration	   as	   a	   pale	  
yellow	  solid	  (1.059	  g,	  87%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.71	  (1H,	  br.s,	  NH),	  8.42	  (2H,	  
d,	  J	  =	  8.8	  Hz,	  Ar),	  8.30	  (2H,	  d,	  J	  =	  8.8	  Hz,	  Ar),	  2.11	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	   δ	   169.5,	   150.6,	   144.8,	   129.6,	   124.8,	   23.6.	   ESI-­‐MS	   of	   [C8H8N2O5S];	   theoretical	  
m/z	  of	  [M-­‐H]-­‐	  =	  243.0076,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  243.0092.	  
	  






Following	   representative	   procedure	   II,	   4-­‐chlorobenzene	   sulfonamide	   (958	   mg,	   5	  
mmol)	  was	   used	   as	   the	   sulfonamide	   species	   and	   acetyl	   chloride	   (427	   μL,	   6	  mmol)	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was	  used	   as	   the	   acid	   chloride	   species.	   The	   title	   compound	  was	   recrystallised	   from	  
hot	   ethanol	   and	   distilled	   water,	   the	   product	   was	   isolated	   by	   filtration	   as	   a	   pale	  
yellow	  solid	  (0.972	  g,	  83%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.09	  (1H,	  br.s,	  NH),	  7.94	  (2H,	  
d,	  J	  =	  8.8	  Hz,	  Ar),	  7.46	  (2H,	  d,	  J	  =	  8.8	  Hz,	  Ar),	  2.01	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	  δ	  169.3,	  139.0,	  138.5,	  129.9,	  129.6,	  23.6.	  ESI-­‐MS	  of	   [C8H8ClNO3S];	   theoretical	  
m/z	  of	  [M-­‐H]-­‐	  =	  231.9835,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  231.9837.	  
	  






Following	  representative	  procedure	  II,	  trimethylsilylethyl	  sulfonamide	  (663	  mg,	  3.65	  
mmol)	  was	   used	   as	   the	   sulfonamide	   species	   and	   acetyl	   chloride	   (427	   μL,	   6	  mmol)	  
was	  used	  as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	   isolated	  as	  a	  yellow	  
solid	  (0.734	  g,	  90%),	  mp	  79-­‐81	  ˚C.	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  8.56	  (1H,	  br.s,	  NH),	  
3.38	  –	  3.22	  (2H,	  m,	  CH2),	  2.09	  (3H,	  s,	  CH3),	  1.03	  –	  0.88	  (2H,	  m,	  CH2),	  0.0	  (9H,	  s,	  SiCH3).	  
13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  171.2,	  52.2,	  25.6,	  11.9,	  0.0.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  1699	  
(C=O).	  ESI-­‐MS	  of	  [C7H17NO3SSi];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  222.0620,	  measured	  m/z	  
of	   [M-­‐H]-­‐	   =	   222.0616.	   	   Requires	   C	   37.52%;	  H	   7.66%;	  N	   6.34%,	   found:	   C	   37.55%;	  H	  
7.62%;	  N	  6.38	  %.	  	  	  
	  






Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (697	  µL,	  6	  mmol)	  was	  used	  as	  
the	   acid	   chloride	   species.	   The	   1H	  NMR	  of	   the	   crude	   reaction	  mixture	   showed	  13%	  
conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.36	  (1H,	  br.s,	  NH),	  7.97	  (2H,	  d,	  J	  =	  8.0	  Hz,	  
Ar),	  7.75	  (2H,	  d,	  J	  =	  8.4	  Hz,	  Ar),	  7.56-­‐7.40	  (1H,	  m,	  Ar),	  7.34	  (2H,	  t,	  J	  =	  8.0	  Hz,	  Ar),	  7.27	  
(2H,	  d,	  J	  =	  8.4	  Hz,	  Ar),	  2.36	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  164.4,	  145.3,	  










Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  valeroyl	  chloride	  (712	  µL,	  6	  mmol)	  was	  used	  as	  
the	   acid	   chloride	   species.	   The	   1H	  NMR	  of	   the	   crude	   reaction	  mixture	   showed	  98%	  
conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.13	  (1H,	  br.s,	  NH),	  7.94	  (2H,	  d,	  J	  =	  8.2	  Hz,	  
Ar),	  7.34	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  2.43	  (3H,	  s,	  CH3),	  2.31-­‐2.20	  (2H,	  m,	  CH2),	  1.52	  (2H,	  m,	  
CH2),	  1.24	  (2H,	  m,	  CH2),	  0.82	  (3H,	  t,	  J	  =	  7.3	  Hz,	  CH3).	   13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  
171.5,	  145.2,	  135.6,	  129.7,	  128.3,	  36.0,	  26.3,	  22.0,	  21.7,	  13.7.	  
	  
2.12	  -­‐	  N-­‐Tosylpivalamide123	  
	  
Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  trimethylacetyl	  chloride	  (739	  µL,	  6	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
86%	  conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.74	  (1H,	  br.s,	  NH),	  7.88	  (2H,	  d,	  J	  =	  8.2	  
Hz,	   Ar),	   7.27	   (2H,	   d,	   J	   =	  8.2	   Hz,	   Ar),	   2.37	   (3H,	   s,	   CH3),	   1.07	   (9H,	   s,	   CH3).	  13C	   NMR:	  
(CDCl3,	  75.5	  MHz)	  δ	  176.2,	  145.0,	  135.5,	  129.6,	  128.4,	  40.0,	  26.7,	  21.7.	  
	  







Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	   the	   sulfonamide	   species	  and	  dichloroacetyl	   chloride	   (577	  µL,	  6	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
61%	  conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.03	  (1H,	  br.s,	  NH),	  7.90	  (2H,	  d,	  J	  =	  8.3	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Hz,	  Ar),	  7.31	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  5.78	  (1H,	  s,	  CH),	  2.39	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  
75.5	  MHz)	  δ	  160.9,	  146.1,	  134.1,	  129.9,	  128.7,	  65.6,	  21.8.	  
	  






Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  hydrocinnamoyl	  chloride	  (892	  µL,	  6	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
97%	  conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.03	  (1H,	  br.s,	  NH),	  7.89	  (2H,	  d,	  J	  =	  8.3	  
Hz,	  Ar),	  7.31	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.25-­‐7.13	  (3H,	  m,	  Ar),	  7.06	  (2H,	  m,	  Ar),	  2.86	  (2H,	  t,	  
J	  =	  7.7	  Hz,	  CH2),	  2.56	  (2H,	  t,	  J	  =	  7.7	  Hz,	  CH2),	  2.45	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	  δ	  170.5,	  145.2,	  139.7,	  135.4,	  129.7,	  128.6,	  128.4,	  128.3,	  126.4,	  37.9,	  30.3,	  21.8.	  
	  






Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  m-­‐toluoyl	  chloride	  (791	  µL,	  6	  mmol)	  was	  used	  
as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  22%	  
conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.73	  (1H,	  br.s,	  NH),	  7.97	  (2H,	  m,	  Ar),	  7.85	  
(2H,	  d,	  J	  =	  7.9	  Hz,	  Ar),	  7.65-­‐7.47	  (2H,	  m,	  Ar),	  7.41	  (2H,	  d,	  J	  =	  7.9,	  Ar),	  2.45	  (3H,	  s,	  CH3),	  
2.41	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   166.3,	   145.2,	   138.0,	   135.5,	   132.1,	  















Following	  representative	  procedure	  II,	  p-­‐toluenesulfonamide	  (856	  mg,	  5	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  2-­‐fluorobenzoyl	  chloride	  (717	  µL,	  6	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
<5%	  conversion.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.07	  (1H,	  br.s,	  NH),	  8.07	  -­‐	  7.64	  (3H,	  m,	  
Ar),	  7.52	  -­‐	  7.35	  (1H,	  m,	  Ar),	  7.30-­‐6.95	  (4H,	  m,	  Ar),	  2.32	  (3H,	  s,	  CH3).	  
	  
Acylation	  of	  Secondary	  Sulfonamide	  (Chapter	  2,	  Section	  2.2)	  
Representative	  Procedure	  III	  







R Et3N (1.5 eq.)
DCM, r.t., 3 h
	  
To	  oven	  dried	  Radleys	  carousel	  tubes	  p-­‐toluenesulfonyl	  chloride	  (3.813	  g,	  20	  mmol)	  
and	  triethylamine	  (4.2	  mL,	  30	  mmol,	  1.5	  eq.)	  were	  added,	  anhydrous	  DCM	  (30	  mL)	  
dissolved	   the	   reagents,	  amine	  was	  added	   to	   the	  solution	  using	  a	   syringe.	  The	   tube	  
was	   then	   sealed	   and	   the	   reaction	  mixture	  was	   stirred	   at	   room	   temperature	   for	   3	  
hours.	  The	  product	  crashed	  out	  of	  solution	  and	  could	  then	  be	  filtered	  off	  and	  dried	  
using	  a	  Buchner	  funnel.	  The	  products	  were	  then	  recrystallized	  from	  layered	  hexane	  
on	  a	  DCM	  solution.	  The	  resulting	  products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  
	  
2.17	  -­‐	  N-­‐Benzyl-­‐4-­‐methylbenzene	  sulfonamide127	  
	  
Following	  representative	  procedure	  III,	  benzylamine	  (2.2	  mL,	  20	  mmol)	  was	  used	  as	  
the	   amine	   species.	   The	   title	   compound	   was	   recovered	   as	   a	   white	   solid	   (5.122	   g,	  
98%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.79	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.38	  –	  7.19	  (7H,	  m,	  Ar),	  




2.18	  -­‐	  N-­‐Hexyl-­‐4-­‐methylbenzene	  sulfonamide128	  
	  
Following	   representative	  procedure	   III,	  hexylamine	   (2.6	  mL,	  20	  mmol)	  was	  used	  as	  
the	   amine	   species.	   The	   title	   compound	   was	   recovered	   as	   a	   white	   solid	   (4.955	   g,	  
97%).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.78	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.34	  (2H,	  d,	  J	  =	  8.2	  Hz,	  
Ar),	  4.39	  (1H,	  t,	  J	  =	  6.5	  Hz,	  NH),	  2.96	  (2H,	  q,	  J	  =	  6.5	  Hz,	  CH2),	  2.46	  (3H,	  s,	  CH3),	  1.47	  
(2H,	  m,	  CH2),	  1.37-­‐1.12	  (6H,	  m,	  CH2),	  0.94-­‐0.81	  (2H,	  m,	  CH3).	  	  
	  
Representative	  Procedure	  IV	  
















To	   oven	   dried	   Radleys	   carousel	   tubes	   lithium	   iodide	   and	  N-­‐alkylsulfonamide	  were	  
added,	  anhydrous	  MeCN	  (2	  mL)	  dissolved	  the	  reagents,	  acid	  chloride	  was	  added	  to	  
the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	   reaction	  
mixture	   was	   immediately	   heated	   to	   82	   ˚C	   and	   stirred	   for	   24	   hours.	   The	   resulting	  
reaction	  mixture	  was	  then	  cooled	  to	  room	  temperature	  and	  then	  washed	  with	  DCM	  
and	   sodium	   thiosulfate	   solution.	   The	   organic	   components	   were	   then	   dried	   and	  
concentrated	   in	   vacuo.	   The	   resulting	   products	   were	   analysed	   by	   their	   1H	   NMR	  
spectra	  and	  mass	  spectrometry	  data.	  
	  






Following	  representative	  procedure	  IV,	  N-­‐benzyl-­‐4-­‐methylbenzene	  sulfonamide	  2.17	  
(1.307	  g,	  5	  mmol)	  was	  used	  as	  the	  N-­‐alkylsulfonamide	  species,	  acetyl	  chloride	  (427	  
µL,	   5	  mmol)	   was	   used	   as	   the	   acid	   chloride	   species	   and	   lithium	   iodide	   (134	  mg,	   1	  
mmol,	  20	  mol%)	  was	  used.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  78%	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conversion	  by	  comparison	  of	  the	  peaks	  at	  4.15	  (2H,	  d,	  J	  =	  6.0	  Hz,	  CH2,	  2.17)	  and	  5.11	  
(2H,	  s,	  CH2,	  2.19).	  	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.64	  (2H,	  d,	  J	  =	  8.4	  Hz,	  Ar),	  7.47-­‐7.19	  
(7H,	   m,	   Ar),	   5.11	   (2H,	   s,	   CH2),	   2.45	   (3H,	   s,	   CH3),	   2.32	   (3H,	   s,	   CH3).	   ESI-­‐MS	   of	  
[C16H17NO3S];	   theoretical	   m/z	   of	   [M+H]+	   =	   304.1007,	   measured	   m/z	   of	   [M+H]+	   =	  
304.1005.	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.19	  -­‐	  N-­‐benzyl-­‐N-­‐tosylacetamide98	  
The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  25%	  conversion	  by	  comparison	  of	  
the	  peaks	  at	  4.15	  (2H,	  d,	  J	  =	  6.0	  Hz,	  CH2,	  2.17)	  and	  5.11	  (2H,	  s,	  CH2,	  2.19).	  	  
	  






Following	   representative	  procedure	   IV,	  N-­‐hexyl-­‐4-­‐methylbenzene	   sulfonamide	  2.18	  
(1.277	  g,	  5	  mmol)	  was	  used	  as	  the	  N-­‐alkylsulfonamide	  species,	  acetyl	  chloride	  (427	  
µL,	   5	  mmol)	   was	   used	   as	   the	   acid	   chloride	   species	   and	   lithium	   iodide	   (134	  mg,	   1	  
mmol,	  20	  mol%)	  was	  used.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  83%	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  2.96	  (2H,	  q,	  J	  =	  6.9	  Hz,	  CH2,	  2.18)	  and	  3.79	  
(2H,	  m,	  CH2,	  2.20).	  	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.80	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.37	  (2H,	  
d,	  J	  =	  8.2	  Hz,	  Ar),	  3.79	  (2H,	  m,	  CH2),	  2.47	  (3H,	  s,	  CH3),	  2.34	  (3H,	  s,	  CH3),	  1.76-­‐1.68	  (2H,	  
m,	   CH2),	   1.42-­‐1.21	   (6H,	   m,	   CH2),	   0.98-­‐0.81	   (3H,	   m,	   CH3).	   ESI-­‐MS	   of	   [C15H23NO3S];	  
theoretical	  m/z	  of	  [M+H]+	  =	  298.1477,	  measured	  m/z	  of	  [M+H]+	  =	  298.1486.	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.20	  -­‐	  N-­‐Hexyl-­‐N-­‐tosylacetamide	  
The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  39%	  conversion	  by	  comparison	  of	  















Following	  representative	  procedure	  IV,	  N-­‐benzyl-­‐4-­‐methylbenzene	  sulfonamide	  2.17	  
(261	  mg,	  1	  mmol)	  was	  used	  as	  the	  N-­‐alkylsulfonamide	  species,	  benzoyl	  chloride	  (140	  
µL,	  1.2	  mmol)	  was	  used	  as	  the	  acid	  chloride	  species	  and	   lithium	  iodide	  (27	  mg,	  0.2	  
mmol,	   20	  mol%)	   was	   used.	   The	   1H	   NMR:	   (CDCl3,	   250	  MHz)	   of	   the	   crude	   reaction	  
mixture	  showed	  3%	  conversion	  by	  comparison	  of	  the	  peaks	  at	  4.16	  (2H,	  d,	  J	  =	  5.1	  Hz,	  
CH2,	  2.17)	  and	  5.33	  (2H,	  s,	  CH2,	  2.19).	  	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.21	  -­‐	  N-­‐Benzyl-­‐N-­‐tosylbenzamide	  
The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  0%	  conversion.	  
	  







Following	   representative	  procedure	   IV,	  N-­‐hexyl-­‐4-­‐methylbenzene	   sulfonamide	  2.18	  
(255	  mg,	  1	  mmol)	  was	  used	  as	  the	  N-­‐alkylsulfonamide	  species,	  benzoyl	  chloride	  (140	  
µL,	  1.2	  mmol)	  was	  used	  as	  the	  acid	  chloride	  species	  and	   lithium	  iodide	  (27	  mg,	  0.2	  
mmol,	   20	  mol%)	   was	   used.	   The	   1H	   NMR:	   (CDCl3,	   250	  MHz)	   of	   the	   crude	   reaction	  
mixture	  showed	  0%	  conversion.	  
	  	  
Absence	  of	  lithium	  iodide	  -­‐	  2.22	  -­‐	  N-­‐Hexyl-­‐N-­‐tosylacetamide	  









Reactivity	  of	  the	  acid	  derivative	  series	  (Chapter	  2,	  Section	  2.2)	  
Representative	  Procedure	  V	  












To	  oven	  dried	  Radleys	  carousel	  tubes	  lithium	  iodide	  and	  p-­‐toluenesulfonamide	  (342	  
mg,	   2	   mmol)	   were	   added,	   anhydrous	   MeCN	   (2	   mL)	   dissolved	   the	   reagents,	   acid	  
derivative	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  
and	  the	  reaction	  mixture	  was	  heated	  to	  82	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  resulting	  
reaction	  mixture	  was	   then	  washed	  with	  DCM	  and	  sodium	  thiosulfate	   solution.	  The	  
organic	   components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	  
products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  
	  
	  
Acetic	  anhydride	  as	  the	  acid	  derivative	  





Following	  representative	  procedure	  V,	  acetic	  anhydride	  (227	  µL,	  2.4	  mmol)	  was	  used	  
as	  the	  acid	  derivative	  and	  lithium	  iodide	  (268	  mg,	  2	  mmol,	  1	  eq.)	  was	  used.	  The	  1H	  
NMR	  of	   the	   crude	   reaction	  mixture	   showed	   81%	   conversion.	   1H	  NMR:	   (CDCl3,	   300	  
MHz)	  δ	  8.73	  (1H,	  br.s,	  NH),	  7.81	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.22	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  
2.32	  (3H,	  s,	  CH3),	  1.94	  (3H,	  s,	  CH3).	  	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.4	  -­‐	  N-­‐Tosylacetamide98	  
The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  81%	  conversion	  consistent	  with	  






t-­‐Butyl	  acetate	  as	  the	  acid	  derivative	  





Following	  representative	  procedure	  V,	  t-­‐butyl	  acetate	  (324	  µL,	  2.4	  mmol)	  was	  used	  
as	  the	  acid	  derivative	  and	   lithium	  iodide	  (268	  mg,	  2	  mmol,	  1	  equivalent)	  was	  used.	  
The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  0%	  conversion.	  	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.4	  -­‐	  N-­‐Tosylacetamide98	  
The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  0%	  conversion.	  	  
	  
Acetic	  acid	  as	  the	  acid	  derivative	  





Following	   representative	   procedure	  V,	   acetic	   acid	   (138	  µL,	   2.4	  mmol)	  was	   used	   as	  
the	  acid	  derivative	  and	  lithium	  iodide	  (268	  mg,	  2	  mmol,	  1	  equivalent)	  was	  used.	  The	  
1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  0%	  conversion.	  	  
	  
Absence	  of	  lithium	  iodide	  -­‐	  2.4	  -­‐	  N-­‐Tosylacetamide98	  
The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  0%	  conversion.	  	  
	  
Potassium	  iodide	  (Chapter	  2,	  Section	  2.3)	  

















To	   oven	   dried	   Radleys	   carousel	   tubes	   an	   iodide	   source	   or	   salt	   (0.2	  mmol)	   and	   p-­‐
toluenesulfonamide	   (171	   mg,	   1	   mmol)	   were	   added,	   1	   mL	   of	   anhydrous	   MeCN	  
dissolved	  the	  reagents,	  acid	  chloride	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  
The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	  immediately	  heated	  to	  82	  ˚C	  
Chapter	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and	   stirred	   for	   24	   hours.	   The	   resulting	   reaction	  mixture	  was	   then	   cooled	   to	   room	  
temperature	   and	   washed	   with	   DCM	   and	   sodium	   thiosulfate	   solution.	   The	   organic	  
components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	   crude	  
products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  
	  
Iodide	  source	  screen	  
(Table	  2.9,	  Chapter	  2,	  Section	  2.3.1)	  
Following	   representative	   procedure	   VI,	   the	   appropriate	   iodide	   source	   was	   used	  
according	  to	  Table	  2.9	  and	  valeroyl	  chloride	  (150	  µL,	  1.2	  mmol)	  was	  used	  as	  the	  acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	  by	  
comparison	  of	  the	  peaks	  at	  7.94	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar)	  and	  7.83	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar).	  
	  
Other	  salts	  
(Table	  2.10,	  Chapter	  2,	  Section	  2.3.1)	  
Following	   representative	  procedure	  VI,	   the	   appropriate	   salt	  was	  used	  according	   to	  
Table	  2.10	  and	  valeroyl	   chloride	   (150	  µL,	   1.2	  mmol)	  was	  used	  as	   the	  acid	   chloride	  
species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	   into	  2.11	  
by	  comparison	  of	  the	  peaks	  at	  7.94	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar,	  2.11)	  and	  7.83	  (2H,	  d,	  J	  =	  8.3	  
Hz,	  Ar).	  	  
	  
Iodide	  source	  screen	  
(Table	  2.11,	  Chapter	  2,	  Section	  2.3.1)	  
Following	   representative	   procedure	   VI,	   the	   appropriate	   iodide	   source	   was	   used	  
according	  to	  Table	  2.11	  and	  benzoyl	  chloride	  (140	  µL,	  1.2	  mmol)	  was	  used	  as	  the	  acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	  by	  









Variation	  of	  potassium	  iodide	  loading	  
(Table	  2.12,	  Chapter	  2,	  Section	  2.3.1)	  
Following	  representative	  procedure	  VI,	  the	  appropriate	  amount	  of	  potassium	  iodide	  
was	  used	  according	  to	  Table	  2.12	  and	  benzoyl	  chloride	  (140	  µL,	  1.2	  mmol)	  was	  used	  
as	   the	  acid	   chloride	   species.	  The	   1H	  NMR	  of	   the	  crude	   reaction	  mixture	   showed	  %	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  7.97	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar,	  2.10)	  and	  5.83	  
(4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  	  
	  
Solvent	  screen	  
(Table	  2.13,	  Chapter	  2,	  Section	  2.3.1)	  
Following	   representative	   procedure	   VI,	   potassium	   iodide	   (99.6	   mg,	   0.6	   mmol,	   60	  
mol%)	  was	  used	  as	  the	  iodide	  source,	  the	  appropriate	  solvent	  was	  used	  according	  to	  
Table	   2.13	   and	  benzoyl	   chloride	   (140	  µL,	   1.2	  mmol)	  was	  used	  as	   the	   acid	   chloride	  
species.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   %	   conversion	   by	  
comparison	  of	  the	  peaks	  at	  7.97	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar,	  2.10)	  and	  5.83	  (4H,	  s,	  CH2	  2,5-­‐
dimethylfuran).	  	  
	  
Representative	  Procedure	  VII	  

















To	   oven	   dried	   Radleys	   carousel	   tubes	   potassium	   iodide	   (99.6	   mg,	   0.6	   mmol,	   60	  
mol%)	   and	   sulfonamide	   were	   added,	   1	   mL	   of	   anhydrous	   MeCN	   dissolved	   the	  
reagents,	  acid	  chloride	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  
then	  sealed	  and	  the	  reaction	  mixture	  was	   immediately	  heated	  to	  82	  ˚C	  and	  stirred	  
for	  24	  hours.	  The	  resulting	  reaction	  mixture	  was	  then	  cooled	  to	  room	  temperature	  
and	   washed	   with	   DCM	   and	   sodium	   thiosulfate	   solution.	   The	   organic	   components	  
were	   then	   dried	   and	   concentrated	   in	   vacuo.	   Purification	   by	   either	   column	  
chromatography	   or	   recrystallization	   was	   carried	   out	   as	   necessary.	   The	   resulting	  










Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	   title	  compound	  was	   recovered	  as	  an	  off-­‐white	   solid	   (739	  mg,	  
89%	  yield)	   after	   column	   chromatography	  eluting	  with	   3:1	  Hexane/EtOAc.	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  9.36	  (1H,	  br.s,	  NH),	  7.97	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.75	  (2H,	  d,	  J	  =	  8.6	  
Hz,	  Ar),	  7.56-­‐7.40	  (1H,	  m,	  Ar),	  7.34	  (2H,	  t,	  J	  =	  7.6	  Hz,	  Ar),	  7.27	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  
2.36	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   164.4,	   145.3,	   135.5,	   133.5,	   131.1,	  
129.7,	   129.7,	   128.7,	   127.9,	   21.75.	   IR	   (film,	   cm-­‐1):	   νmax	   =	   1703	   (C=O).	   ESI-­‐MS	   of	  
[C14H13NO3S];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   274.0537,	   measured	   m/z	   of	   [M-­‐H]-­‐	   =	  
274.0537.	  
	  






Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  valeroyl	  chloride	  (434	  μL,	  3.6	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	   title	  compound	  was	   recovered	  as	  an	  off-­‐white	   solid	   (676	  mg,	  
88%	  yield)	   after	   column	   chromatography	  eluting	  with	   3:1	  Hexane/EtOAc.	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  9.13	  (1H,	  br.s,	  NH),	  7.94	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.34	  (2H,	  d,	  J	  =	  8.2	  
Hz,	  Ar),	  2.43	  (3H,	  s,	  CH3),	  2.31-­‐2.20	  (2H,	  m,	  CH2),	  1.52	  (2H,	  m,	  CH2),	  1.24	  (2H,	  m,	  CH2),	  
0.82	  (3H,	  t,	  J	  =	  7.3	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  171.5,	  145.2,	  135.6,	  129.7,	  
128.3,	   36.0,	   26.3,	   22.0,	   21.7,	   13.7.	   IR	   (film,	   cm-­‐1):	   νmax	   =	   1704	   (C=O).	   ESI-­‐MS	   of	  













Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  pivaloyl	  chloride	  (445	  μL,	  3.6	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	   title	  compound	  was	   recovered	  as	  an	  off-­‐white	   solid	   (614	  mg,	  
80%	  yield)	   after	   column	   chromatography	  eluting	  with	   3:1	  Hexane/EtOAc.	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.74	  (1H,	  br.s,	  NH),	  7.88	  (2H,	  d,	  J	  =	  8.2	  
Hz,	   Ar),	   7.27	   (2H,	   d,	   J	   =	  8.2	   Hz,	   Ar),	   2.37	   (3H,	   s,	   CH3),	   1.07	   (9H,	   s,	   CH3).	  13C	   NMR:	  
(CDCl3,	  75.5	  MHz)	  δ	  176.2,	  145.0,	  135.5,	  129.6,	  128.4,	  40.0,	  26.7,	  21.7.	  IR	  (film,	  cm-­‐1):	  
νmax	   =	   1708	   (C=O).	   ESI-­‐MS	   of	   [C12H17NO3S];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   254.0851,	  
measured	  m/z	  of	  [M-­‐H]-­‐	  =	  254.0846.	  
	  







Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	   the	   sulfonamide	   species	  and	  dichloroacetyl	   chloride	   (577	  µL,	  6	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  an	  off-­‐white	  
solid	   (344	   mg,	   41%	   yield)	   after	   column	   chromatography	   eluting	   with	   1:1	  
Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.03	  (1H,	  br.s,	  NH),	  7.90	  (2H,	  d,	  J	  =	  8.3	  
Hz,	  Ar),	  7.31	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  5.78	  (1H,	  s,	  CH),	  2.39	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  
75.5	  MHz)	  δ	  160.9,	  146.1,	  134.1,	  129.9,	  128.7,	  65.6,	  21.8.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  1706	  
(C=O).	  ESI-­‐MS	  of	  [C9H935Cl2NO3S];	  theoretical	  m/z	  of	  [M+Na]+	  =	  303.9578,	  measured	  














Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  hydrocinnamoyl	  chloride	  (535	  μL,	  3.6	  mmol)	  as	  
the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  pale	  yellow	  solid	  
(829	  mg,	  91%	  yield)	  after	  column	  chromatography	  eluting	  with	  3:1	  Hexane/EtOAc.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.03	  (1H,	  br.s,	  NH),	  7.89	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.31	  (2H,	  d,	  J	  
=	  8.3	  Hz,	  Ar),	  7.25-­‐7.13	  (3H,	  m,	  Ar),	  7.06	  (2H,	  m,	  Ar),	  2.86	  (2H,	  t,	  J	  =	  7.7	  Hz,	  CH2),	  2.56	  
(2H,	  t,	  J	  =	  7.7	  Hz,	  CH2),	  2.45	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  170.5,	  145.2,	  
139.7,	  135.4,	  129.7,	  128.6,	  128.4,	  128.3,	  126.4,	  37.9,	  30.3,	  21.8.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  
1680	  (C=O).	  ESI-­‐MS	  of	  [C16H17NO3S];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  302.0851,	  measured	  
m/z	  of	  [M-­‐H]-­‐	  =	  302.0855.	  
	  






Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	   as	   the	   sulfonamide	   species	   and	  o-­‐toluoyl	   chloride	   (470	   μL,	   3.6	  mmol)	   as	   the	  
acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  an	  off-­‐white	  solid	   (800	  
mg,	   92%	   yield)	   after	   column	   chromatography	   eluting	   with	   3:1	   Hexane/EtOAc.	   1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.75	  (1H,	  br.s,	  NH),	  7.93	  (2H,	  d,	  J	  =	  8.0	  Hz,	  Ar),	  7.39-­‐7.21	  
(4H,	  m,	  Ar),	  7.12(2H,	  d,	  J	  =	  8.0	  Hz,	  Ar),	  2.37	  (3H,	  s,	  CH3),	  2.27	  (3H,	  s,	  CH3).	  13C	  NMR:	  
(CDCl3,	   75.5	  MHz)	   δ	   166.3,	   145.2,	   138.0,	   135.5,	   132.1,	   131.8,	   131.7,	   129.7,	   128.5,	  
127.3,	  126.0,	  21.8,	  20.1.	   IR	   (film,	   cm-­‐1):	  νmax	  =	  1698	   (C=O).	  ESI-­‐MS	  of	   [C15H15NO3S];	  













Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  4-­‐bromobenzoyl	  chloride	  (790	  mg,	  3.6	  mmol)	  as	  
the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  grey	  solid	  (711	  mg,	  
67%	  yield)	   after	   column	   chromatography	  eluting	  with	   3:1	  Hexane/EtOAc.	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  9.09	  (1H,	  br.s,	  NH),	  8.03	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.66	  (2H,	  d,	  J	  =	  8.8	  
Hz,	  Ar),	  7.58	  (2H,	  d,	  J	  =	  8.8	  Hz,	  Ar),	  7.36	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  2.45	  (3H,	  s,	  CH3).	  13C	  
NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   163.4,	   145.5,	   135.3,	   132.3,	   130.1,	   129.7,	   129.3,	   128.7,	  
126.5,	  21.7.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  1703	  (C=O).	  ESI-­‐MS	  of	  [C14H1279BrNO3S];	  theoretical	  
m/z	  of	  [M-­‐H]-­‐	  =	  351.9643,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  351.9649.	  
	  






Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (514	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  4-­‐methoxybenzoyl	  chloride	  (487	  μL,	  3.6	  mmol)	  
as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  pale	  yellow	  solid	  
(893	  mg,	  97%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Hexane/EtOAc.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.28	  (1H,	  br.s,	  NH),	  8.04	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.79	  (2H,	  d,	  J	  
=	  8.9	  Hz,	  Ar),	  7.34	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  6.89	  (2H,	  d,	  J	  =	  8.9	  Hz,	  Ar),	  3.82	  (3H,	  s,	  CH3),	  
2.43	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   163.8,	   145.1,	   135.6,	   130.1,	   129.6,	  
129.6,	  128.6,	  123.3,	  114.2,	  55.6,	  21.7.	   IR	   (film,	   cm-­‐1):	  νmax	  =	  1766	   (C=O).	   ESI-­‐MS	  of	  














Following	  representative	  procedure	  VII,	  p-­‐toluenesulfonamide	  (171	  mg,	  1	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  (s)-­‐2-­‐phenylpropoyl	  chloride	  (205	  μL,	  1.2	  mmol,	  
>99%	   enantiomeric	   excess)	   as	   the	   acid	   chloride	   species.	   The	   title	   compound	   was	  
recovered	  as	  an	  off-­‐white	  solid	  (164	  mg,	  54%	  yield,	  80%	  enantiomeric	  excess)	  after	  
preparative	  chiral	  HPLC.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.17	  (1H,	  br.s,	  NH),	  7.72	  (2H,	  d,	  
J	  =	  8.2	  Hz,	  Ar),	  7.19	  (5H,	  d,	   J	  =	  6.2	  Hz,	  Ar),	  7.00	  (2H,	  d,	   J	  =	  8.2	  Hz,	  Ar),	  3.48	  (1H,	  q,	  
CH3),	  2.37	  (3H,	  s,	  CH3),	  1.30	  (3H,	  s,	  CH3).	  	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  171.5,	  145.1,	  
139.0,	  135.2,	  130.0,	  129.3,	  128.4,	  127.9,	  127.6,	  47.4,	  21.7,	  18.0.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  
1709	  (C=O).	  ESI-­‐MS	  of	  [C16H17NO3S];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  302.0851,	  measured	  
m/z	  of	  [M-­‐H]-­‐	  =	  302.0841.	  
	  






Following	  representative	  procedure	  VII,	  benzenesulfonamide	  (471	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (752	  mg,	  96%	  
yield)	  after	  column	  chromatography	  eluting	  with	  2:1	  Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  
300	  MHz)	  δ	  9.10	  (1H,	  br.s,	  NH),	  8.10	  (2H,	  d,	  J	  =	  7.1	  Hz,	  Ar),	  7.73	  (2H,	  d,	  J	  =	  7.1	  Hz,	  Ar),	  
7.59	  (1H,	  1,	  J	  =	  7.5	  Hz,	  Ar),	  7.49	  (3H,	  t,	  J	  =	  7.5	  Hz,	  Ar),	  7.36	  (2H,	  t,	  J	  =	  7.5	  Hz,	  Ar).	  13C	  
NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   164.2,	   138.5,	   134.1,	   133.6,	   131.1,	   129.0,	   129.0,	   128.6,	  
127.8.	   IR	  (film,	  cm-­‐1):	  νmax	  =	  1694	  (C=O).	  ESI-­‐MS	  of	  [C13H11NO3S];	  theoretical	  m/z	  of	  













Following	  representative	  procedure	  VII,	  methanesulfonamide	  (285	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  white	  solid	   (496	  mg,	  83%	  
yield)	   recrystallized	   after	   layering	   hexane	   on	   DCM	   solution.	   1H	   NMR:	   (CDCl3,	   300	  
MHz)	  δ	  8.98	  (1H,	  br.s,	  NH),	  7.81	  (2H,	  d,	  J	  =	  7.4	  Hz,	  Ar),	  7.56	  (1H,	  t,	  J	  =	  7.4	  Hz,	  Ar),	  7.43	  
(2H,	  t,	  J	  =	  7.4	  Hz,	  Ar),	  3.37	  (3H,	  s,	  CH3).	  	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  165.5,	  133.9,	  
130.9,	   129.1,	   127.9,	   41.8.	   IR	   (film,	   cm-­‐1):	  νmax	   =	   1678	   (C=O).	   ESI-­‐MS	  of	   [C8H9NO3S];	  
theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  198.0225,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  198.0228.	  
	  






Following	   representative	   procedure	   VII,	   2,4,6-­‐trimethylbenzenesulfonamide	   (598	  
mg,	  3	  mmol)	  was	  used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  
mmol)	   as	   the	   acid	   chloride	   species.	   The	   title	   compound	   was	   recovered	   as	   a	   pale	  
yellow	   solid	   (664	   mg,	   73%	   yield)	   after	   column	   chromatography	   eluting	   with	   8:1	  
Hexane/EtOAc,	  mp	  174-­‐176	  ˚C,	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.41	  (1H,	  br.s,	  NH),	  7.76	  
(2H,	  m,	  Ar),	  7.50	  (1H,	  t,	  J	  =	  8.0	  Hz,	  Ar),	  7.37	  (2H,	  t,	  J	  =	  8.0	  Hz,	  Ar),	  6.93	  (2H,	  s,	  Ar),	  2.71	  
(6H,	   s,	   CH3);	   2.23	   (3H,	   s,	   CH3).	   	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   164.8,	   143.9,	   140.7,	  
133.5,	  132.2,	  131.2,	  129.0,	  129.0,	  127.8,	  22.9,	  21.1.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  2986,	  1696	  
(C=O),	  1600,	  1452,	  1337,	  1156,	  1054,	  708.	  ESI-­‐MS	  of	  [C16H17NO3S];	  theoretical	  m/z	  of	  
[M-­‐H]-­‐	   =	   304.34,	  measured	  m/z	   of	   [M-­‐H]-­‐	   =	   304.2	   Requires	   C	   63.34%;	   H	   5.65%;	   N	  













Following	   representative	   procedure	   VII,	   4-­‐nitrobenzenesulfonamide	   (607	   mg,	   3	  
mmol)	  was	  used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  mmol)	  
as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  pale	  yellow	  solid	  
(716	  mg,	  78%	  yield)	  after	  column	  chromatography	  eluting	  with	  3:1	  Hexane/EtOAc.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.00	  (1H,	  br.s,	  NH),	  8.39-­‐8.24	  (4H,	  m,	  Ar),	  7.71	  (2H,	  d,	  J	  	  =	  
7.2	  Hz,	  Ar),	  7.47-­‐7.32	  (3H,	  m,	  Ar).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  164.2,	  148.8,	  134.1,	  
130.2,	  129.2,	  127.8,	  127.7,	  124.2,	  114.6.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  1692	  (C=O).	  ESI-­‐MS	  of	  
[C13H10N2O5S];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   305.0304,	   measured	   m/z	   of	   [M-­‐H]-­‐	   =	  
305.0302.	  
	  






Following	   representative	  procedure	  VII,	   4-­‐methoxybenzenesulfonamide	   (562	  mg,	   3	  
mmol)	  was	  used	  as	  the	  sulfonamide	  species	  and	  benzoyl	  chloride	  (418	  μL,	  3.6	  mmol)	  
as	  the	  acid	  chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  pale	  yellow	  solid	  
(728	  mg,	  83%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Hexane/EtOAc.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.32	  (1H,	  br.s,	  NH),	  8.10	  (2H,	  d,	  J	  =	  9.1	  Hz,	  Ar),	  7.82	  (2H,	  d,	  J	  
=	  7.4	  Hz,	  Ar),	  7.55	  (1H,	  m,	  Ar),	  7.42	  (2H,	  t,	  J	  =	  7.4	  Hz,	  Ar),	  7.01	  (2H,	  d,	  J	  =	  9.1	  Hz,	  Ar),	  
3.87	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   164.4,	   164.1,	   133.5,	   131.2,	   131.1,	  
129.7,	   128.9,	   127.8,	   114.2,	   55.8.	   IR	   (film,	   cm-­‐1):	   νmax	   =	   1695	   (C=O).	   ESI-­‐MS	   of	  




























Step	  1:	  DMF	  (3	  mL,	  39	  mmol)	  was	  added	  to	  a	  flask	  and	  cooled	  to	  0	  ˚C,	  in	  an	  ice	  bath,	  
sulfonyl	   chloride	   (3.16	   mL,	   39	   mmol)	   was	   added	   dropwise	   to	   the	   cooled	   DMF,	  
maintaining	  the	  temperature	  below	  25	  ˚C.	  A	  precipitate	  formed	  after	  10	  minutes	  and	  
was	  held	  at	  <25	  ˚C	  for	  30	  minutes.	  2-­‐bromothiophene	  (2.9	  mL,	  30	  mmol)	  was	  added	  
to	   the	  DMF-­‐SO2Cl2	   complex	   and	   the	  mixture	  was	   immediately	   heated	   to	   98	   ˚C	   for	  
one	  hour.	  The	  viscous	  brown	  mixture	  was	  cooled	  to	  room	  temperature	  and	  added	  to	  
ice-­‐water	   and	   subsequently	   extracted	   with	   CHCl3.	   Then	   a	   subsequent	   aqueous	  
extraction	   with	   5%	   lithium	   chloride	   solution	   and	   DCM	   was	   performed	   to	   remove	  
excess	  DMF.	   The	   organic	   components	  were	   then	   dried	   and	   concentrated	   in	   vacuo	  
and	  subsequently	  purified	  by	  bulb-­‐to-­‐bulb	  distillation	   in	  vacuo	  bp	  95-­‐100	   ˚C/1	  Torr	  
affording	  5-­‐bromothiophene-­‐2-­‐sulfonylchloride	  2.37	  as	  a	  yellow	  oil.	  
Step	   2:	   5-­‐bromothiophene-­‐2-­‐sulfonylchloride	   2.37	   (3.1235	   g,	   11.94	   mmol)	   and	   2-­‐
methyltetrahydrofuran	   (30	   mL,	   solvent)	   were	   combined	   under	   argon	   in	   a	   flask	  
forming	   a	   light	   yellow	   solution.	   The	   solution	   was	   cooled	   to	   0	   ˚C	   in	   an	   ice	   bath.	  
Concentrated	  aqueous	  NH4OH	  (250	  mL,	  48	  mmol,	  5	  N)	  was	  added	  dropwise	  to	  the	  
reaction	  over	  30	  minutes.	  The	  reaction	  was	  allowed	  to	  warm	  to	  room	  temperature	  
and	  stirred	  overnight.	  The	  reaction	  mixture	  was	  then	  diluted	  with	  100	  mL	  DI	  water.	  
The	  pH	  of	  the	  reaction	  mixture	  was	  then	  adjusted	  to	  pH	  <6	  using	  37%	  conc.	  aq	  HCL.	  
The	   phases	   were	   separated	   and	   the	   aqueous	   layer	   was	   back	   extracted	   with	   2-­‐
methyltetrahydrofuran	  (3	  X	  10	  mL)	  and	  subsequently	  washed	  with	  brine	  (3	  X	  10	  mL).	  
The	   organic	   components	   were	   then	   dried	   and	   concentrated	   in	   vacuo	   to	   afford	   5-­‐












The	   title	   compound	   was	   recovered	   as	   a	   pale	   yellow	   oil	   (3.1235	   g,	   40%	   yield).	   1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.58	  (1H,	  d,	  J	  =	  4.2	  Hz,	  Ar),	  7.10	  (1H,	  d,	  J	  =	  4.2	  Hz,	  Ar).	  
	  





The	   title	   compound	  was	   recovered	   as	   a	   beige	   solid	   (2.579	   g,	   89%	   yield).	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.45	  (1H,	  d,	  J	  =	  4.0	  Hz,	  Ar),	  7.09	  (1H,	  d,	  J	  =	  4.0	  Hz,	  Ar),	  5.10	  (2H,	  
br.s,	   NH2).	   13C	   NMR:	   (CDCl3,	   75.5	   MHz)	   δ	   146.9,	   131.3,	   131.0,	   117.2.	   ESI-­‐MS	   of	  
[C4H479BrNO2S2];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   239.8789,	   measured	  m/z	   of	   [M-­‐H]-­‐	   =	  
239.8793.	  
	  



















	  To	   oven	   dried	   Radleys	   carousel	   tubes	   potassium	   iodide	   (199.2	  mg,	   1.2	  mmol,	   60	  
mol%)	  and	  5-­‐bromothiophene-­‐2-­‐sulfonamide	  (484	  mg,	  2	  mmol,	  2.38)	  were	  added,	  1	  
mL	  of	  anhydrous	  MeCN	  dissolved	  the	  reagents,	  2,4-­‐dichlorobenzoyl	  chloride	  (336	  µL,	  
2.4	  mmol)	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  
and	  the	  reaction	  mixture	  was	  immediately	  heated	  to	  82	  ˚C	  and	  stirred	  for	  24	  hours.	  
The	   resulting	   reaction	  mixture	  was	   then	   cooled	   to	   room	   temperature	   and	  washed	  
with	  DCM	  and	  sodium	  thiosulfate	  solution.	  The	  organic	  components	  were	  then	  dried	  
and	   concentrated	   in	   vacuo.	   Purification	   by	   column	   chromatography	   3:1	  
Hexane/EtOAc.	   The	   resulting	   products	   were	   analysed	   by	   their	   1H	   and	   13C	   NMR	  












The	  title	  compound	  was	  recovered	  as	  a	  white	  solid	   (0.1584	  g,	  19%	  yield).	   1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  8.99	  (1H,	  br.s,	  NH),	  7.70	  (1H,	  d,	  J	  =	  8.5	  Hz,	  Ar),	  7.67	  (1H,	  d,	  J	  =	  4.1	  
Hz,	  Ar),	  7.40	  (1H,	  s,	  Ar),	  7.32	  (2H,	  m,	  Ar),	  7.07	  (1H,	  d,	  J	  =	  4.1	  Hz,	  Ar).	  13C	  NMR:	  (CDCl3,	  
75.5	  MHz)	   δ	   164.5,	   139.9,	   136.2,	   135.1,	   132.4,	   131.3,	   131.2,	   130.6,	   129.5,	   127.5,	  
121.1.	   ESI-­‐MS	   of	   [C11H679Br35Cl2NO3S2];	   theoretical	   m/z	   of	   [M+Na]+	   =	   435.8247,	  
measured	  m/z	  of	  [M+Na]+	  =	  435.8257.	  
	  
Amides	  (Chapter	  2,	  Section	  2.3.2)	  












To	  oven	  dried	  Radleys	  carousel	  tubes	  an	  iodide	  source	  (0.5	  mmol,	  50	  mol%)	  and	  p-­‐
toluamide	   (135	  mg,	   1	  mmol)	  were	   added,	   1	  mL	  of	   anhydrous	  MeCN	  dissolved	   the	  
reagents,	   benzoyl	   chloride	   (140	  µL,	   1.2	  mmol)	   was	   added	   to	   the	   solution	   using	   a	  
micropipette.	  The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	   immediately	  
heated	   to	   82	   ˚C	   and	   stirred	   for	   24	   hours.	   The	   resulting	   reaction	  mixture	  was	   then	  
cooled	  to	  room	  temperature	  and	  washed	  with	  DCM	  and	  sodium	  thiosulfate	  solution.	  
The	  organic	  components	  were	  then	  dried	  and	  concentrated	   in	  vacuo.	  The	  resulting	  
crude	  products	  were	  analysed	  by	   their	   1H	  and	   13C	  NMR	  spectra	  against	  an	   internal	  
standard	  of	  2,5-­‐dimethylfuran	  (0.5	  mmol).	  
	  
Iodide	  source	  screen	  
(Table	  2.16,	  Chapter	  2,	  Section	  2.3.2)	  
Following	   representative	   procedure	   VII,	   the	   appropriate	   iodide	   source	   was	   used	  
according	   to	   Table	   2.16.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   %	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  7.86	  (2H,	  d,	  J	  =	  8.6	  Hz,	  Ar,	  2.40)	  and	  5.75	  
(4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.93	  (1H,	  br.s,	  NH),	  7.86	  
Chapter	  5	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(2H,	  d,	  J	  =	  8.6	  Hz,	  Ar),	  7.77	  (2H,	  d,	  J	  =	  8.1	  Hz,	  Ar),	  7.66-­‐7.43	  (3H,	  m,	  Ar),	  7.30	  (2H,	  d,	  J	  
=	  8.1	  Hz,	  Ar),	   2.43	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	  δ	  166.5,	   166.2,	   144.1,	  
133.5,	  133.1,	  130.5,	  129.6,	  128.9,	  128.0,	  127.9,	  21.7.	  
	  
Variation	  of	  potassium	  iodide	  loading	  
(Table	  2.17,	  Chapter	  2,	  Section	  2.3.2)	  
Following	  representative	  procedure	  VII,	  the	  appropriate	  amount	  of	  potassium	  iodide	  
was	  used	  according	  to	  Table	  2.17.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
%	  conversion	  by	  comparison	  of	  the	  peaks	  at	  7.86	  (2H,	  d,	  J	  =	  8.6	  Hz,	  Ar,	  2.40)	  and	  5.75	  
(4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  	  
	  
Variation	  of	  acid	  chloride	  and	  potassium	  iodide	  amount	  
(Table	  2.18,	  Chapter	  2,	  Section	  2.3.2)	  
Following	  representative	  procedure	  VII,	  the	  appropriate	  amount	  of	  potassium	  iodide	  
and	  benzoyl	   chloride	  was	   used	   according	   to	   Table	   2.18.	   The	   1H	  NMR	  of	   the	   crude	  
reaction	  mixture	  showed	  %	  conversion	  by	  comparison	  of	  the	  peaks	  at	  7.86	  (2H,	  d,	  J	  =	  







O Oi) KI (50 mol%),
   82 ˚C, 24 h
ii) H2O
	  
To	  oven	  dried	  Radleys	  carousel	  tubes	  potassium	  iodide	  (83	  mg,	  0.5	  mmol,	  50	  mol%)	  
and	   MeCN	   (52	   μL,	   1	   mmol)	   were	   added,	   benzoyl	   chloride	   (116	   μL,	   1	   mmol)	   was	  
added	   to	   the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	  
reaction	   mixture	   was	   immediately	   heated	   to	   82	   ˚C	   and	   stirred	   for	   24	   hours.	   The	  
resulting	  reaction	  mixture	  was	   then	  cooled	  to	  room	  temperature	  and	  washed	  with	  
DCM	  and	  sodium	  thiosulfate	  solution.	  The	  organic	  components	  were	  then	  dried	  and	  
concentrated	  in	  vacuo.	  The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  
showed	  5%	  conversion	  into	  2.41	  by	  comparison	  of	  the	  peaks	  at	  7.95	  (2H,	  d,	  J	  =	  8.5	  




Representative	  Procedure	  VIII	  

















To	  oven	  dried	  Radleys	   carousel	   tubes	   potassium	   iodide	   (498	  mg,	   3	  mmol,	   1.2	   eq.)	  
and	   amide	   were	   added,	   3	   mL	   of	   anhydrous	   MeCN	   dissolved	   the	   reagents,	   acid	  
chloride	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  
and	  the	  reaction	  mixture	  was	  immediately	  heated	  to	  82	  ˚C	  and	  stirred	  for	  24	  hours.	  
The	   resulting	   reaction	  mixture	  was	   then	   cooled	   to	   room	   temperature	   and	  washed	  
with	  DCM	  and	  sodium	  thiosulfate	  solution.	  The	  organic	  components	  were	  then	  dried	  
and	  concentrated	   in	  vacuo.	  The	  resulting	  crude	  products	  were	  analysed	  by	  their	  1H	  
and	  13C	  NMR	  spectra	  and	  mass	  spectrometry	  data.	  
	  






Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	  amide	  species	  and	  p-­‐toluoyl	   chloride	   (1.587	  mL,	  12	  mmol)	  as	   the	  acid	  chloride	  
species.	   The	   1H	  NMR	  of	   the	   crude	   reaction	  mixture	   showed	   100%	   conversion	   into	  
2.40	  by	  comparison	  of	  the	  peaks	  at	  7.86	  (2H,	  d,	  J	  =	  8.6	  Hz,	  Ar,	  2.40)	  and	  5.75	  (4H,	  s,	  
CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.93	  (1H,	  br.s,	  NH),	  7.86	  (2H,	  d,	  J	  
=	  8.6	  Hz,	  Ar),	  7.77	  (2H,	  d,	  J	  =	  8.1	  Hz,	  Ar),	  7.66-­‐7.43	  (3H,	  m,	  Ar),	  7.30	  (2H,	  d,	  J	  =	  8.1	  Hz,	  
Ar),	  2.43	  (3H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  166.5,	  166.2,	  144.1,	  133.5,	  133.1,	  
130.5,	   129.6,	   128.9,	   128.0,	   127.9,	   21.7.	   ESI-­‐MS	   of	   [C15H13NO2];	   theoretical	   m/z	   of	  













Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	  amide	  species	  and	  acetyl	  chloride	  (853	  µL,	  12	  mmol)	  as	  the	  acid	  chloride	  species.	  
The	   1H	  NMR	   of	   the	   crude	   reaction	  mixture	   showed	   100%	   conversion	   into	  2.41	   by	  
comparison	   of	   the	   peaks	   at	   2.54	   (3H,	   s,	   CH3,	   2.41)	   and	   5.75	   (4H,	   s,	   CH2	   2,5-­‐
dimethylfuran).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.19	  (1H,	  br.s,	  NH),	  7.83	  (2H,	  d,	  J	  =	  7.1	  
Hz,	  Ar),	  7.62-­‐7.36	  (3H,	  m,	  Ar),	  2.54	  (3H,	  s,	  CH3).	  
	  





Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   benzoyl	   chloride	   (1.384	  mL,	   12	  mmol)	   as	   the	   acid	   chloride	  
species.	   The	   1H	  NMR	  of	   the	   crude	   reaction	  mixture	   showed	   100%	   conversion	   into	  
2.42	  by	  comparison	  of	  the	  peaks	  at	  7.91	  (2H,	  d,	  J	  =	  7.3	  Hz,	  Ar)	  and	  5.75	  (4H,	  s,	  CH2	  
2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.66	  (1H,	  br.s,	  NH),	  7.91	  (4H,	  d,	  J	  =	  
7.3	  Hz,	  Ar),	  7.79-­‐7.36	  (6H,	  m,	  Ar).	  
	  





Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   2-­‐methylbenzoyl	   chloride	   (1.565	  mL,	   12	  mmol)	   as	   the	   acid	  
chloride	   species.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   100%	  
conversion	  into	  2.43	  by	  comparison	  of	  the	  peaks	  at	  7.90	  (2H,	  d,	  J	  =	  7.2	  Hz,	  Ar)	  and	  
5.87	  (4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  8.89	  (1H,	  br.s,	  NH),	  
7.90	  (2H,	  d,	  J	  =	  7.2	  Hz,	  Ar),	  7.69-­‐7.25	  (7H,	  m,	  Ar),	  2.52	  (3H,	  s,	  CH3).	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Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   3-­‐methylbenzoyl	   chloride	   (1.198	  mL,	   12	  mmol)	   as	   the	   acid	  
chloride	   species.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   100%	  
conversion	  into	  2.44	  by	  comparison	  of	  the	  peaks	  at	  7.96	  (2H,	  d,	  J	  =	  8.5	  Hz,	  Ar)	  and	  
5.75	  (4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (DMSO,	  250	  MHz)	  δ	  9.46	  (1H,	  br.s,	  NH),	  
7.96	  (2H,	  d,	  J	  =	  8.5	  Hz,	  Ar),	  7.81-­‐7.71	  (2H,	  m,	  Ar),	  7.56-­‐7.31	  (5H,	  m,	  Ar),	  2.37	  (3H,	  s,	  
CH3).	  
	  





Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	  amide	  species	  and	  4-­‐methoxybenzoyl	  chloride	  (1.625	  mL,	  12	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  58%	  conversion	  
into	  2.45	  by	  comparison	  of	  the	  peaks	  at	  7.88	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar)	  and	  5.84	  (4H,	  s,	  
CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.54	  (1H,	  br.s,	  NH),	  8.07	  (2H,	  d,	  J	  
=	  8.9	  Hz,	  Ar),	  7.88	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.70-­‐7.37	  (3H,	  m,	  Ar),	  6.97	  (2H,	  d,	  J	  =	  8.9	  Hz,	  
Ar),	  3.85	  (3H,	  s,	  CH3).	  
	  






Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   valeroyl	   chloride	   (1.424	  mL,	   12	  mmol)	   as	   the	   acid	   chloride	  
species.	   The	   1H	  NMR	  of	   the	   crude	   reaction	  mixture	   showed	   100%	   conversion	   into	  
2.46	  by	  comparison	  of	  the	  peaks	  at	  7.90	  (2H,	  d,	  J	  =	  8.6	  Hz,	  Ar)	  and	  5.78	  (4H,	  s,	  CH2	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2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.70	  (1H,	  br.s,	  NH),	  7.90	  (2H,	  d,	  J	  =	  
8.6,	  Ar),	  7.65-­‐7.35	  (3H,	  m,	  Ar),	  2.90	  (2H,	   t,	   J	  =	  7.4	  Hz,	  CH2),	  1.75-­‐1.47	  (2H,	  m,	  CH2),	  
1.47-­‐1.19	  (2H,	  m,	  CH2),	  0.97-­‐0.81	  (3H,	  m,	  CH3).	  
	  






Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   trimethylacetyl	   chloride	   (1.478	   mL,	   12	   mmol)	   as	   the	   acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  66%	  conversion	  
into	  2.47	  by	  comparison	  of	  the	  peaks	  at	  7.77	  (2H,	  d,	  J	  =	  7.0	  Hz,	  Ar)	  and	  5.84	  (4H,	  s,	  
CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  8.63	  (1H,	  br.s,	  NH),	  7.77	  (2H,	  d,	  J	  
=	  7.0	  Hz,	  Ar),	  7.67-­‐7.43	  (3H,	  m,	  Ar),	  1.35	  (9H,	  s,	  CH3).	  
	  





Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   cinnamoyl	   chloride	   (1.999	   g,	   12	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  48%	  conversion	  into	  2.48	  
by	  comparison	  of	   the	  peaks	  at	  7.97	   (2H,	  d,	   J	  =	  8.7	  Hz,	  Ar)	  and	  5.86	   (4H,	  s,	  CH2	  2,5-­‐
dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.90	  (1H,	  br.s,	  NH),	  7.97	  (2H,	  d,	  J	  =	  8.7,	  
Ar),	  7.69-­‐7.36	  (8H,	  m,	  Ar),	  6.63	  (2H,	  d,	  J	  =	  15.6	  Hz,	  HC=CH).	  
	  






Following	  representative	  procedure	  VIII,	  benzamide	  (606	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   cyclopropanecarbonyl	   chloride	   (1.089	  mL,	   12	  mmol)	   as	   the	  
Chapter	  5	  
158	  
acid	   chloride	   species.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   58%	  
conversion	  into	  2.49	  by	  comparison	  of	  the	  peaks	  at	  7.89	  (2H,	  d,	  J	  =	  4.9	  Hz,	  Ar)	  and	  
5.86	  (4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.57	  (1H,	  br.s,	  NH),	  
7.89	   (2H,	  d,	   J	  =	  4.9	  Hz,	  Ar),	  7.54-­‐7.43	   (3H,	  m,	  Ar),	  2.55-­‐2.40	   (1H,	  m,	  CH),	  1.06-­‐0.83	  
(4H,	  m,	  CH2).	  
	  






Following	  representative	  procedure	  VIII,	  p-­‐toluamide	  (676	  mg,	  5	  mmol)	  was	  used	  as	  
the	   sulfonamide	   species	   and	   benzoyl	   chloride	   (1.384	   mL,	   12	   mmol)	   as	   the	   acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  79%	  conversion	  
into	  2.40	  by	  comparison	  of	   the	  peaks	  at	  7.86	   (2H,	  d,	   J	  =	  8.6	  Hz,	  Ar,	  2.40)	  and	  5.75	  
(4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  8.93	  (1H,	  br.s,	  NH),	  7.86	  
(2H,	  d,	  J	  =	  8.6	  Hz,	  Ar),	  7.77	  (2H,	  d,	  J	  =	  8.1	  Hz,	  Ar),	  7.66-­‐7.43	  (3H,	  m,	  Ar),	  7.30	  (2H,	  d,	  J	  
=	  8.1	  Hz,	  Ar),	   2.43	   (3H,	   s,	   CH3).	   13C	  NMR:	   (CDCl3,	   75.5	  MHz)	  δ	  166.5,	   166.2,	   144.1,	  
133.5,	   133.1,	   130.5,	   129.6,	   128.9,	   128.0,	   127.9,	   21.7.	   ESI-­‐MS	   of	   [C15H13NO2];	  
theoretical	  m/z	  of	  [M+H]+	  =	  240.1014,	  measured	  m/z	  of	  [M+H]+	  =	  240.1025.	  
	  





Following	   representative	  procedure	  VIII,	   acetamide	   (296	  mg,	  5	  mmol)	  was	  used	  as	  
the	   amide	   species	   and	   benzoyl	   chloride	   (1.384	  mL,	   12	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  66%	  conversion	  into	  2.41	  
by	   comparison	   of	   the	   peaks	   at	   2.54	   (3H,	   s,	   CH3,	   2.41)	   and	   5.75	   (4H,	   s,	   CH2	   2,5-­‐
dimethylfuran).	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  δ	  9.19	  (1H,	  br.s,	  NH),	  7.83	  (2H,	  d,	  J	  =	  7.1	  










Following	   representative	   procedure	   VIII,	   4-­‐methoxybenzamide	   (756	   mg,	   5	   mmol)	  
was	  used	  as	  the	  amide	  species	  and	  benzoyl	  chloride	  (1.384	  mL,	  12	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  70%	  conversion	  
into	  2.50	  by	  comparison	  of	  the	  peaks	  at	  7.88	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar)	  and	  5.84	  (4H,	  s,	  
CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.54	  (1H,	  br.s,	  NH),	  8.07	  (2H,	  d,	  J	  
=	  8.9,	  Ar),	  7.88	  (2H,	  d,	  J	  =	  8.3	  Hz,	  Ar),	  7.70-­‐7.37	  (3H,	  m,	  Ar),	  6.97	  (2H,	  d,	  J	  =	  8.9	  Hz,	  
Ar),	  3.85	  (3H,	  s,	  CH3).	  
	  






Following	   representative	   procedure	   VIII,	   hexamide	   (576	  mg,	   5	  mmol)	  was	   used	   as	  
the	   amide	   species	   and	   benzoyl	   chloride	   (1.384	  mL,	   12	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  75%	  conversion	  into	  2.51	  
by	  comparison	  of	   the	  peaks	  at	  7.96	   (2H,	  d,	   J	  =	  7.4	  Hz,	  Ar)	  and	  5.84	   (4H,	  s,	  CH2	  2,5-­‐
dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.60	  (1H,	  br.s,	  NH),	  7.96	  (2H,	  d,	  J	  =	  7.4,	  
Ar),	  7.66-­‐7.39	  (3H,	  m,	  Ar),	  3.02	  (2H,	  t,	  J	  =	  7.5	  Hz,	  CH2),	  1.65	  (2H,	  q,	  J	  =	  7.5	  Hz,	  CH2),	  
1.50-­‐1.25	  (2H,	  m,	  CH2),	  0.93	  (3H,	  t,	  J	  =	  7.1	  Hz,	  CH3).	  
	  






Following	   representative	  procedure	  VIII,	  2-­‐phenylacetamide	   (676	  mg,	  5	  mmol)	  was	  
used	   as	   the	   amide	   species	   and	   benzoyl	   chloride	   (1.384	  mL,	   12	  mmol)	   as	   the	   acid	  
chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  80%	  conversion	  
into	  2.52	  by	  comparison	  of	  the	  peaks	  at	  7.80	  (2H,	  d,	  J	  =	  7.1	  Hz,	  Ar)	  and	  5.84	  (4H,	  s,	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CH2	  2,5-­‐dimethylfuran).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  9.09	  (1H,	  br.s,	  NH),	  7.80	  (2H,	  d,	  J	  
=	  7.1,	  Ar),	   7.63-­‐7.49	   (1H,	  m,	  Ar),	   7.47-­‐7.35	   (2H,	  m,	  Ar),	   7.33-­‐7.10	   (5H,	  m,	  Ar),	   3.58	  
(2H,	  s,	  CH2).	  
	  
Other	  nucleophiles	  (Chapter	  2,	  Section	  2.3.3)	  






















To	  oven	  dried	  Radleys	   carousel	   tubes	   potassium	   iodide	   (598	  mg,	   3.6	  mmol)	   and	   a	  
hindered	   phenol	   (3	   mmol)	   were	   added,	   3	   mL	   of	   anhydrous	   MeCN	   dissolved	   the	  
reagents,	  acid	  chloride	  (7.2	  mmol)	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  
The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	  immediately	  heated	  to	  82	  ˚C	  
and	   stirred	   for	   24	   hours.	   The	   resulting	   reaction	  mixture	  was	   then	   cooled	   to	   room	  
temperature	   and	   washed	   with	   DCM	   and	   sodium	   thiosulfate	   solution.	   The	   organic	  
components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   Purification	   by	   either	  
column	  chromatography	  or	  recrystallization	  was	  carried	  out	  as	  necessary.	  
	  





Following	   representative	  procedure	   IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐4-­‐methylphenol	   (661	  mg,	  3	  
mmol)	   as	   the	   hindered	   phenol	   and	   acetyl	   chloride	   (510	   μL,	   7.2	  mmol)	   as	   the	   acid	  
chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (746	  mg,	  95%	  
yield)	   after	   column	   chromatography	   eluting	   with	   99:1	   Hexane/EtOAc.	   1H	   NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.17-­‐7.12	   (2H,	  m,	  Ar),	  2.36	   (3H,	   s,	  CH3),	  2.35	   (3H,	   s,	  CH3),	  1.37	  
(18H,	  s,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  171.4,	  145.7,	  142.0,	  134.6,	  127.1,	  35.3,	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31.5,	  22.7,	  21.6.	   IR	  (film,	  cm-­‐1):	  νmax	  =	  1759	  (C=O).	  ESI-­‐MS	  of	  [C17H26O2];	  theoretical	  
m/z	  of	  [M+H]+	  =	  285.1831,	  measured	  m/z	  of	  [M+H]+	  =	  285.1829.	  
	  





Following	   representative	  procedure	   IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐4-­‐methylphenol	   (661	  mg,	  3	  
mmol)	  as	  the	  hindered	  phenol	  and	  valeroyl	  chloride	  (855	  μL,	  7.2	  mmol)	  as	  the	  acid	  
chloride	   species.	   The	   title	   compound	  was	   recovered	   as	   a	   yellow	   oil	   (882	  mg,	   97%	  
yield)	   after	   column	   chromatography	   eluting	   with	   99:1	   Hexane/EtOAc.	   1H	   NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.12	   (2H,	   s,	  Ar),	   2.68-­‐2.53	   (2H,	  m,	  CH2),	  2.32	   (3H,	   s,	  CH3),	  1.76	  
(2H,	  m,	  CH2),	  1.46	  (2H,	  m,	  CH2),	  1.33	  (18H,	  s,	  CH3),	  0.98	  (3H,	   t,	   J	  =	  7.3	  Hz,	  CH3).	  13C	  
NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  173.8,	  145.9,	  142.0,	  134.4,	  127.0	  Hz,	  35.2,	  31.5,	  30.2,	  26.4,	  
22.4,	  21.6,	  13.8.	   IR	  (film,	  cm-­‐1):	  νmax	  =	  1758	  (C=O).	  ESI-­‐MS	  of	  [C17H32O2];	  theoretical	  
m/z	  of	   [M+H]+	  =	  305.2481,	  measured	  m/z	  of	   [M+H]+	  =	  305.2485.	  C	  H	  N	   requires	  C	  
78.90%;	  H	  10.59%;	  N	  0%,	  found:	  C	  78.60%;	  H	  10.50%;	  N	  0%	  	   	   	  
	   	   	  






Following	   representative	  procedure	   IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐4-­‐methylphenol	   (661	  mg,	  3	  
mmol)	  as	  the	  hindered	  phenol	  and	  pivaloyl	  chloride	  (890	  μL,	  7.2	  mmol)	  as	  the	  acid	  
chloride	  species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  solid	  (493	  mg,	  54%	  
yield)	   after	   column	   chromatography	   eluting	   with	   99:1	   Hexane/EtOAc.	   1H	   NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.13	  (2H,	  s,	  Ar),	  2.34	  (3H,	  s,	  CH3),	  1.40	  (9H,	  s,	  CH3),	  1.35	  (18H,	  s,	  
CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  177.4,	  147.7,	  140.6,	  134.8,	  127.8,	  127.4,	  123.5,	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30.1,	   27.3,	   21.2.	   ESI-­‐MS	   of	   [C20H32O2];	   theoretical	   m/z	   of	   [M+Na]+	   =	   327.2300,	  
measured	  m/z	  of	  [M+Na]+	  =	  327.2314.	  
	  






Following	   representative	  procedure	   IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐4-­‐methylphenol	   (661	  mg,	  3	  
mmol)	  as	  the	  hindered	  phenol	  and	  benzoyl	  chloride	  (835	  μL,	  7.2	  mmol)	  as	  the	  acid	  
chloride	   species.	   The	   title	   compound	  was	   recovered	   as	   a	   yellow	   oil	   (504	  mg,	   52%	  
yield)	   after	   column	   chromatography	   eluting	   with	   99:1	   Hexane/EtOAc.	   1H	   NMR:	  
(CDCl3,	  300	  MHz)	  δ	  8.24	  (2H,	  d,	  J	  =	  8.5	  Hz,	  Ar),	  7.72-­‐7.45	  (3H,	  m,	  Ar),	  7.17	  (2H,	  s,	  Ar),	  
2.28	   (3H,	   s,	   CH3),	   1.44	   (18H,	   s,	   CH3).	   13C	   NMR:	   (CDCl3,	   75.5	   MHz)	   δ	   171.9,	   151.5,	  
135.7,	  130.3,	  128.7,	  128.7,	  128.3,	  125.6,	  123.9,	  34.3,	  30.3,	  21.2.	  ESI-­‐MS	  of	  [C22H28O2];	  
theoretical	  m/z	  of	  [M+H]+	  =	  325.2124,	  measured	  m/z	  of	  [M+H]+	  =	  325.2105.	  
	  





Following	  representative	  procedure	  IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐phenol	  (617	  mg,	  3	  mmol)	  as	  
the	   hindered	   phenol	   and	   valeroyl	   chloride	   (855μL,	   7.2	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  oil	  (847mg,	  97%	  yield)	  after	  
column	  chromatography	  eluting	  with	  99:1	  Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  
δ	  7.87	  (2H,	  s,	  Ar),	  5.62	  (1H,	  s,	  OH),	  2.94	  –	  2.76,	  (2H,	  m,	  CH2COAr),	  2.68	  -­‐	  2.49	  (2H,	  m,	  
CH2),	   1.29	   (20H,	  m,	   (18H)CH3,	  (2H)CH2),	   0.94	  –	   0.90	   (3H,	  m,	  CH3).	  13C	  NMR:	   (CDCl3,	  
75.5	  MHz)	  δ	  200.2,	  173.1,	  143.1,	  134.0,	  126.4,	  38.2,	  35.6,	  31.3,	  26.2,	  22.5,	  14.0.	   IR	  
(film,	   cm-­‐1):	  νmax	  =	  3054	   (OH),	  1761	   (C=O).	  ESI-­‐MS	  of	   [C19H30O2];	   theoretical	  m/z	  of	  











Following	  representative	  procedure	  IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐phenol	  (617	  mg,	  3	  mmol)	  as	  
the	  hindered	  phenol	   and	  pivaloyl	   chloride	   (890	  μL,	   7.2	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  oil	  (502	  mg,	  58%	  yield)	  after	  
column	  chromatography	  eluting	  with	  99:1	  Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  
δ	   7.72	   (2H,	   s,	   Ar),	   5.54	   (1H,	   s,	  OH),	   1.39	   (18H,	   s,	   CH3),	   1.31	   (9H,	   s,	   CH3).	  13C	  NMR:	  
(CDCl3,	  75.5	  MHz)	  δ	  206.8,	  157.0	  Hz,	  128.5,	  126.7,	  43.7,	  34.4,	  30.2,	  28.7.	  IR	  (film,	  cm-­‐
1):	  νmax	  =	  3062	   (OH),	  1748	   (C=O).	   ESI-­‐MS	  of	   [C19H30O2];	   theoretical	  m/z	  of	   [M-­‐H]-­‐	   =	  
289.2200,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  289.2194.	  
	  







Following	  representative	  procedure	  IX,	  2,6-­‐di-­‐tert-­‐butyl-­‐phenol	  (617	  mg,	  3	  mmol)	  as	  
the	  hindered	  phenol	   and	  benzoyl	   chloride	   (835	  μL,	   7.2	  mmol)	   as	   the	   acid	   chloride	  
species.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  oil	  (280	  mg,	  30%	  yield)	  after	  
column	  chromatography	  eluting	  with	  99:1	  Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  300	  MHz)	  
δ	  7.77	  (2H,	  d,	  J	  =	  8.0,	  Ar),	  7.72	  (2H,	  s,	  Ar),	  7.58-­‐7.44	  (3H,	  m,	  Ar),	  5.74	  (1H,	  s,	  OH),	  1.44	  
(18H,	   s,	   CH3).	   13C	   NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   206.8,	   157.0	   Hz,	   135.7,	   130.3,	   128.7,	  
128.5,	  128.3,	  126.7	  125.6,	  123.9,	  30.2,	  28.7.	   IR	   (film,	  cm-­‐1):	  νmax	  =	  3114	   (OH),	  1749	  
(C=O).	  ESI-­‐MS	  of	  [C21H26O2];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  309.1900,	  measured	  m/z	  of	  












Following	  representative	  procedure	  IX,	  anisole	  (110	  μL,	  1	  mmol)	  as	  the	  electron-­‐rich	  
aromatic	  and	  benzoyl	  chloride	  (140	  μL,	  1.2	  mmol)	  as	  the	  acid	  chloride	  species.	  The	  
title	   compound	   was	   recovered	   as	   a	   yellow	   oil	   (75	   mg,	   35%	   yield)	   after	   column	  
chromatography	  eluting	  with	  99:1	  Hexane/EtOAc.	  1H	  NMR:	  (CDCl3,	  400	  MHz)	  δ	  7.85-­‐
7.82	  (2H,	  m,	  Ar),	  7.76-­‐7.74	  (2H,	  m,	  Ar),	  7.58-­‐7.45	  (3H,	  m,	  Ar),	  6.98-­‐6.95	  (2H,	  m,	  Ar),	  
3.88	   (3H,	   s,	   CH3).	  13C	  NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   195.6,	   163.2,	   138.3,	   132.6,	   131.9,	  
130.1,	   129.8,	   128.2,	   113.6,	   55.5.	   IR	   (film,	   cm-­‐1):	   νmax	   =	   1758	   (C=O).	   ESI-­‐MS	   of	  
[C14H12O2];	   theoretical	   m/z	   of	   [M+H]+	   =	   213.2651,	   measured	   m/z	   of	   [M+H]+	   =	  
213.2678.	  
	  
Mechanistic	  investigations	  (Chapter	  2,	  Section	  2.4)	  
Representative	  Procedure	  X	  
O






To	   an	   oven	   dried	   NMR	   tube	   potassium	   iodide	   (99.6	   mg,	   0.6	   mmol,	   60	   mol%)	   or	  
appropriate	   iodide	   source	   was	   added,	   1	   mL	   of	   anhydrous	   CD3CN	   dissolved	   the	  
reagent,	   benzoyl	   chloride	   (140	   µL,	   1.2	   mmol)	   was	   added	   to	   the	   solution	   using	   a	  
micropipette.	  The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	   immediately	  
placed	  in	  the	  pre-­‐heated	  NMR	  machine	  at	  70	  ˚C.	  13C	  NMR	  spectra	  were	  then	  taken	  
every	  30	  minutes	  over	  24	  hours.	  
	  
2.61	  -­‐	  Benzoyl	  iodide	  formation	  experiment100	  
Following	   representative	   procedure	   X.	   13C	  NMR	   spectra	  were	   then	   taken	   every	   30	  
minutes	   over	   24	   hours.	   	   The	   13C	   NMR	   spectra	   showed	   relative	   %	   conversion	   by	  
comparison	  of	  the	  peaks	  at	  168.6	  (benzoyl	  chloride,	  C=O)	  and	  159.6	  (benzoyl	  iodide,	  
C=O,	  2.61).	  	  
Chapter	  5	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Relative	  %	  conversion	  of	  benzoyl	  chloride	  into	  benzoyl	  iodide	  2.61	  
(Figure	  2.1,	  Chapter	  2,	  Section	  2.4)	  
Following	   representative	   procedure	   X.	   13C	  NMR	   spectra	  were	   then	   taken	   every	   30	  
minutes	   over	   24	   hours.	   	   The	   13C	   NMR	   spectra	   showed	   relative	   %	   conversion	   by	  
comparison	  of	  the	  peaks	  at	  168.6	  (benzoyl	  chloride,	  C=O)	  and	  159.6	  (benzoyl	  iodide,	  
C=O,	   2.61).	   The	   relative	   integrations	   were	   calculated	   for	   each	   spectrum	   and	   the	  
figures	  plotted	  in	  the	  graph	  shown	  in	  Figure	  2.1.	  
	  
2.61	  -­‐	  Benzoyl	  iodide	  formation	  experiment100	  
Following	   representative	   procedure	   X.	   13C	  NMR	   spectra	  were	   then	   taken	   every	   30	  
minutes	   over	   24	   hours.	   	   The	   13C	   NMR	   spectra	   showed	   relative	   %	   conversion	   by	  
comparison	  of	  the	  peaks	  at	  168.6	  (benzoyl	  chloride,	  C=O)	  and	  159.6	  (benzoyl	  iodide,	  
C=O,	  2.61).	  	  
	  
2.61	  -­‐	  Benzoyl	  iodide	  formation	  experiment100	  
Following	   representative	   procedure	   X,	   tetrabutylammonium	   iodide	   (221.3	  mg,	   0.6	  
mmol,	  60	  mol%)	  was	  added	  as	  the	  iodide	  source.	  13C	  NMR	  spectra	  were	  then	  taken	  
every	  30	  minutes	  over	  24	  hours.	  	  The	  13C	  NMR	  spectra	  showed	  no	  conversion	  by	  the	  
absence	  of	  a	  peak	  at	  159.6	  (benzoyl	  iodide,	  C=O,	  2.61).	  	  
	  
Other	  salts	  
(Table	  2.23,	  Chapter	  2,	  Section	  2.4)	  
Following	  representative	  procedure	  VII,	   the	  appropriate	  salt	  was	  used	  according	  to	  
Table	   2.23	   and	  benzoyl	   chloride	   (140	  µL,	   1.2	  mmol)	  was	  used	  as	   the	   acid	   chloride	  
species.	   The	   1H	   NMR	   of	   the	   crude	   reaction	   mixture	   showed	   %	   conversion	   by	  









Crown	  ether	  sequestration	  experiment	  
(Table	  2.24,	  Chapter	  2,	  Section	  2.4)	  
Following	  representative	  procedure	  VII,	  the	  appropriate	  crown	  ether	  (1.32	  mmol,	  2.2	  
eq.)	   was	   used	   according	   to	   Table	   2.24,	   potassium	   iodide	   (99.6	   mg,	   0.6	   mmol,	   60	  
mol%)	  was	  used	  as	  the	   iodide	  source	  and	  benzoyl	  chloride	  (140	  µL,	  1.2	  mmol)	  was	  
used	  as	  the	  acid	  chloride	  species.	  The	  1H	  NMR	  of	  the	  crude	  reaction	  mixture	  showed	  
%	  conversion	  by	  comparison	  of	  the	  peaks	  at	  7.97	  (2H,	  d,	  J	  =	  8.0	  Hz,	  Ar,	  2.10)	  and	  5.83	  
(4H,	  s,	  CH2	  2,5-­‐dimethylfuran).	  
	  
Benzoyl	  iodide	  in	  the	  presence	  of	  a	  nucleophile	  
O











To	   an	   oven	   dried	  NMR	   tube	   potassium	   iodide	   (99.6	  mg,	   0.6	  mmol,	   60	  mol%)	  was	  
added,	  1	  mL	  of	  anhydrous	  CD3CN	  dissolved	  the	  reagent,	  benzoyl	  chloride	  (140	  µL,	  1.2	  
mmol)	  was	   added	   to	   the	   solution	   using	   a	  micropipette.	   The	   tube	  was	   then	   sealed	  
and	  the	  reaction	  mixture	  was	  immediately	  placed	  in	  the	  pre-­‐heated	  NMR	  machine	  at	  
70	  ˚C.	  The	  NMR	  tube	  was	  spun	  for	  3	  hours,	  13C	  NMR	  spectra	  confirmed	  the	  presence	  
of	  ~20%	  benzoyl	  iodide	  2.61	  by	  comparison	  of	  the	  peaks	  at	  168.6	  (benzoyl	  chloride,	  
C=O)	  and	  159.6	   (benzoyl	   iodide,	  C=O,	  2.61).	  The	  NMR	  tube	  was	  removed	   from	  the	  
NMR	  machine	   and	   immediately	   benzylamine	   (0.2	  mmol)	  was	   added,	   the	   tube	  was	  
returned	  to	  the	  NMR	  machine	  and	  analysis	  by	  13C	  NMR	  was	  performed.	  The	  13C	  NMR	  
spectra	   showed	   there	  was	   no	   peak	   at	   159.6	   (benzoyl	   iodide,	   C=O,	  2.61).	   However	  
there	  was	  a	  peak	  at	  168.6	  (benzoyl	  chloride,	  C=O).	  The	  NMR	  tube	  was	  again	  spun	  for	  
3	  hours,	   13C	  NMR	  spectra	   confirmed	   the	  presence	  of	   ~20%	  benzoyl	   iodide	  2.61	  by	  









Benzoyl	  iodide	  formation	  in	  the	  presence	  of	  sulfonamide	  














To	   an	   oven	   dried	  NMR	   tube	   potassium	   iodide	   (99.6	  mg,	   0.6	  mmol,	   60	  mol%)	  was	  
added,	  1	  mL	  of	  anhydrous	  CD3CN	  dissolved	  the	  reagent,	  benzoyl	  chloride	  (140	  µL,	  1.2	  
mmol)	  was	   added	   to	   the	   solution	   using	   a	  micropipette.	   The	   tube	  was	   then	   sealed	  
and	  the	  reaction	  mixture	  was	  immediately	  placed	  in	  the	  pre-­‐heated	  NMR	  machine	  at	  
70	  ˚C.	  13C	  NMR	  spectra	  were	  then	  taken	  every	  30	  minutes	  over	  24	  hours.	   13C	  NMR	  
spectra	  confirmed	  no	  formation	  of	  benzoyl	   iodide	  2.61	  by	  comparison	  of	  the	  peaks	  
at	   168.6	   (benzoyl	   chloride,	   C=O)	   and	   159.6	   (benzoyl	   iodide,	   C=O,	   2.61).	   After	   24	  
hours	  the	  NMR	  tube	  was	  spun	  for	  3	  hours,	  13C	  NMR	  spectra	  confirmed	  the	  presence	  
of	  ~20%	  benzoyl	  iodide	  2.61	  by	  comparison	  of	  the	  peaks	  at	  168.6	  (benzoyl	  chloride,	  
C=O)	  and	  159.6	  (benzoyl	  iodide,	  C=O,	  2.61).	  
	  
Future	  work,	  other	  nucleophiles	  
















To	   oven	   dried	   Radleys	   carousel	   tubes	   potassium	   iodide	   (99.6	   mg,	   0.6	   mmol,	   60	  
mol%)	  and	  diethylphosphoramidate	  (153	  mg,	  1	  mmol)	  were	  added,	  anhydrous	  MeCN	  
(2	  mL)	  dissolved	  the	  reagents,	  benzoyl	  chloride	  (140	  µL,	  1.2	  mmol)	  was	  added	  to	  the	  
solution	  using	   a	  micropipette.	   The	   tube	  was	   then	   sealed	   and	   the	   reaction	  mixture	  
was	  heated	  to	  82	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  resulting	  reaction	  mixture	  was	  then	  
washed	  with	  DCM	  and	   sodium	   thiosulfate	   solution.	   The	  organic	   components	  were	  
then	  dried	  and	  concentrated	  in	  vacuo.	  The	  resulting	  products	  were	  analysed	  by	  their	  














The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	  











Mn(0) (3 eq,), 3Å M.S.
DMA, r.t., 1 h
	  
To	   oven	   dried	   Youngs	   tubes,	   were	   appropriate	   potassium	   iodide	   according	   to	  
Scheme	   2.16,	   Mn(0)	   (165	   mg,	   3	   mmol,	   3	   eq.),	   NiCl2(dme)	   (22	   mg,	   0.1	   mmol,	   10	  
mol%),	  dtbpy	  (27	  mg,	  0.11	  mmol,	  11	  mol%)	  and	  3	  Å	  molecular	  sieves	  (30	  mg)	  were	  
added	  and	  purged	  under	  argon	  for	  10	  minutes.	  Anhydrous	  DMA	  (2	  mL)	  dissolved	  the	  
reagents,	  benzyl	  chloride	  (82.3	  µL,	  1	  mmol)	  and	  benzoyl	  chloride	  (140	  µL,	  1.2	  mmol)	  
was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  and	  the	  
reaction	  mixture	  was	  stirred	  at	  room	  temperature	  for	  1	  hour.	  The	  resulting	  reaction	  
mixture	  was	  then	  transferred	  to	  a	  separating	  funnel	  using	  1	  M	  HCl	  (25	  mL)	  and	  Et2O	  
(50	  mL).	   The	  mixture	  was	   diluted	  with	   H2O	   (50	  mL)	   and	   the	   aqueous	   and	   organic	  
layers	  separated.	  The	  combined	  organic	  layers	  were	  washed	  with	  brine	  (1	  x	  50	  mL).	  
The	  organic	  components	  were	  then	  dried	  and	  concentrated	   in	  vacuo.	  The	  resulting	  










2.63	  –	  1,2-­‐Diphenylethanone146	  
O 	  
The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	  
into	  2.63	  by	  comparison	  of	  the	  peaks	  at	  4.63	  (2H,	  s,	  CH2,	  benzyl	  chloride)	  and	  4.20	  
(2H,	  s,	  CH2	  2.63).	  
	  
5.3	  Chapter	  3	  Experimental	  Methods	  
Representative	  Procedure	  XI	  






To	   oven	   dried	   Youngs	   carousel	   tubes	   base,	   catalyst	   and	   ligand	   were	   added	   and	  
purged	   under	   argon	   for	   10	   minutes,	   1	   mL	   of	   anhydrous	   solvent	   dissolved	   the	  
reagents,	  1,4-­‐butanediol	  and	  acetophenone	   (117	  µL,	  1.0	  mmol)	  were	  added	  to	   the	  
solution	  using	   a	  micropipette.	   The	   tube	  was	   then	   sealed	   and	   the	   reaction	  mixture	  
was	   immediately	   heated	   to	   the	   appropriate	   temperature	   and	   stirred	   for	   the	  
appropriate	  amount	  of	  time.	  The	  resulting	  reaction	  mixture	  was	  then	  cooled	  to	  room	  
temperature	  and	  extracted	  with	  DCM	  and	  water.	  The	  organic	  components	  were	  then	  
dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	   crude	   products	   were	   analyzed	   by	  
their	   1H	   NMR	   spectra	   and	   then	   purified	   by	   column	   chromatography	   and	  
enantiomeric	   excesses	   determined	   by	   HPLC	   analysis	   (Daicel	   Chiracel	   OD,	   10%	   i-­‐
PrOH/hexane,	  0.5	  mL/min).	  
Solvent	  Screen	  
(Table	  3.1	  –	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   the	   appropriate	   anhydrous	   solvent	   (1	   mL)	  
was	  used	  according	  to	  Table	  3.1,	  Cs2CO3	  (33	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	  the	  
base,	   [Ru(p-­‐cymene)Cl2]2	   (15	   mg,	   0.025	   mmol,	   5	   mol%)	   was	   used	   as	   the	   catalyst,	  
(S,S)-­‐TsDpen	  (18	  mg,	  0.05	  mmol,	  5	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  
Chapter	  5	  
170	  
µL,	  0.5	  mmol)	  was	  added	  and	  the	  reaction	  was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  24	  
hours.	  The	  1H	  NMR	  and	  HPLC	  analysis	  were	  consistent	  with	  3.1.	  
	  
3.1	  –	  (S)-­‐1-­‐Phenylethanol	  
OH
	  
1H	  NMR:	   (CDCl3,	  250	  MHz)	  δ	  7.47-­‐7.24	   (5H,	  m,	  Ar),	  4.91	   (1H,	  q,	   J	  =	  6.5	  Hz,	  CHOH),	  
1.51	  (3H,	  d,	  J	  =	  6.5	  Hz	  CH3).	  HPLC	  analysis:	  Daicel	  Chiracel	  OD,	  10%	   i-­‐PrOH/hexane,	  
0.5	  mL/min;	  tR	  10.40	  R,	  12.94	  S.	  
	  
Varying	  catalyst	  and	  ligand	  loading	  
	  (Table	  3.2,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   toluene	   (1	   mL)	   was	   used	   as	   the	   solvent,	  
Cs2CO3	   (33	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	   the	  base,	   [Ru(p-­‐cymene)Cl2]2	  was	  
used	  as	   appropriate	   according	   to	   Table	   3.2,	   (S,S)-­‐TsDpen	   was	   used	  as	   appropriate	  
according	  to	  Table	  3.2,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  reaction	  
was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  1H	  NMR	  and	  HPLC	  analysis	  were	  
consistent	  with	  3.1.	  
	  
Varying	  temperature,	  reaction	  time	  and	  concentration	  in	  solvent	  
	  (Table	  3.3,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   toluene	   (1	   mL)	   was	   used	   as	   the	   solvent,	  
Cs2CO3	   (33	  mg,	   0.1	  mmol,	   10	  mol%)	  was	   used	   as	   the	   base,	   [Ru(p-­‐cymene)Cl2]2	  (15	  
mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (S,S)-­‐TsDpen	  (18	  mg,	  0.05	  mmol,	  
5	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  
reaction	   was	   performed	   at	   the	   appropriate	   temperature	   and	   for	   the	   appropriate	  
amount	   of	   time	   according	   to	   Table	   3.3.	   The	   1H	   NMR	   and	   HPLC	   analysis	   were	  






Varying	  base	  with	  PhMe	  as	  the	  solvent	  
(Chapter	  3,	  Section	  3.2)	  
Following	  representative	  procedure	  XI,	  toluene	  (1	  mL)	  was	  used	  as	  the	  solvent,	  the	  
appropriate	  base	  was	  used	  according	   to	   the	   text,	   [Ru(p-­‐cymene)Cl2]2	  (15	  mg,	  0.025	  
mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	   (S,S)-­‐TsDpen	  (18	  mg,	  0.05	  mmol,	  5	  mol%)	  
was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  reaction	  
was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  and	  HPLC	  analysis	  were	  
consistent	  with	  3.1.	  
	  
Varying	  base	  with	  9:1	  THF/H2O	  as	  the	  solvent	  
(Table	  3.4,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	   the	   appropriate	  base	  was	  used	  according	   to	   Table	   3.4,	   [Ru(p-­‐cymene)Cl2]2	  
(15	  mg,	   0.025	  mmol,	   5	  mol%)	  was	  used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (18	  mg,	   0.05	  
mmol,	  5	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  
and	   the	   reaction	  was	  performed	  at	   30	   ˚C	   and	   stirred	   for	   1	  hour.	   The	   1H	  NMR	  and	  
HPLC	  analysis	  were	  consistent	  with	  3.1.	  
	  
Repeating	  to	  check	  consistency	  
(Table	  3.5,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (5.6	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  
(15	  mg,	   0.025	  mmol,	   5	  mol%)	  was	  used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (18	  mg,	   0.05	  
mmol,	  5	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  
and	   the	   reaction	  was	  performed	  at	   30	   ˚C	   and	   stirred	   for	   1	  hour.	   The	   1H	  NMR	  and	  









Varying	  amount	  of	  KOH	  
	  (Table	  3.6,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	   the	   appropriate	   amount	   of	   KOH	   was	   used	   according	   to	   Table	   3.6,	   [Ru(p-­‐
cymene)Cl2]2	  (15	  mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (S,S)-­‐TsDpen	  (18	  
mg,	  0.05	  mmol,	  5	  mol%)	  was	  used	  as	   the	   ligand,	  1,4-­‐butanediol	   (45	  µL,	  0.5	  mmol)	  
was	  added	  and	  the	  reaction	  was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  
NMR	  and	  HPLC	  analysis	  were	  consistent	  with	  3.1.	  
	  
Varying	  amount	  of	  1,4-­‐butanediol	  
	  (Table	  3.7,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (17	  mg,	  0.3	  mmol,	  30	  mol%)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  
(15	  mg,	   0.025	  mmol,	   5	  mol%)	  was	  used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (18	  mg,	   0.05	  
mmol,	   5	  mol%)	  was	   used	   as	   the	   ligand,	   the	   appropriate	   amount	   of	   1,4-­‐butanediol	  
was	   added	   according	   to	   Table	   3.7	   and	   the	   reaction	   was	   performed	   at	   30	   ˚C	   and	  
stirred	  for	  1	  hour.	  The	  1H	  NMR	  analysis	  was	  consistent	  with	  3.1.	  
	  
Reaction	  in	  the	  presence	  of	  γ-­‐butyrolactone	  
(Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (5.6	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  
(15	  mg,	   0.025	  mmol,	   5	  mol%)	  was	  used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (18	  mg,	   0.05	  
mmol,	   5	   mol%)	   was	   used	   as	   the	   ligand,	   1,4-­‐butanediol	   (45	   µL,	   0.5	   mmol)	   and	   γ-­‐
butyrolactone	  (38	  µL,	  0.5	  mmol)	  were	  added	  and	  the	  reaction	  was	  performed	  at	  30	  
˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  analysis	  was	  consistent	  with	  3.1.	  
	  
Increasing	  amount	  of	  KOH	  
(Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (62	  mg,	  1.1	  mmol,	  1.1	  eq.)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	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mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (S,S)-­‐TsDpen	  (18	  mg,	  0.05	  mmol,	  
5	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  
reaction	  was	  performed	  at	   30	   ˚C	   and	   stirred	   for	   1	  hour.	   The	   1H	  NMR	  analysis	  was	  
consistent	  with	  3.1.	  
	  
Changing	  the	  ligand	  
	  (Table	  3.8,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (62	  mg,	  1.1	  mmol,	  1.1	  eq.)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  
mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  the	  appropriate	  ligand	  was	  used	  
according	  to	  Table	  3.8,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  reaction	  
was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  analysis	  was	  consistent	  
with	  3.1.	  
	  
Increasing	  amount	  of	  KOH	  
	  (Table	  3.9,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  the	  appropriate	  amount	  of	  KOH	  was	  used	  as	  the	  base	  according	  to	  Table	  3.9,	  
[Ru(p-­‐cymene)Cl2]2	  (15	  mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (1S,2R)-­‐(-­‐
)-­‐cis-­‐1-­‐amino-­‐2-­‐indanol	   (22	  mg,	   0.15	  mmol,	   15	  mol%)	  was	   used	   as	   the	   ligand,	   1,4-­‐
butanediol	   (45	  µL,	  0.5	  mmol)	  was	  added	  and	   the	   reaction	  was	  performed	  at	  30	   ˚C	  
and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  analysis	  was	  consistent	  with	  3.1.	  
	  
Increasing	  temperature	  
(Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (62	  mg,	  1.1	  mmol,	  1.1	  eq.)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  
mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (1S,2R)-­‐(-­‐)-­‐cis-­‐1-­‐amino-­‐2-­‐indanol	  
(22	  mg,	  0.15	  mmol,	  15	  mol%)	  was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (90	  µL,	  1	  mmol)	  
was	  added	  and	  the	  reaction	  was	  performed	  at	  50	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  
NMR	  analysis	  was	  consistent	  with	  3.1.	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Increasing	  amount	  of	  KOH	  
(Scheme	  3.6,	  Chapter	  3,	  Section	  3.2)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	  KOH	  (62	  mg,	  1.1	  mmol,	  1.1	  eq.)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  
mg,	   0.025	   mmol,	   5	   mol%)	   was	   used	   as	   the	   catalyst,	   the	   appropriate	   amount	   of	  
(1S,2R)-­‐(-­‐)-­‐cis-­‐1-­‐amino-­‐2-­‐indanol	   was	   used	   as	   the	   ligand	   according	   to	   Scheme	   3.6,	  
1,4-­‐butanediol	  (90	  µL,	  1	  mmol)	  was	  added	  and	  the	  reaction	  was	  performed	  at	  30	  ˚C	  
and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  analysis	  was	  consistent	  with	  3.1.	  
	  
Varying	  the	  amount	  of	  ligand	  
(Table	  3.10,	  Chapter	  3,	  Section	  3.2)	  
Following	  representative	  procedure	  XI,	  no	  solvent	  was	  used,	  KOH	  (62	  mg,	  1.1	  mmol,	  
1.1	  eq.)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  mg,	  0.025	  mmol,	  5	  mol%)	  was	  
used	   as	   the	   catalyst,	   the	   appropriate	   amount	   of	   (1S,2R)-­‐(-­‐)-­‐cis-­‐1-­‐amino-­‐2-­‐indanol	  
was	  used	  as	  the	  ligand	  according	  to	  Table	  3.10,	  1,4-­‐butanediol	  (98	  µL,	  1.1	  mmol,	  1.1	  
eq.)	  was	  added	  and	  the	  reaction	  was	  performed	  at	  50	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  
1H	  NMR	  analysis	  was	  consistent	  with	  3.1.	  
	  
(S,S)-­‐TsDpen	  as	  the	  ligand	  
(Scheme	  3.7,	  Chapter	  3,	  Section	  3.2)	  
Following	  representative	  procedure	  XI,	   the	  appropriate	  solvent	  was	  used	  according	  
to	   Scheme	   3.7,	   KOH	   (62	   mg,	   1.1	   mmol,	   1.1	   eq.)	   was	   used	   as	   the	   base,	   [Ru(p-­‐
cymene)Cl2]2	  (15	  mg,	  0.025	  mmol,	  5	  mol%)	  was	  used	  as	  the	  catalyst,	  (S,S)-­‐TsDpen	  (23	  
mg,	   0.0625	  mmol,	   6.25	  mol%)	   was	   used	   as	   the	   ligand,	   1,4-­‐butanediol	   (98	  µL,	   1.1	  
mmol,	  1.1	  eq.)	  was	  added	  and	  the	  reaction	  was	  performed	  at	  50	  ˚C	  and	  stirred	  for	  1	  









Changing	  the	  catalyst	  
(Table	  3.11,	  Chapter	  3,	  Section	  3.3)	  
Following	   representative	   procedure	   XI,	   9:1	   THF/H2O	   (0.5	   mL)	   was	   used	   as	   the	  
solvent,	   KOH	   (5.6	  mg,	   0.1	  mmol,	   10	  mol%)	  was	   used	   as	   the	  base,	   the	   appropriate	  
catalyst	  was	  used	  according	  to	  Table	  3.11,	  (S,S)-­‐TsDpen	  (18	  mg,	  0.05	  mmol,	  5	  mol%)	  
was	  used	  as	  the	  ligand,	  1,4-­‐butanediol	  (45	  µL,	  0.5	  mmol)	  was	  added	  and	  the	  reaction	  
was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  and	  HPLC	  analysis	  were	  
consistent	  with	  3.1.	  
	  
Wills	  catalyst	  
Representative	  Procedure	  XII	  
O OHWills Catalyst (5 mol%)
1,4-butanediol (1.1 eq.)
KOH, 50 ˚C, 1 h
	  
To	  oven	  dried	  Youngs	  carousel	   tubes,	  KOH	  and	   (S,S)-­‐teth-­‐TsDpenRuCl	   (31	  mg,	  0.05	  
mmol,	   5	   mol%)	   	   were	   added	   and	   purged	   under	   argon	   for	   10	   minutes.	   The	  
appropriate	  hydrogen	  acceptor,	   anhydrous	   solvent	  and	  acetophenone	   (117	  µL,	   1.0	  
mmol)	  were	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  
and	   the	   reaction	   mixture	   was	   immediately	   heated	   or	   cooled	   to	   the	   appropriate	  
temperature	  and	  stirred	  for	  the	  appropriate	  amount	  of	  time.	  The	  resulting	  reaction	  
mixture	  was	  then	  cooled	  or	  warmed	  to	  room	  temperature	  and	  extracted	  with	  DCM	  
and	  water.	  The	  organic	  components	  were	  then	  dried	  and	  concentrated	  in	  vacuo.	  The	  
resulting	  crude	  products	  were	  analyzed	  by	  their	  1H	  NMR	  spectra	  and	  then	  purified	  by	  
column	   chromatography	   and	   enantiomeric	   excesses	   determined	   by	   HPLC	   analysis	  
(Daicel	  Chiracel	  OD,	  10%	  i-­‐PrOH/hexane,	  0.5	  mL/min).	  	  
	  
Amount	  of	  KOH	  
(Table	  3.12,	  Chapter	  3,	  Section	  3.3)	  
Following	   representative	   procedure	   XII,	   no	   solvent	   was	   used,	   the	   appropriate	  
amount	  of	  KOH	  was	  used	  according	  to	  Table	  3.12,	  1,4-­‐butanediol	  (98	  µL,	  1.1	  mmol,	  
1.1	  eq.)	  was	  added	  as	  the	  hydrogen	  acceptor	  and	  the	  reaction	  was	  performed	  at	  50	  
˚C	  and	  stirred	  for	  1	  hour.	  The	  1H	  NMR	  and	  HPLC	  analysis	  were	  consistent	  with	  3.1.	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THF	  as	  solvent	  
(Table	  3.13,	  Chapter	  3,	  Section	  3.3)	  
Following	  representative	  procedure	  XII,	  the	  appropriate	  amount	  of	  9:1	  THF/H2O	  was	  
used	  as	  the	  solvent	  according	  to	  Table	  3.13,	  KOH	  (5.6	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  
used	   as	   the	   base,	   1,4-­‐butanediol	   (98	   µL,	   1.1	   mmol,	   1.1	   eq.)	   was	   added	   as	   the	  
hydrogen	  acceptor	  and	  the	  reaction	  was	  performed	  at	  30	  ˚C	  and	  stirred	  for	  1	  hour.	  
The	  1H	  NMR	  and	  HPLC	  analysis	  were	  consistent	  with	  3.1.	  
	  
Varying	  the	  amount	  of	  1,4-­‐butanediol	  
(Table	  3.14,	  Chapter	  3,	  Section	  3.3)	  
Following	   representative	   procedure	   XII,	   no	   solvent	   was	   used,	   KOH	   (5.6	   mg,	   0.1	  
mmol,	   10	  mol%)	  was	   used	   as	   the	   base,	   the	   appropriate	   amount	   of	   1,4-­‐butanediol	  
was	  added	  according	  to	  Table	  3.14	  as	  the	  hydrogen	  acceptor	  and	  the	  reaction	  was	  
performed	  at	  0	  ˚C	  in	  an	  ice/water	  bath	  and	  stirred	  for	  4	  hours.	  The	  1H	  NMR	  and	  HPLC	  
analysis	  were	  consistent	  with	  3.1.	  
	  
cis-­‐1,4-­‐Butenediol	  as	  the	  hydrogen	  acceptor	  
(Scheme	  3.11,	  Chapter	  3,	  Section	  3.4)	  
Following	   representative	   procedure	   XII,	   no	   solvent	   was	   used,	   KOH	   (5.6	   mg,	   0.1	  
mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  cis-­‐1,4-­‐butenediol	  (82	  µL,	  1.0	  mmol,	  1.0	  eq.)	  
was	  added	  as	  the	  hydrogen	  acceptor	  and	  the	  reaction	  was	  performed	  at	  0	  ˚C	   in	  an	  
ice/water	   bath	   and	   stirred	   for	   4	   hours.	   The	   1H	   NMR	   and	   HPLC	   analysis	   were	  
consistent	  with	  3.1.	  
	  
Lowering	  the	  temperature	  with	  cis-­‐1,4-­‐butenediol	  
(Scheme	  3.12,	  Chapter	  3,	  Section	  3.4)	  
Following	   representative	   procedure	   XII,	   no	   solvent	   was	   used,	   KOH	   (5.6	   mg,	   0.1	  
mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  cis-­‐1,4-­‐butenediol	  (82	  µL,	  1.0	  mmol,	  1.0	  eq.)	  
was	   added	   as	   the	   hydrogen	   acceptor	   and	   the	   reaction	   was	   performed	   at	   -­‐10	   ˚C,	  
maintained	   using	   an	   ice/KCl	  water	   bath	   and	   stirred	   for	   4	   hours.	   The	   1H	   NMR	   and	  




Racemization	  of	  (S)-­‐1-­‐phenylethanol	  
(Scheme	  3.12,	  Chapter	  3,	  Section	  3.4)	  
Following	   representative	   procedure	   XII,	   no	   solvent	   was	   used,	   KOH	   (5.6	   mg,	   0.1	  
mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  cis-­‐1,4-­‐butenediol	  (82	  µL,	  1.0	  mmol,	  1.0	  eq.)	  
was	   added	   as	   the	   hydrogen	   acceptor,	   (S)-­‐1-­‐phenylethanol	   (121	  µL,	   1.0	  mmol)	  was	  
used	  in	  place	  of	  acetophenone	  and	  the	  reaction	  was	  performed	  at	  -­‐10	  ˚C,	  maintained	  
using	  an	  ice/KCl	  water	  bath	  and	  stirred	  for	  4	  hours.	  The	  1H	  NMR	  and	  HPLC	  analysis	  
were	  consistent	  with	  3.1.	  
	  
Substrate	  scope	  
Representative	  Procedure	  XIII	  




OHWills Catalyst (5 mol%)cis-1,4-butenediol (2 eq.)
KOH (20 mol%)
-10 ˚C, 4 h 	  
To	  oven	  dried	  Youngs	  carousel	  tubes,	  KOH	  (11.2	  mg,	  0.2	  mmol,	  20	  mol%)	  and	  (S,S)-­‐
teth-­‐TsDpenRuCl	  (31	  mg,	  0.05	  mmol,	  5	  mol%)	  	  were	  added,	  purged	  under	  argon	  for	  
10	   minutes	   and	   cooled	   to	   -­‐10	   ˚C	   in	   an	   ice/KCl	   water	   bath.	   The	   reagents	   were	  
dissolved	   in	   THF	   (0.25	   mL).	   cis-­‐1,4-­‐butenediol	   (164	   µL,	   2.0	   mmol)	   	   and	   the	  
appropriate	   ketone	   according	   to	   Table	   3.15	   were	   added	   to	   the	   solution	   using	   a	  
micropipette.	  The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	  stirred	   for	  4	  
hours.	   The	   resulting	   reaction	   mixture	   was	   then	   cooled	   to	   room	   temperature	   and	  
extracted	   with	   DCM	   and	   water.	   The	   organic	   components	   were	   then	   dried	   and	  
concentrated	   in	   vacuo.	   The	   resulting	   crude	   products	   were	   purified	   by	   column	  
chromatography.	  The	  products	  were	  analysed	  by	  their	  1H	  and	  13C	  NMR	  spectra	  and	  
mass	  spectrometry	  data	  and	  enantiomeric	  excesses	  determined	  by	  HPLC	  analysis.	  	  
	  
Synthesis	  of	  racemic	  alcohols	  for	  HPLC	  comparison	  
To	   oven	   dried	   Radleys	   carousel	   tubes,	   the	   appropriate	   ketone	   was	   added	   and	  
dissolved	  in	  ethanol	  (1	  mL).	  The	  mixture	  was	  cooled	  to	  0	  ˚C	  and	  NaBH4	  (18.9	  mg,	  0.5	  
mmol)	  was	  added	  carefully.	  The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	  
allowed	   to	  warm	  to	   room	  temperature	  and	   then	  heated	   to	  80	   ˚C	  and	  stirred	   for	  2	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hours.	   The	   resulting	   reaction	   mixture	   was	   then	   cooled	   to	   room	   temperature	   and	  
quenched	  with	   acetone	   (10	  mL)	   and	   subsequently	   extracted	  with	   Et2O	   and	  water.	  
The	  organic	  components	  were	  then	  dried	  and	  concentrated	   in	  vacuo.	  The	  resulting	  
crude	   products	   were	   purified	   by	   column	   chromatography	   where	   appropriate.	   The	  
products	   were	   analysed	   by	   their	   1H	   and	   13C	   NMR	   spectra	   and	  mass	   spectrometry	  
data	  and	  by	  HPLC	  analysis.	  
	  
	  3.1	  -­‐	  (S)-­‐1-­‐Phenylethanol147	  
OH
	  
Following	   representative	  procedure	  XIII,	   acetophenone	   (117	  µL,	  1	  mmol)	  was	  used	  
as	   the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	   (104	  mg,	  83%	  
yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	   1H	  NMR:	   (CDCl3,	  
300	  MHz)	  δ	  7.47-­‐7.24	  (5H,	  m,	  Ar),	  4.91	  (1H,	  q,	  J	  =	  6.4	  Hz,	  CHOH),	  1.51	  (3H,	  d,	  J	  =	  6.4	  
Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  145.8,	  128.5,	  127.5,	  125.4,	  70.5,	  25.2.	  IR	  (film,	  
cm-­‐1):	  νmax	   =	   3338,	   2970,	   1467,	   1379,	   1305,	   1160,	   1128,	   951,	   817,	   699.	   ESI-­‐MS	   of	  
[C8H9O];	   theoretical	   m/z	   of	   [M+Na]+	   =	   145.0624,	   measured	   m/z	   of	   [M+Na]+	   =	  
145.0649.	   HPLC	   analysis:	   Daicel	   Chiracel	   OD,	   10%	   i-­‐PrOH/hexane,	   0.5	   mL/min;	   tR	  
10.40	  R,	  12.94	  S,	  >99%	  e.e.	  
	  
3.7	  -­‐	  (S)-­‐1-­‐Phenylpropan-­‐1-­‐ol148	  
OH
	  
Following	  representative	  procedure	  XIII,	  propiophenone	  (133	  µL,	  1	  mmol)	  was	  used	  
as	   the	   ketone	   species.	   The	   title	   compound	  was	   recovered	   as	   a	   colourless	   oil	   (69.5	  
mg,	  51%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.49-­‐7.19	  (5H,	  m,	  Ar),	  4.61	  (1H,	  td,	  J	  =	  6.8,	  2.8	  Hz,	  CHOH),	  1.94-­‐
1.65	  (2H,	  m,	  CH2),	  0.92	  (3H,	  t,	  J	  =	  7.4	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  144.6,	  
128.4,	  127.5,	  126.0,	  76.1,	  31.9,	  10.2.	   IR	  (film,	  cm-­‐1):	  νmax	  =	  3335,	  2970,	  1467,	  1379,	  
1306,	  1160,	  1128,	  951,	  817,	  670.	  ESI-­‐MS	  of	   [C9H12O];	   theoretical	  m/z	  of	   [M+Na]+	  =	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159.0780,	  measured	  m/z	  of	  [M+Na]+	  =	  159.0795.	  HPLC	  analysis:	  Daicel	  Chiracel	  OD,	  
1%	  i-­‐PrOH/hexane,	  1.0	  mL/min;	  tR	  22.18	  R,	  27.45	  S,	  96%	  e.e.	  
	  
3.8	  -­‐	  (S)-­‐1-­‐(4-­‐Methoxyphenyl)ethanol147	  
OH
O 	  
Following	  representative	  procedure	  XIII,	  4-­‐methoxyacetophenone	  (150	  mg,	  1	  mmol)	  
was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  brown	  oil	  (151	  mg,	  
99%	   yield)	   after	   column	   chromatography	   eluting	   with	   9:1	   Et2O/hexane.	   1H	   NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.24	  (2H,	  d,	  J	  =	  8.5	  Hz,	  Ar),	  6.82	  (2H,	  d,	  J	  =	  8.8	  Hz,	  Ar),	  4.80	  (1H,	  
qd,	  J	  =	  6.3,	  2.3	  Hz,	  CHOH),	  1.42	  (3H,	  d,	  J	  =	  6.4	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  
138.0,	   126.7,	   113.9,	   70.0,	   55.3,	   53.4,	   29.3,	   25.1.	   IR	   (film,	   cm-­‐1):	  νmax	   =	   3375,	   2970,	  
1360,	   1257,	   1172,	   1029,	   951,	   833,	   816.	   ESI-­‐MS	   of	   [C9H12O2];	   theoretical	   m/z	   of	  
[M+Na]+	   =	   175.0730,	  measured	  m/z	   of	   [M+Na]+	   =	   175.0690.	   HPLC	   analysis:	   Daicel	  
Chiracel	  OD,	  3%	  i-­‐PrOH/hexane,	  1.0	  mL/min;	  tR	  18.29	  R,	  20.51	  S,	  96%	  e.e.	  
	  
3.9	  -­‐	  (S)-­‐1-­‐(p-­‐Tolyl)ethanol148	  
OH
	  
Following	   representative	   procedure	   XIII,	   4-­‐methylacetophenone	   (134	   µL,	   1	   mmol)	  
was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	  (131	  
mg,	  96%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.20	  (2H,	  d,	  J	  =	  7.5	  Hz,	  Ar),	  7.09	  (2H,	  d,	  J	  =	  7.9	  Hz,	  Ar),	  4.80	  (1H,	  q,	  
J	  =	  6.4	  Hz,	  CHOH),	  2.27	  (3H,	  s,	  Ar-­‐CH3)	  1.42	  (3H,	  d,	  J	  =	  6.5	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  
75.5	  MHz)	  δ	  142.9,	  137.2,	  129.2,	  125.4,	  70.3,	  25.1,	  21.1.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  3338,	  
2970,	  1467,	  1379,	  1307,	  1160,	  1128,	  951,	  817.	  ESI-­‐MS	  of	  [C9H12O];	  theoretical	  m/z	  of	  
[M+Na]+	   =	   159.0780,	  measured	  m/z	   of	   [M+Na]+	   =	   159.0806.	   HPLC	   analysis:	   Daicel	  





3.10	  -­‐	  (S)-­‐1-­‐(4-­‐Chlorophenyl)ethanol148	  
OH
Cl 	  
Following	   representative	   procedure	   XIII,	   4-­‐chloroacetophenone	   (130	   µL,	   1	   mmol)	  
was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	  (146	  
mg,	  93%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.31	  (5H,	  s,	  Ar),	  4.89	  (1H,	  q,	  J	  =	  6.4	  Hz,	  CHOH),	  1.48	  (3H,	  d,	  J	  =	  6.5	  
Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  144.3,	  133.1,	  128.6,	  126.8,	  69.8,	  25.3.	  IR	  (film,	  
cm-­‐1):	   νmax	   =	   3338,	   2971,	   1493,	   1370,	   1088,	   1013,	   950,	   828,	   778.	   ESI-­‐MS	   of	  
[C8H935ClO];	   theoretical	   m/z	   of	   [M-­‐H]-­‐	   =	   155.0269,	   measured	   m/z	   of	   [M-­‐H]-­‐	   =	  
155.0275.	  HPLC	  analysis:	  Daicel	  Chiracel	  OD,	  5%	  i-­‐PrOH/hexane,	  0.5	  mL/min;	  tR	  12.16	  
R,	  13.16	  S,	  >99%	  e.e.	  
	  
3.11	  -­‐	  (S)-­‐1-­‐(4-­‐Nitrophenyl)ethanol148	  
OH
O2N 	  
Following	  representative	  procedure	  XIII,	  4-­‐nitroacetophenone	  (165	  mg,	  1	  mmol)	  was	  
used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  yellow	  oil	  (92.3	  mg,	  55%	  
yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	   1H	  NMR:	   (CDCl3,	  
300	  MHz)	  δ	  8.21	  (2H,	  d,	  J	  =	  8.8	  Hz,	  Ar),	  7.55	  (2H,	  d,	  J	  =	  8.4	  Hz,	  Ar),	  5.03	  (1H,	  qd,	  J	  =	  
6.4,	  3.1	  Hz,	  CHOH),	  1.53	  (3H,	  d,	  J	  =	  6.5	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  153.0,	  
126.1,	  123.8,	  77.2,	  69.6,	  25.6.	   IR	   (film,	  cm-­‐1):	  νmax	  =	  3346,	  2973,	  1517,	  1343,	  1089,	  
854,	  699.	  ESI-­‐MS	  of	  [C8H9NO3];	  theoretical	  m/z	  of	  [M-­‐H]-­‐	  =	  166.0504,	  measured	  m/z	  
of	   [M-­‐H]-­‐	   =	   166.0502.	   HPLC	   analysis:	   Daicel	   Chiracel	   OB-­‐H,	   5%	   i-­‐PrOH/hexane,	   0.5	  








3.12	  -­‐	  (S)-­‐1-­‐(4-­‐(Methylsulfonyl)phenyl)ethanol149	  
OH
S
O O 	  
Following	   representative	  procedure	  XIII,	  1-­‐(4-­‐(methylsulfonyl))ethanone	   (198	  mg,	  1	  
mmol)	  was	  used	  as	   the	   ketone.	   The	   title	   compound	  was	   recovered	  as	   a	   grey	   solid	  
(181.5	  mg,	  91%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.83	  (2H,	  d,	  J	  =	  8.2	  Hz,	  Ar),	  7.51	  (2H,	  d,	  J	  =	  8.4	  Hz),	  4.94	  (1H,	  
q,	   J	   =	  6.4	  Hz,	   CHOH),	   2.97	   (3H,	   s,	   SO2CH3),	   1.44	   (3H,	   d,	   J	   =	   6.5	  Hz,	   CH3).	   13C	  NMR:	  
(CDCl3,	  75.5	  MHz)	  δ	  139.3,	  127.6,	  126.3,	  69.6,	  44.6,	  25.5.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  3469,	  
3007,	  2975,	  2921,	  1410,	  1277,	  1144,	  1089,	  973,	  833,	  783,	  761,	  720,	  652.	  ESI-­‐MS	  of	  
[C9H12O2];	   theoretical	   m/z	   of	   [M+Na]+	   =	   223.0399,	   measured	   m/z	   of	   [M+Na]+	   =	  
223.0415.	   Enantiomeric	  excess	  determined	  by	   lanthanide	   shift	   reagent	   in	   1H	  NMR,	  
Europium	   tris[3-­‐(trifluoromethylhydroxymethylene)-­‐(+)-­‐camphorate]	   (2	   mg),	   75%	  
e.e.	  based	  on	  1H	  NMR	  data.	  	  
	  




Following	   representative	   procedure	   XIII,	   3-­‐trifluoromethylacetophenone	   (152	  µL,	   1	  
mmol)	  was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	  
(112	  mg,	  59%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  
NMR:	  (CDCl3,	  300	  MHz)	  δ	  7.58	  (1H,	  s,	  Ar),	  7.44	  (dt,	  J	  =	  24.6,	  7.6	  Hz,	  Ar),	  4.91	  (1H,	  q,	  J	  
=	  6.4	  Hz,	  CHOH),	  1.45	  (3H,	  d,	  J	  =	  6.5	  Hz,	  CH3).	  13C	  NMR:	  (CDCl3,	  75.5	  MHz)	  δ	  146.7,	  
129.0,	  128.8,	  124.2	  (q,	  J	  =	  4.0	  Hz),	  124.0	  (q,	  J	  =	  275	  Hz),	  121.4	  (q,	  J	  =	  3.9	  Hz),	  69.9,	  
25.4.	   19F	   NMR:	   (376	  MHz,	   CDCl3)	   δ	   -­‐62.5.	   IR	   (film,	   cm-­‐1):	  νmax	   =	   3337,	   2972,	   1328,	  
1163,	   1125,	   1072,	   950,	   803,	   703.	   ESI-­‐MS	   of	   [C9H9F3O];	   theoretical	  m/z	   of	   [M-­‐H]-­‐	   =	  
189.0533,	  measured	  m/z	  of	  [M-­‐H]-­‐	  =	  189.0516.	  [α :	  -­‐26	  (c	  =	  1.0,	  CHCl3),	  Lit	  value	  =	  -­‐








Following	   representative	   procedure	   XIII,	   3-­‐fluoroacetophenone	   (123	   µL,	   1	   mmol)	  
was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	  (116	  
mg,	  83%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.27-­‐7.20	  (1H,	  m,	  Ar),	  7.07-­‐7.01	  (2H,	  m,	  Ar),	  6.92-­‐6.85	  (1H,	  m,	  Ar),	  
4.83	   (1H,	  q,	   J	  =	  6.4	  Hz,	  CHOH),	  1.42	   (3H,	  d,	   J	  =	  6.5	  Hz,	  CH3).	   13C	  NMR:	   (CDCl3,	  75.5	  
MHz)	  δ	  163.0	  (d,	  J	  =	  245.7	  Hz),	  148.5	  (d,	  J	  =	  6.4	  Hz),	  130.0	  (d,	  J	  =	  8.1	  Hz),	  120.9	  (d,	  J	  =	  
2.9	  Hz),	  114.3	   (d,	   J	   =	  21.2	  Hz),	  112.2	   (d,	   J	   =	  21.8	  Hz),	  69.8	   (d,	   J	   =	  1.8	  Hz),	  25.3.	   19F	  
NMR:	  (376	  MHz,	  CDCl3)	  δ	  -­‐112.9.	  IR	  (film,	  cm-­‐1):	  νmax	  =	  3344,	  2971,	  1466,	  1379,	  1305,	  
1161,	   1128,	   950,	   817,	   696.	   ESI-­‐MS	   of	   [C8H9OF];	   theoretical	   m/z	   of	   [M+Na]+	   =	  
163.0530,	  measured	  m/z	  of	  [M+Na]+	  =	  163.0564.	  [α :	  -­‐32	  (c	  =	  1.0,	  CHCl3),	  Lit	  value	  –	  
39.8	  (c	  =	  1.8,	  CHCl3),	  80%	  e.e.	  based	  on	  rotation.	  
	  
3.15	  -­‐	  (S)-­‐1-­‐(2-­‐Bromophenyl)ethanol147	  
OHBr
	  
Following	   representative	   procedure	   XIII,	   2-­‐Bromoacetophenone	   (135	   µL,	   1	   mmol)	  
was	  used	  as	  the	  ketone.	  The	  title	  compound	  was	  recovered	  as	  a	  colourless	  oil	  (179	  
mg,	  89%	  yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	  1H	  NMR:	  
(CDCl3,	  300	  MHz)	  δ	  7.60	  (1H,	  dd,	  J	  =	  7.8,	  1.7	  Hz,	  Ar),	  7.52	  (1H,	  dd,	  J	  =	  8.0,	  1.2	  Hz),	  7.35	  
(1H,	  td,	  J	  =	  7.7,	  1.1	  Hz),	  7.17-­‐7.08	  (1H,	  m),	  5.25	  (1H,	  q,	  J	  =	  6.3	  Hz,	  CHOH),	  1.49	  (3H,	  d,	  
J	   =	   6.4	   Hz,	   CH3).	   13C	   NMR:	   (CDCl3,	   75.5	  MHz)	   δ	   144.6,	   132.7,	   128.8,	   127.9,	   126.7,	  
121.8,	  69.2,	  23.6.	   IR	   (film,	  cm-­‐1):	  νmax	  =	  3320,	  2972,	  1440,	  1368,	  1127,	  1091,	  1024,	  
948,	  899,	  751,	  667.	  ESI-­‐MS	  of	   [C8H979BrO];	   theoretical	  m/z	  of	   [M+Na]+	  =	  222.9729,	  
measured	   m/z	   of	   [M+Na]+	   =	   222.9716.	   HPLC	   analysis:	   Daicel	   Chiracel	   OD,	   2%	   i-­‐





3.16	  -­‐	  (S)-­‐Chroman-­‐4-­‐ol147	  
OH
O 	  
Following	  representative	  procedure	  XIII,	  4-­‐chromanone	  (148	  mg,	  1	  mmol)	  was	  used	  
as	   the	  ketone.	  The	   title	  compound	  was	   recovered	  as	  a	  white	   solid	   (120.4	  mg,	  80%	  
yield)	  after	  column	  chromatography	  eluting	  with	  9:1	  Et2O/hexane.	   1H	  NMR:	   (CDCl3,	  
300	  MHz)	  δ	  7.26-­‐7.11	   (2H,	  m,	  Ar),	  6.88-­‐6.76	   (2H,	  m,	  Ar),	  4.72-­‐4.71	   (1H,	  m,	  CHOH),	  
4.22-­‐4.18	  (2H,	  m,	  CHOHCH2),	  2.11-­‐1.90	  (2H,	  m,	  CHOHCH2CH2).	  13C	  NMR:	  (CDCl3,	  75.5	  
MHz)	  δ	  160.2,	  154.6,	  129.8,	  129.7,	  124.3,	  120.6,	  117.1,	  63.3,	  61.9,	  30.8.	  IR	  (film,	  cm-­‐
1):	  νmax	   =	  3337,	   2970,	   1489,	   1379,	   1127,	   1066,	   950,	   816,	   754.	   ESI-­‐MS	  of	   [C9H10O2];	  
theoretical	  m/z	  of	  [M+Na]+	  =	  173.0573,	  measured	  m/z	  of	  [M+H]+	  =	  173.0588.	  HPLC	  
analysis:	   Daicel	   Chiracel	   OD,	   5%	   i-­‐PrOH/hexane,	   1.0	   mL/min;	   tR	   23.46	   R,	   30.19	   S,	  
>99%	  e.e.	  
	  
cis-­‐1,4-­‐Butenediol	  with	  untethered	  catalyst	  
(Table	  3.16,	  Chapter	  3,	  Section	  3.5)	  
Following	  representative	  procedure	  XI,	  THF	  (0.25	  mL)	  was	  used	  as	  the	  solvent,	  KOH	  
(5.6	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  mg,	  0.025	  
mmol,	   5	  mol%)	  was	   used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (23	  mg,	   0.0625	  mmol,	   6.25	  
mol%)	   was	   used	   as	   the	   ligand,	   the	   appropriate	   amount	   of	   cis-­‐1,4-­‐butenediol	   was	  
used	   according	   to	   Table	   3.16	   instead	   of	   1,4-­‐butanediol	   and	   the	   reaction	   was	  




(Scheme	  3.13,	  Chapter	  3,	  Section	  3.5)	  
Following	  representative	  procedure	  XI,	  THF	  (0.25	  mL)	  was	  used	  as	  the	  solvent,	  KOH	  
(5.6	  mg,	  0.1	  mmol,	  10	  mol%)	  was	  used	  as	  the	  base,	  [Ru(p-­‐cymene)Cl2]2	  (15	  mg,	  0.025	  
mmol,	   5	  mol%)	  was	   used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (23	  mg,	   0.0625	  mmol,	   6.25	  
mol%)	  was	  used	  as	  the	  ligand,	  cis-­‐1,4-­‐butenediol	  (82	  µL,	  1.0	  mmol)	  was	  added	  to	  the	  
solution	   using	   a	  micropipette	   every	   30	  minutes	   instead	   of	   1,4-­‐butanediol	   and	   the	  
Chapter	  5	  
184	  
reaction	   was	   performed	   at	   30	   ˚C	   and	   stirred	   for	   2	   hours.	   The	   1H	   NMR	   and	   HPLC	  
analysis	  were	  consistent	  with	  3.1.	  
	  
Increasing	  catalyst	  loading	  
(Scheme	  3.14,	  Chapter	  3,	  Section	  3.5)	  
Following	  representative	  procedure	  XI,	  THF	  (0.25	  mL)	  was	  used	  as	  the	  solvent,	  KOH	  
(62	  mg,	   1.1	  mmol,	   1.1	   eq.)	  was	  used	   as	   the	  base,	   [Ru(p-­‐cymene)Cl2]2	  (30	  mg,	   0.05	  
mmol,	   10	  mol%)	  was	   used	   as	   the	   catalyst,	   (S,S)-­‐TsDpen	   (46	  mg,	   0.125	  mmol,	   12.5	  
mol%)	  was	  used	  as	  the	  ligand,	  cis-­‐1,4-­‐butenediol	  (82	  µL,	  1.0	  mmol)	  was	  added	  to	  the	  
solution	   using	   a	  micropipette	   every	   30	  minutes	   instead	   of	   1,4-­‐butanediol	   and	   the	  
reaction	   was	   performed	   at	   30	   ˚C	   and	   stirred	   for	   2	   hours.	   The	   1H	   NMR	   and	   HPLC	  
analysis	  were	  consistent	  with	  3.1.	  
	  
Mechanistic	  investigation	  
Representative	  Procedure	  XIV	  
O OH[Ru(p-cymene)Cl2]2 (5 mol%)
cis-1,4-butenediol (1 eq.)
(S,S)-TsDPEN (6.25 mol%)
KOH (1.1 eq.), r.t., 2 h
THF-d8 	  
To	  an	  oven	  dried	  NMR	  tube	  the	  KOH	  (62	  mg,	  1.1	  mmol,	  1.1	  eq.),	  [Ru(p-­‐cymene)Cl2]2	  
(15	  mg,	  0.025	  mmol,	  5	  mol%),	  (S,S)-­‐TsDpen	  (23	  mg,	  0.0625	  mmol,	  6.25	  mol%)	  were	  
added	  and	  purged	  under	  argon	  for	  10	  minutes.	  THF-­‐d8	  (1	  mL)	  dissolved	  the	  reagents,	  
cis-­‐1,4-­‐butenediol	   (82	  µL,	   1.0	  mmol)	   and	   acetophenone	   (117	  µL,	   1.0	  mmol)	   were	  
added	   to	   the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	  
reaction	  mixture	  was	  immediately	  placed	  in	  the	  pre-­‐heated	  NMR	  machine	  at	  30	  ˚C.	  
1H	  NMR	  spectra	  were	  then	  taken	  every	  2	  minutes	  over	  30	  minutes.	  1H	  NMR	  spectra	  
confirmed	   the	   formation	   of	   a	   small	   amount	   of	  3.6	   by	   comparison	   of	   the	   peaks	   at	  
4.31	   (2H,	   t,	   J	  =	  7.0	  Hz,	  CH2,	  3.6)	  and	  5.75	   (2H,	  m,	  HC=CH,	  cis-­‐1,4-­‐butenediol).	  Over	  
the	  30	  minute	  experiment	  cis-­‐1,4-­‐butenediol	  disappears	  and	  1,4-­‐butanediol	  appears	  
by	  comparison	  of	  the	  peaks	  at	  3.73-­‐3.64	  (2H,	  m,	  CH2,	  1,4-­‐butanediol)	  and	  5.75	  (2H,	  








1H	  NMR:	  (Acetone-­‐d6,	  400	  MHz)	  δ	  4.31	  (2H,	  t,	  J	  =	  7.0	  Hz,	  CH2),	  2.44	  (2H,	  t,	  J	  =	  8.0	  Hz,	  
CH2),	  2.25	  (2H,	  p,	  J	  =	  7.7,	  7.9	  Hz,	  CH2).	  
	  
	  
5.4	  Chapter	  4	  Experimental	  Methods	  
	  
Representative	  Procedure	  XV	  










Cs2CO3 (10 mol%), tBuOH
125 ˚C, 24 h
3-methyl-2-butanone (2.5 eq.) NH
Z R
or
Z = C=O or SO2 	  
To	   oven	   dried	   Youngs	   carousel	   tubes,	   Cs2CO3	   (98	  mg,	   0.3	  mmol,	   10	  mol%),	   [Ru(p-­‐
cymene)Cl2]2	  (46	  mg,	  0.075	  mmol,	  5	  mol%),	  dppb	  (64	  mg,	  0.15	  mmol,	  5	  mol%)	  and	  
the	   appropriate	   sulfonamide	   or	   amide	   according	   to	   Table	   4.1	   were	   added	   and	  
purged	   under	   argon	   for	   10	   minutes.	   tBuOH	   (3	   mL)	   dissolved	   the	   reagents,	   the	  
appropriate	   hydrogen	   acceptor	   and	   the	   appropriate	   alcohol	   were	   added	   to	   the	  
solution	  using	   a	  micropipette.	   The	   tube	  was	   then	   sealed	   and	   the	   reaction	  mixture	  
was	   immediately	  heated	   to	  125	   ˚C	  and	   stirred	   for	  24	  hours.	   The	   resulting	   reaction	  
mixture	  was	  then	  cooled	  to	  room	  temperature	  and	  extracted	  with	  DCM	  and	  water.	  
The	  organic	  components	  were	  then	  dried	  and	  concentrated	   in	  vacuo.	  The	  resulting	  













Following	   representative	  procedure	  XV,	  methanesulfonamide	   (0.317	   g,	   3.33	  mmol,	  
1.1	   eq.)	   was	   used	   as	   the	   sulfonamide	   species,	   3-­‐phenyl-­‐1-­‐propanol	   (409	   µL,	   3.0	  
mmol)	  was	  used	  as	  the	  alcohol	  and	  3-­‐methyl-­‐2-­‐butanone	  (0.8	  mL,	  7.5	  mmol,	  2.5	  eq.)	  
was	   used	   as	   the	   hydrogen	   acceptor.	   1H	  NMR	  of	   the	   crude	   product	   showed	   a	   43%	  
conversion	   into	   4.1	   by	   comparison	   of	   the	   peaks	   at	   3.13	   (3H,	   s,	   CH3	  
methansulfonamide)	   and	  2.97	   (3H,	   s,	   CH3,	  4.1).	   1H	  NMR:	   (CDCl3,	   250	  MHz)	  δ	  7.36-­‐
7.15	  (5H,	  m,	  Ar),	  4.41	  (1H,	  br.s,	  NH),	  3.25-­‐3.14	  (2H,	  m,	  CH2),	  2.97	  (3H,	  s,	  CH3),	  2.81-­‐
2.65	  (2H,	  m,	  CH2),	  2.02-­‐1.85	  (2H,	  m,	  CH2).	  ESI-­‐MS	  of	  [C10H15NO2S];	  theoretical	  m/z	  of	  
[M+Na]+	  =	  236.1508,	  measured	  m/z	  of	  [M+Na]+	  =	  236.1503.	  
	  






Following	  representative	  procedure	  XV,	  p-­‐toluenesulfonamide	  (0.570	  g,	  3.33	  mmol,	  
1.1	   eq.)	   was	   used	   as	   the	   sulfonamide	   species,	   3-­‐phenyl-­‐1-­‐propanol	   (409	   µL,	   3.0	  
mmol)	  was	  used	  as	  the	  alcohol	  and	  3-­‐methyl-­‐2-­‐butanone	  (0.8	  mL,	  7.5	  mmol,	  2.5	  eq.)	  
was	   used	   as	   the	   hydrogen	   acceptor.	   1H	  NMR	  of	   the	   crude	   product	   showed	   a	   79%	  
conversion	   into	  4.2	   by	   comparison	   of	   the	   peaks	   at	   3.71	   (2H,	   t,	   J	   =	   6.4	  Hz,	   CH2,	   3-­‐
phenylpropan-­‐1-­‐ol)	  and	  3.06-­‐2.91	  (2H,	  m,	  CH2,	  4.2).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  7.76	  
(2H,	  d,	   J	  =	  8.2	  Hz,	  Ar),	  7.36-­‐7.05	   (7H,	  m,	  Ar),	  4.98	   (1H,	  br.s,	  NH),	  3.06-­‐2.91	   (2H,	  m,	  
CH2),	   2.70-­‐2.56	   (2H,	   m,	   CH2),	   2.46	   (3H,	   s,	   CH3),	   1.87-­‐1.73	   (2H,	   m,	   CH2).	   ESI-­‐MS	   of	  













Following	  representative	  procedure	  XV,	  benzamide	  (403	  g,	  3.33	  mmol,	  1.1	  eq.)	  was	  
used	  as	  the	  amide	  species,	  3-­‐phenyl-­‐1-­‐propanol	  (409	  µL,	  3.0	  mmol)	  was	  used	  as	  the	  
alcohol	   and	   3-­‐methyl-­‐2-­‐butanone	   (0.8	   mL,	   7.5	   mmol,	   2.5	   eq.)	   was	   used	   as	   the	  
hydrogen	  acceptor.	  1H	  NMR	  of	  the	  crude	  product	  showed	  a	  29%	  conversion	  into	  4.3	  
by	  comparison	  of	  the	  peaks	  at	  3.71	  (2H,	  t,	  J	  =	  6.4	  Hz,	  CH2,	  3-­‐phenylpropan-­‐1-­‐ol)	  and	  
3.65-­‐3.62	  (2H,	  m,	  CH2,	  4.3).	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  δ	  7.70	  (2H,	  d,	  J	  =	  7.4	  Hz),	  7.61-­‐
7.11	  (8H,	  m,	  Ar),	  6.19	  (1H,	  br.s,	  NH),	  3.65-­‐3.62	  (2H,	  m,	  CH2),	  2.67-­‐2.54	  (2H,	  m,	  CH2),	  
1.99-­‐1.83	  (2H,	  m,	  CH2).	  ESI-­‐MS	  of	  [C16H17NO];	  theoretical	  m/z	  of	  [M+NA]+	  =	  262.1208,	  
measured	  m/z	  of	  [M+Na]+	  =	  262.1191.	  
	  





Following	  representative	  procedure	  XV,	  4-­‐methylbenzamide	  (450	  mg,	  3.33	  mmol,	  1.1	  
eq.)	   was	   used	   as	   the	   amide	   species,	   3-­‐phenyl-­‐1-­‐propanol	   (409	  µL,	   3.0	  mmol)	   was	  
used	  as	  the	  alcohol	  and	  3-­‐methyl-­‐2-­‐butanone	  (0.8	  mL,	  7.5	  mmol,	  2.5	  eq.)	  was	  used	  
as	   the	   hydrogen	   acceptor.	   The	   1H	   NMR:	   (CDCl3,	   250	   MHz)	   of	   the	   crude	   product	  
showed	  a	  6%	  conversion	  into	  4.4	  by	  comparison	  of	  the	  peaks	  at	  3.71	  (2H,	  t,	  J	  =	  6.4	  
Hz,	  CH2,	  3-­‐phenylpropan-­‐1-­‐ol)	  and	  3.55-­‐3.44	  (2H,	  m,	  CH2,	  4.4).	  ESI-­‐MS	  of	  [C17H19NO];	  
theoretical	  m/z	  of	  [M+H]+	  =	  254.1545,	  measured	  m/z	  of	  [M+H]+	  =	  254.1540.	  
	  





Following	   representative	   procedure	   XV,	   butyramide	   (290	  mg,	   3.33	  mmol,	   1.1	   eq.)	  
was	  used	  as	  the	  amide	  species,	  3-­‐phenyl-­‐1-­‐propanol	  (409	  µL,	  3.0	  mmol)	  was	  used	  as	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the	   alcohol	   and	  3-­‐methyl-­‐2-­‐butanone	   (0.8	  mL,	   7.5	  mmol,	   2.5	   eq.)	  was	  used	  as	   the	  
hydrogen	  acceptor.	  The	  1H	  NMR:	   (CDCl3,	  250	  MHz)	  of	   the	  crude	  product	  showed	  a	  
19%	  conversion	  into	  4.5	  by	  comparison	  of	  the	  peaks	  at	  3.71	  (2H,	  t,	  J	  =	  6.4	  Hz,	  CH2,	  3-­‐
phenylpropan-­‐1-­‐ol)	  and	  3.55-­‐3.42	  (2H,	  m,	  CH2,	  4.5).	  	  
Varying	  hydrogen	  acceptor	  
(Table	  4.2,	  Chapter	  4,	  Section	  4.2)	  
Following	  representative	  procedure	  XV,	  methanesulfonamide	  (317	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species,	  3-­‐phenyl-­‐1-­‐propanol	  (409	  µL,	  3.0	  mmol)	  was	  used	  
as	  the	  alcohol	  and	  the	  appropriate	  hydrogen	  acceptor	  was	  added	  according	  to	  Table	  
4.2.	   The	   1H	   NMR:	   (CDCl3,	   250	   MHz)	   of	   the	   crude	   reaction	   mixture	   showed	   %	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  3.13	  (3H,	  s,	  CH3	  methansulfonamide)	  and	  
2.97	  (3H,	  s,	  CH3,	  4.1).	  
	  
Synthesis	  of	  sulfonimine	  4.6	  














To	   an	   oven	   dried	   flask,	   benzenesulfinic	   acid	   sodium	   salt	   (9.02	   g,	   55	  mmol)	   and	  p-­‐
toluenesulfonamide	  (8.560	  g,	  50	  mmol)	  were	  added.	  Formic	  acid	  50%	  solution	  (100	  
mL)	  dissolved	  the	  reagents,	  hydrocinnamaldehyde	  (6.58	  mL,	  50	  mmol)	  was	  added	  to	  
the	  solution	  using	  a	  syringe.	  The	  reaction	  mixture	  was	  stirred	  for	  18	  hours	  at	  room	  
temperature.	   The	   resulting	   reaction	  mixture	  was	   then	   diluted	  with	   H2O	   (100	  mL),	  
filtered	  and	  washed	  with	  H2O	  and	  hexane.	  The	  filter	  cake	  was	  dissolved	  in	  DCM	  (375	  
mL)	  and	  stirred	  with	  NaHCO3	  (saturated	  solution,	  375	  mL)	  for	  2	  hours.	  The	  reaction	  
mixture	   was	   then	   extracted	   with	   DCM	   and	   water.	   The	   organic	   components	   were	  
then	  dried	  and	  concentrated	  in	  vacuo.	  The	  product	  was	  analysed	  by	  its	  1H	  NMR	  and	  












Compound	   4.6	   was	   isolated	   as	   a	  white	   solid	   (10.65	   g,	   74%).	   1H	   NMR:	   (CDCl3,	   250	  
MHz)	  δ	  8.56	  (1H,	  t,	  J	  =	  4.0	  Hz),	  7.70	  (2H,	  d,	  J	  =	  8.4	  Hz),	  7.31-­‐7.01	  (7H,	  m),	  2.96-­‐2.83	  
(2H,	  m),	  2.83-­‐2.69	   (2H,	  m),	  2.38	   (3H,	   s).	  ESI-­‐MS	  of	   [C16H17NO2S];	   theoretical	  m/z	  of	  
[M+H]+	  =	  288.1058,	  measured	  m/z	  of	  [M+H]+	  =	  288.1048.	  
	  
Using	  4.6	  as	  the	  hydrogen	  acceptor	  
(Scheme	  4.5,	  Chapter	  4,	  Section	  4.2)	  
Following	  representative	  procedure	  XV,	  methanesulfonamide	  (317	  mg,	  3	  mmol)	  was	  
used	  as	  the	  sulfonamide	  species,	  benzyl	  alcohol	  (310	  µL,	  3.0	  mmol)	  was	  used	  as	  the	  
alcohol	  and	  sulfonimine	  4.6	   (2.155	  g,	  7.5	  mmol,	  2.5	  eq.)	  was	  used	  as	  the	  hydrogen	  
acceptor.	   The	   1H	  NMR:	   (CDCl3,	   250	  MHz)	  of	   the	   crude	   reaction	  mixture	   showed	  %	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  3.13	  (3H,	  s,	  CH3	  methansulfonamide)	  and	  
2.97	  (3H,	  s,	  CH3,	  4.7).	  
	  
Synthesis	  of	  NHC	  precursor	  4.8118	  






i) PhMe, <40 ˚C
   10 Min
ii) 6N HCl, 0 ˚C
iii) Glyoxal2 eq. 	  
To	  an	  oven	  dried	  flask,	  isopropylamine	  (3.09	  mL,	  30	  mmol)	  was	  added	  dropwise	  to	  a	  
suspension	   of	   paraformaldehyde	   (2.25	   mL,	   30	   mmol)	   in	   toluene	   (10	   mL)	   using	   a	  
syringe.	  Ensuring	  the	  temperature	  was	  kept	  below	  40	  ˚C	  the	  mixture	  was	  stirred	  for	  
10	  minutes.	  The	  mixture	  was	  then	  cooled	  to	  0	  ˚C	  in	  an	  ice/water	  bath	  and	  a	  second	  
portion	  of	   isopropylamine	  (3.09	  mL,	  30	  mmol)	  was	  added	  dropwise	  using	  a	  syringe,	  
subsequently	  HCL	   (6	  mL,	  30	  mmol,	   6N)	  was	  added	   to	   the	   solution	  using	  a	   syringe.	  
The	  reaction	  mixture	  was	  allowed	  to	  warm	  to	  room	  temperature	  and	  glyoxal	   (3.41	  
mL,	   30	  mmol)	  was	   added	  dropwise	  using	   a	   syringe.	   The	   resulting	   reaction	  mixture	  
was	  then	  stirred	  overnight	  to	  give	  a	  brown	  solution.	  The	  reaction	  mixture	  was	  then	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extracted	   with	   DCM	   and	   water.	   The	   organic	   components	   were	   then	   dried	   and	  
concentrated	  in	  vacuo.	  The	  product	  was	  analysed	  by	  1H	  NMR.	  
	  
4.8	  -­‐	  1,3-­‐Diisopropyl-­‐1H-­‐imidazol-­‐3-­‐ium	  chloride118	  
N N
Cl 	  
Compound	  4.8	  was	  isolated	  as	  a	  brown	  oil	  (4.126	  g,	  73%).	  1H	  NMR:	  (D2O,	  250	  MHz)	  δ	  
8.81-­‐8.65	  (1H,	  m,	  CH),	  7.53-­‐7.35	  (1H,	  m,	  CH),	  4.50	  (2H,	  m,	  CH),	  1.42	  (12H,	  d,	  J	  =	  8.1	  
Hz,	  CH3).	  
	  
Using	  NHC	  precursor	  











NHC 4.8 (5 mol%)
NaH (20 mol%)
MeCN (5 mol%) 





To	   oven	   dried	   and	   degassed	   Youngs	   carousel	   tubes,	   NaH	   (2.4	   mg,	   0.1	   mmol,	   20	  
mol%),	   RuH2(PPh3)4	  (28	  mg,	   0.025	  mmol,	   5	  mol%)	   and	  NHC	  precursor	  4.8	   (4.7	  mg,	  
0.025	   mmol,	   5	   mol%)	   were	   added	   under	   an	   inert	   atmosphere	   in	   a	   glovebox.	  
Anhydrous	   toluene	   (0.5	  mL)	   dissolved	   the	   reagents	   and	   anhydrous	  MeCN	   (1.2	  µL,	  
0.025	  mmol,	  5	  mol%)	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  
then	  sealed	  and	  the	  reaction	  mixture	  was	  immediately	  heated	  to	  115	  ˚C	  and	  stirred	  
for	   1	   hour.	   To	   the	   pre-­‐reaction	  mixture	  methanesulfonamide	   (47.5	  mg,	   0.5	  mmol)	  
and	   3-­‐phenyl-­‐1-­‐propanol	   (68	   µL,	   0.5	   mmol)	   were	   then	   added	   and	   the	   reaction	  
mixture	  was	  stirred	  at	  115	  ˚C	  for	  24	  hours.	  The	  resulting	  reaction	  mixture	  was	  then	  
cooled	   to	   room	   temperature	   and	   extracted	   with	   DCM	   and	   water.	   The	   organic	  
components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	   crude	  





Using	  Milstein’s	  catalyst80	  


















To	   oven	   dried	   and	   degassed	   Youngs	   carousel	   tubes,	   RuH(CO)(PNN)	   (4.5	   mg,	   0.01	  
mmol,	  1	  mol%)	  and	  p-­‐toluenesulfonamide	  (171	  mg,	  1	  mmol)	  were	  added	  under	  an	  
inert	   atmosphere	   of	   argon	   in	   a	   glovebox.	   Anhydrous	   toluene	   (3	  mL)	   dissolved	   the	  
reagents,	  3-­‐phenyl-­‐1-­‐propanol	   (136	  µL,	  1	  mmol)	  was	  added	  to	   the	  solution	  using	  a	  
micropipette.	  The	  tube	  was	  then	  sealed	  and	  the	  reaction	  mixture	  was	   immediately	  
heated	  to	  115	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  resulting	  reaction	  mixture	  was	  then	  
cooled	   to	   room	   temperature	   and	   extracted	   with	   DCM	   and	   water.	   The	   organic	  
components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	   crude	  
products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  	  
	  
Representative	  Procedure	  XVI	  












r.t., 5 h 	  
To	   oven	   dried	   Radleys	   carousel	   tubes,	   the	   appropriate	   amount	   of	   KOtBu	   and	  
Al(OtBu)3	  according	  to	  Table	  4.3	  and	  p-­‐toluenesulfonamide	  (171	  mg,	  1	  mmol)	  were	  
added.	  Anhydrous	  acetone	  (3	  mL)	  dissolved	  the	  reagents,	  3-­‐phenyl-­‐1-­‐propanol	  (136	  
µL,	   1	   mmol)	   was	   added	   to	   the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	  
sealed	  and	   the	   reaction	  mixture	  was	  stirred	   for	  5	  hours	  at	   room	  temperature.	  The	  
resulting	   reaction	   mixture	   was	   then	   extracted	   with	   DCM	   and	   water.	   The	   organic	  
components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   The	   resulting	   crude	  
products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  




Changing	  catalyst	  and	  oxidant	  










50 ˚C, 24 h
Catalyst
	  
To	  oven	  dried	  Radleys	  carousel	  tubes,	  the	  appropriate	  oxidant	  and	  catalyst	  according	  
to	   Table	   4.4	   and	  p-­‐toluenesulfonamide	   (171	  mg,	   1	  mmol)	  were	   added.	   Anhydrous	  
DCM	   (2	   mL)	   dissolved	   the	   reagents,	   3-­‐phenyl-­‐1-­‐propanol	   (136	   µL,	   1	   mmol)	   was	  
added	   to	   the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	  
reaction	   mixture	   was	   immediately	   heated	   to	   50	   ˚C	   and	   stirred	   for	   24	   hours.	   The	  
resulting	  reaction	  mixture	  was	  cooled	  to	  room	  temperature	  and	  then	  extracted	  with	  
DCM	   and	   water.	   The	   organic	   components	   were	   then	   dried	   and	   concentrated	   in	  
vacuo.	  The	  resulting	  crude	  products	  were	  analysed	  by	  their	  1H	  NMR	  spectra.	  The	  1H	  
NMR:	   (CDCl3,	   250	  MHz)	   of	   the	   crude	   reaction	  mixture	   showed	   no	   conversion	   into	  
2.27.	  	  
	  
Using	  methyl	  levulinate	  as	  the	  hydrogen	  acceptor	  












Base (10 mol%), tBuOH
125 ˚C, 24 h
Methyl levulinate (2 eq.) 	  
To	  oven	  dried	  Youngs	  carousel	  tubes,	  the	  appropriate	  base	  (0.1	  mmol,	  10	  mol%)	  and	  
the	   appropriate	   catalyst	   (5	   mol%)	   according	   to	   Table	   4.5,	   DPEphos	   (27	   mg,	   0.05	  
mmol,	  5	  mol%)	  and	  p-­‐toluenesulfonamide	  (171	  mg,	  1	  mmol)	  were	  added	  and	  purged	  
under	  argon	  for	  10	  minutes.	  tBuOH	  (1	  mL)	  dissolved	  the	  reagents,	  methyl	  levulinate	  
(248	  µL,	  2	  mmol,	  2	  eq.)	  and	  benzyl	  alcohol	  (207	  µL,	  2.0	  mmol,	  2	  eq.)	  were	  added	  to	  
the	   solution	   using	   a	   micropipette.	   The	   tube	   was	   then	   sealed	   and	   the	   reaction	  
mixture	  was	   immediately	   heated	   to	   115	   ˚C	   and	   stirred	   for	   24	   hours.	   The	   resulting	  
reaction	  mixture	  was	  then	  cooled	  to	  room	  temperature	  and	  extracted	  with	  DCM	  and	  
water.	  The	  organic	  components	  were	  then	  dried	  and	  concentrated	  in	  vacuo.	  The	  1H	  




Synthesis	  of	  SmI2121	  
(Scheme	  4.13,	  Chapter	  4,	  Section	  4.4)	  
Sm(0) + I I
THF SmI2 + 	  
To	  an	  oven	  dried	  and	  degassed	  Schlenk	  flask,	  diiodoethane	  (1.322	  mL,	  10	  mmol)	  was	  
dissolved	  in	  anhydrous	  THF	  (250	  mL).	  Samarium	  metal	  (3.000	  g,	  20	  mmol)	  was	  added	  
under	   an	   inert	   atmosphere	   of	   argon.	   The	   flask	   was	   then	   sealed	   and	   the	   reaction	  
mixture	  was	   stirred	   for	   24	   hours.	   The	   resulting	   solution	  was	   a	   characteristic	   deep	  
blue	  colour.	   In	  order	  to	  maintain	  the	  freshness	  of	  the	  sample	  the	  excess	  Samarium	  
metal	  was	  kept	  in	  the	  Schlenk	  flask	  and	  the	  solution	  was	  continuously	  stirred	  under	  
an	  argon	  atmosphere.	  The	  resulting	  solution	  was	  SmI2	  (0.04	  M	  in	  THF).	  
	  
Preparation	  of	  SmI2(THF)2122	  
(Chapter	  4,	  Section	  4.4)	  
To	  an	  oven	  dried	  and	  degassed	  Schlenk	  flask,	  SmI2	  (1.25	  mL,	  0.05	  mmol,	  0.04	  M)	  was	  
added	   by	   using	   a	   syringe.	   The	   solvent	  was	   then	   removed	   in	   vacuo.	   The	   remaining	  
dried	  compound	  was	  SmI2(THF)2	  in	  accordance	  with	  the	  literature	  procedure.122	  	  
	  
Using	  the	  SmI2(THF)2	  









+ SmI2(THF)2 (5 mol%)
Hydrogen acceptor (100 eq.)
125 ˚C, 72 h 	  
To	  oven	  dried	  Youngs	  carousel	  tubes,	  SmI2	  (1.25	  mL,	  0.05	  mmol,	  0.04	  M)	  was	  added	  
by	  using	  a	   syringe.	  The	   solvent	  was	   then	   removed	   in	  vacuo.	  p-­‐Toluenesulfonamide	  
(171	  mg,	   1	  mmol)	  was	   added	  and	  degassed.	  Anhydrous	  DCM	   (1	  mL)	  dissolved	   the	  
reagents,	  benzyl	  alcohol	  (104	  µL,	  1.0	  mmol)	  and	  the	  appropriate	  hydrogen	  acceptor	  
according	  to	  Table	  4.6	  were	  added	  to	  the	  solution	  using	  a	  micropipette	  or	  syringe	  as	  
appropriate.	   The	   tube	  was	   then	   sealed	   and	   the	   reaction	  mixture	  was	   immediately	  
heated	  to	  125	  ˚C	  and	  stirred	  for	  72	  hours.	  The	  resulting	  reaction	  mixture	  was	  then	  
cooled	   to	   room	   temperature	   and	   extracted	   with	   DCM	   and	   water.	   The	   organic	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components	  were	  then	  dried	  and	  concentrated	  in	  vacuo.	  1H	  NMR:	  (DMSO,	  250	  MHz)	  
of	  the	  crude	  reaction	  mixture	  showed	  no	  conversion	  into	  2.23.	  	  
	  






1H	  NMR:	  (DMSO,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  no	  conversion	  into	  
4.12.	  
	  




1H	  NMR:	  (DMSO,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  %	  conversion	  by	  
comparison	  of	   the	  peaks	  at	  4.51	  (2H,	  s,	  CH2	  benzyl	  alcohol)	  and	  8.91	   (1H,	  s,	  N=CH,	  
4.13).	  
	  
Using	  the	  SmI2	  









+ SmI2 0.04 M in THF (5 mol%)
Hydrogen acceptor (100 eq.)
125 ˚C, 72 h 	  
To	  oven	  dried	  Youngs	  carousel	  tubes,	  SmI2	  (1.25	  mL,	  0.05	  mmol,	  0.04	  M)	  was	  added	  
by	   using	   a	   syringe.	   p-­‐Toluenesulfonamide	   (171	   mg,	   1	   mmol)	   was	   added	   and	  
degassed.	   Benzyl	   alcohol	   (207	  µL,	   2.0	  mmol,	   2	   eq.)	   and	   the	   appropriate	   hydrogen	  
acceptor	  according	  to	  Table	  4.7	  were	  added	  to	  the	  solution	  using	  a	  micropipette	  or	  
syringe	   as	   appropriate.	   The	   tube	   was	   then	   sealed	   and	   the	   reaction	   mixture	   was	  
immediately	   heated	   to	   125	   ˚C	   and	   stirred	   for	   72	   hours.	   The	   resulting	   reaction	  
mixture	  was	  then	  cooled	  to	  room	  temperature	  and	  extracted	  with	  DCM	  and	  water.	  
The	   organic	   components	   were	   then	   dried	   and	   concentrated	   in	   vacuo.	   1H	   NMR:	  
(DMSO,	  250	  MHz)	  of	  the	  crude	  reaction	  mixture	  showed	  no	  conversion	  into	  2.23.	  1H	  
NMR:	   (DMSO,	  250	  MHz)	  of	   the	   crude	   reaction	  mixture	   showed	  no	  conversion	   into	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4.12.	   The	   1H	   NMR:	   (DMSO,	   250	   MHz)	   of	   the	   crude	   reaction	   mixture	   showed	   %	  
conversion	  by	  comparison	  of	  the	  peaks	  at	  4.51	  (2H,	  s,	  CH2	  benzyl	  alcohol)	  and	  8.91	  
(1H,	  s,	  N=CH,	  4.13).	  
	  
Using	  CuSO4	  as	  an	  oxidant	  











150 ˚C, 24 h 	  
To	  oven	  dried	  Youngs	  carousel	  tubes,	  the	  appropriate	  catalyst	  according	  to	  Table	  4.8,	  
CuSO4	   (160	  mg,	  1	  mmol,	  1	  eq.)	   and	  p-­‐toluenesulfonamide	   (171	  mg,	  1	  mmol)	  were	  
added	  and	  purged	  under	  argon	  for	  10	  minutes.	  Benzyl	  alcohol	  (414	  µL,	  4.0	  mmol,	  4	  
eq.)	  was	  added	  to	  the	  solution	  using	  a	  micropipette.	  The	  tube	  was	  then	  sealed	  and	  
the	  reaction	  mixture	  was	  immediately	  heated	  to	  115	  ˚C	  and	  stirred	  for	  24	  hours.	  The	  
resulting	  reaction	  mixture	  was	  then	  cooled	  to	  room	  temperature	  and	  extracted	  with	  
DCM	   and	   water.	   The	   organic	   components	   were	   then	   dried	   and	   concentrated	   in	  
vacuo.	   1H	   NMR:	   (CDCl3,	   250	   MHz)	   of	   the	   crude	   reaction	   mixture	   showed	   no	  
conversion	   into	  2.23.	  The	  1H	  NMR:	   (CDCl3,	  250	  MHz)	  of	   the	  crude	  reaction	  mixture	  
showed	  %	  conversion	  by	  comparison	  of	  the	  peaks	  at	  4.60	  (2H,	  s,	  CH2	  benzyl	  alcohol)	  
and	  4.15	  (2H,	  d,	  J	  =	  6.2	  Hz,	  CH2,	  4.12).	  The	  1H	  NMR:	  (CDCl3,	  250	  MHz)	  of	  the	  crude	  
reaction	  mixture	   showed	  %	   conversion	  by	   comparison	  of	   the	  peaks	   at	   4.60	   (2H,	   s,	  



































Chapter	  6:	  References	  
(1)	   van	   Leeuwen,	   P.	   W.	   N.	   M.,	   Homogeneous	   Catalysis	   -­‐	   Understanding	   the	   Art.	  
Springer:	  2004.	  
(2)	  Housecroft,	  C.	  E.;	  Sharpe,	  A.	  G.,	   Inorganic	  Chemistry.	  1st	  ed.;	  Pearson	  Education	  
Limited:	  2001.	  
(3)	   (a)	  Evans,	  D.;	  Yagupsky,	  G.;	  Wilkinson,	  G.,	  J.	  Chem.	  Soc.,	  A	  1968,	  2660-­‐2665;	   (b)	  
O'Connor,	   C.;	   Wilkinson,	   G.,	   J.	   Chem.	   Soc.,	   A	   1968,	   2665-­‐2671;	   (c)	   Yagupsky,	   M.;	  
Brown,	  C.	  K.;	  Yagupsky,	  G.;	  Wilkinson,	  G.,	  J.	  Chem.	  Soc.,	  A	  1970,	  937-­‐941.	  
(4)	  Knowles,	  W.	  S.,	  J.	  Chem.	  Educ.	  1986,	  63,	  222.	  
(5)	  Forster,	  D.;	  Dekleva,	  T.	  W.,	  J.	  Chem.	  Educ.	  1986,	  63,	  204.	  
(6)	   (a)	   Falbe,	   J.,	   The	   Hydroformylation	   Reaction	   Oxo	   Reaction/Roelen	   Reaction.	   In	  
Carbon	  Monoxide	  in	  Organic	  Synthesis,	  Springer	  Berlin	  Heidelberg:	  1970;	  Vol.	  10,	  pp	  
3-­‐77;	  (b)	  Cornils,	  B.,	  J.	  Mol.	  Catal.	  A:	  Chem.	  1999,	  143,	  1-­‐10.	  
(7)	  Reuben,	  B.;	  Wittcoff,	  H.,	  J.	  Chem.	  Educ.	  1988,	  65,	  605.	  
(8)	   (a)	   Miyaura,	   N.;	   Suzuki,	   A.,	   J.	   Chem.	   Soc.,	   Chem.	   Commun.	   1979,	   866-­‐867;	   (b)	  
Miyaura,	   N.;	   Yamada,	   K.;	   Suzuki,	   A.,	   Tetrahedron	   Lett.	   1979,	   20,	   3437-­‐3440;	   (c)	  
Miyaura,	  N.;	  Yanagi,	  T.;	  Suzuki,	  A.,	  Synth.	  Commun.	  1981,	  11,	  513-­‐519.	  
(9)	  (a)	  Miyashita,	  A.;	  Yasuda,	  A.;	  Takaya,	  H.;	  Toriumi,	  K.;	  Ito,	  T.;	  Souchi,	  T.;	  Noyori,	  R.,	  
J.	  Am.	  Chem.	  Soc.	  1980,	  102,	  7932-­‐7934;	  (b)	  Noyori,	  R.;	  Ohta,	  M.;	  Hsiao,	  Y.;	  Kitamura,	  
M.;	  Ohta,	  T.;	  Takaya,	  H.,	  J.	  Am.	  Chem.	  Soc.	  1986,	  108,	  7117-­‐7119;	  (c)	  Kitamura,	  M.;	  
Ohkuma,	  T.;	  Inoue,	  S.;	  Sayo,	  N.;	  Kumobayashi,	  H.;	  Akutagawa,	  S.;	  Ohta,	  T.;	  Takaya,	  H.;	  
Noyori,	  R.,	   J.	  Am.	  Chem.	   Soc.	  1988,	  110,	   629-­‐631;	   (d)	  Kitamura,	  M.;	   Tokunaga,	  M.;	  
Ohkuma,	  T.;	  Noyori,	  R.,	  Tetrahedron	  Lett.	  1991,	  32,	  4163-­‐4166.	  
(10)	  (a)	  Heck,	  R.	  F.,	  J.	  Am.	  Chem.	  Soc.	  1968,	  90,	  5518-­‐5526;	  (b)	  Mizoroki,	  T.;	  Mori,	  K.;	  
Ozaki,	  A.,	  Bull.	  Chem.	  Soc.	  Jpn.	  1971,	  44,	  581-­‐581;	  (c)	  Heck,	  R.	  F.;	  Nolley,	  J.	  P.,	  J.	  Org.	  
Chem.	  1972,	  37,	  2320-­‐2322;	  (d)	  Dieck,	  H.	  A.;	  Heck,	  R.	  F.,	  J.	  Am.	  Chem.	  Soc.	  1974,	  96,	  
1133-­‐1136.	  
(11)	   (a)	   Marciniec,	   B.,	   Silicon	   Chemistry	   2002,	   1,	   155-­‐174;	   (b)	   Marciniec,	   B.,	  
Hydrosilylation	  of	  Alkenes	  and	  Their	  Derivatives.	  In	  Hydrosilylation,	  Marciniec,	  B.,	  Ed.	  
Springer	  Netherlands:	  2009;	  Vol.	  1,	  pp	  3-­‐51.	  
(12)	   Renner,	  H.;	   Schlamp,	  G.;	   Kleinwächter,	   I.;	  Drost,	   E.;	   Lüschow,	  H.	  M.;	   Tews,	   P.;	  
Panster,	   P.;	   Diehl,	  M.;	   Lang,	   J.;	   Kreuzer,	   T.;	   Knödler,	   A.;	   Starz,	   K.	   A.;	   Dermann,	   K.;	  
Chapter	  6	  
198	  
Rothaut,	   J.;	   Drieselmann,	   R.;	   Peter,	   C.;	   Schiele,	   R.,	   Platinum	   Group	   Metals	   and	  
Compounds.	   In	   Ullmann's	   Encyclopedia	   of	   Industrial	   Chemistry,	   Wiley-­‐VCH	   Verlag	  
GmbH	  &	  Co.	  KGaA:	  2000.	  
(13)	  (a)	  Sakaki,	  S.;	  Mizoe,	  N.;	  Sugimoto,	  M.,	  Organometallics	  1998,	  17,	  2510-­‐2523;	  (b)	  
Wender,	  I.;	  Pino,	  P.,	  Organic	  Syntheses	  via	  Metal	  Carbonyls.	  Interscience	  Publishers:	  
1977.	  
(14)	  (a)	  Speier,	   J.	  L.;	  Webster,	   J.	  A.;	  Barnes,	  G.	  H.,	  J.	  Am.	  Chem.	  Soc.	  1957,	  79,	  974-­‐
979;	  (b)	  Saam,	  J.	  C.;	  Speier,	  J.	  L.,	  J.	  Am.	  Chem.	  Soc.	  1958,	  80,	  4104-­‐4106;	  (c)	  Ryan,	  J.	  
W.;	  Speier,	  J.	  L.,	  J.	  Am.	  Chem.	  Soc.	  1964,	  86,	  895-­‐898.	  
(15)	   (a)	   Kakiuchi,	   F.;	   Sekine,	   S.;	   Tanaka,	   Y.;	   Kamatani,	   A.;	   Sonoda,	  M.;	   Chatani,	   N.;	  
Murai,	  S.,	  Bull.	  Chem.	  Soc.	  Jpn.	  1995,	  68,	  62-­‐83;	  (b)	  Du,	  H.;	  Liu,	  Q.;	  Shi,	  S.;	  Zhang,	  S.,	  J.	  
Organomet.	  Chem.	  2001,	  627,	  127-­‐131.	  
(16)	  Grubbs,	  R.	  H.;	  Miller,	  S.	  J.;	  Fu,	  G.	  C.,	  Acc.	  Chem.	  Res.	  1995,	  28,	  446-­‐452.	  
(17)	  Crimmins,	  M.	  T.;	  Tabet,	  E.	  A.,	  J.	  Am.	  Chem.	  Soc.	  2000,	  122,	  5473-­‐5476.	  
(18)	  King,	  F.	  E.;	  Beer,	  R.	  J.	  S.,	  J.	  Chem.	  Soc.,	  (Resumed)	  1945,	  791-­‐794.	  
(19)	  Hinsberg,	  O.,	  Ber.	  1890,	  23,	  2962-­‐2965.	  
(20)	  Wermuth,	  C.	  G.,	  The	  Practice	  of	  Medicinal	  Chemistry.	  Academic	  Press:	  2003.	  
(21)	  (a)	  Declerck,	  V.;	  Aitken,	  D.,	  Amino	  Acids	  2011,	  41,	  587-­‐595;	  (b)	  Aitken,	  D.	  J.;	  Bull,	  
S.	  D.;	  Davies,	  I.	  R.;	  Drouin,	  L.;	  Ollivier,	  J.;	  Peed,	  J.,	  Synlett	  2010,	  18,	  2729-­‐2732.	  
(22)	   (a)	   Henry,	   R.	   J.,	   Bacteriological	   reviews	   1943,	   7,	   175-­‐262;	   (b)	   Otten,	   H.,	   J.	  
Antimicrob.	  Chemother.	  1986,	  17,	  689-­‐690.	  
(23)	  Yates,	  M.	  K.,	  N.;	  Ley,	  C.;	  Wei,	  J.,	  Org.	  Process	  Res.	  Dev.	  2009,	  13,	  255-­‐262.	  
(24)	  Banwell,	  M.	  G.;	  Crasto,	  C.	  F.;	  Easton,	  C.	  J.;	  Forrest,	  A.	  K.;	  Karoli,	  T.;	  March,	  D.	  R.;	  
Mensah,	  L.;	  Nairn,	  M.	  R.;	  O'Hanlon,	  P.	  J.;	  Oldham,	  M.	  D.;	  Yue,	  W.,	  Bioorg.	  Med.	  Chem.	  
Lett.	  2000,	  10,	  2263-­‐2266.	  
(25)	  Wikipedia	  Saccharin.	  http://en.wikipedia.org/wiki/Saccharin.	  
(26)	  Chambers,	  M.	  S.;	  Hobbs,	  S.	  C.;	  Graham,	  M.	  I.;	  Watt,	  A.	  P.;	  Fletcher,	  S.	  R.;	  Baker,	  
R.;	  Freedman,	  S.	  B.;	  Patel,	  S.;	  Smith,	  A.	   J.;	  Matassa,	  V.	  G.,	  Bioorg.	  Med.	  Chem.	  Lett.	  
1995,	  5,	  2303-­‐2308.	  
(27)	  Hasegawa,	  T.;	  Yamamoto,	  H.,	  Bull.	  Chem.	  Soc.	  Jpn.	  2000,	  73,	  423-­‐428.	  
(28)	  Yee,	  Y.	  K.;	  Bernstein,	  P.	  R.;	  Adams,	  E.	  J.;	  Brown,	  F.	  J.;	  Cronk,	  L.	  A.;	  Hebbel,	  K.	  C.;	  
Vacek,	  E.	  P.;	  Krell,	  R.	  D.;	  Snyder,	  D.	  W.,	  J.	  Med.	  Chem.	  1990,	  33,	  2437-­‐2451.	  
Chapter	  6	  
199	  
(29)	   (a)	   Chang,	   L.	   L.;	   Ashton,	   W.	   T.;	   Flanagan,	   K.	   L.;	   Chen,	   T.-­‐B.;	   O'Malley,	   S.	   S.;	  
Zingaro,	  G.	  J.;	  Siegl,	  P.	  K.	  S.;	  Kivlighn,	  S.	  D.;	  Lotti,	  V.	  J.,	  J.	  Med.	  Chem.	  1994,	  37,	  4464-­‐
4478;	  (b)	  Sehon,	  C.;	  McClure,	  K.;	  Hack,	  M.;	  Morton,	  M.;	  Gomez,	  L.;	  Li,	  L.;	  Barrett,	  T.	  
D.;	  Shankley,	  N.;	  Breitenbucher,	  J.	  G.,	  Bioorg.	  Med.	  Chem.	  Lett.	  2006,	  16,	  77-­‐80.	  
(30)	  (a)	  Bernstein,	  P.	  R.;	  Gomes,	  B.	  C.;	  Kosmider,	  B.	  J.;	  Vacek,	  E.	  P.;	  Williams,	  J.	  C.,	  J.	  
Med.	   Chem.	   1995,	   38,	   212-­‐215;	   (b)	   Kulkarni,	   S.	   S.;	   Hu,	   X.;	   Doi,	   K.;	   Wang,	   H.-­‐G.;	  
Manetsch,	  R.,	  ACS	  Chem.	  Biol.	  2011,	  6,	  724-­‐732;	  (c)	  Backes,	  B.	  J.;	  Ellman,	  J.	  A.,	  J.	  Org.	  
Chem.	   1999,	   64,	   2322-­‐2330;	   (d)	   Huang,	   S.;	   Connolly,	   P.	   J.;	   Lin,	   R.;	   Emanuel,	   S.;	  
Middleton,	  S.	  A.,	  Bioorg.	  Med.	  Chem.	  Lett.	  2006,	  16,	  3639-­‐3641.	  
(31)	  Fowkes,	  F.	  S.;	  McClelland,	  E.	  W.,	  J.	  Chem.	  Soc.	  1945,	  405-­‐407.	  
(32)	  (a)	  Johnson	  Ii,	  D.	  C.;	  Widlanski,	  T.	  S.,	  Tetrahedron	  Lett.	  2001,	  42,	  3677-­‐3679;	  (b)	  
Jacobs,	   R.	   T.;	   Brown,	   F.	   J.;	   Cronk,	   L.	   A.;	   Aharony,	   D.;	   Buckner,	   C.	   K.;	   Kusner,	   E.	   J.;	  
Kirkland,	  K.	  M.;	  Neilson,	  K.	  L.,	  J.	  Med.	  Chem.	  1993,	  36,	  394-­‐409.	  
(33)	  Pelletier,	  J.	  C.;	  Hesson,	  D.	  P.,	  Synlett	  1995,	  11,	  1141,1142.	  
(34)	  Drummond,	  J.	  T.;	  Johnson,	  G.,	  Tetrahedron	  Lett.	  1988,	  29,	  1653-­‐1656.	  
(35)	  Morisawa,	  Y.;	  Kataoka,	  M.;	  Nagahori,	  H.;	   Sakamoto,	  T.;	  Kitano,	  N.;	  Kusano,	  K.;	  
Sato,	  K.,	  J.	  Med.	  Chem.	  1980,	  23,	  1376-­‐1380.	  
(36)	  Martin,	  M.	   T.;	   Roschangar,	   F.;	   Eaddy,	   J.	   F.,	   Tetrahedron	   Lett.	   2003,	   44,	   5461-­‐
5463.	  
(37)	  Reza	  Massah,	  A.;	  Reza	  Momeni,	  A.;	  Dabagh,	  M.;	  Aliyan,	  H.;	  Javaherian	  Naghash,	  
H.,	  Synth.	  Commun.	  2008,	  38,	  265-­‐273.	  
(38)	  Alan	  R.	  Katritzky,	  S.	  H.	  a.	  K.	  S.,	  Arkivoc	  2004,	  xii,	  14-­‐22.	  
(39)	  Katritzky,	  A.	  R.;	  He,	  H.-­‐Y.;	  Suzuki,	  K.,	  J.	  Org.	  Chem.	  2000,	  65,	  8210-­‐8213.	  
(40)	  Georg,	  G.	  I.;	  Mashava,	  P.	  M.;	  Guan,	  X.,	  Tetrahedron	  Lett.	  1991,	  32,	  581-­‐584.	  
(41)	  Mukaiyama,	  T.	  U.,	  Masahiro;	  Saigo,	  Kazuhiko,	  Chem.	  Lett.	  1976,	  5,	  49-­‐50.	  
(42)	  Soltani	  Rad,	  M.	  N.;	  Khalafi-­‐Nezhad,	  A.;	  Asrari,	  Z.;	  Behrouz,	  S.,	  Synthesis	  2010,	  15,	  
2599-­‐2603.	  
(43)	  Valeur,	  E.;	  Bradley,	  M.,	  Chem.	  Soc.	  Rev.	  2009,	  38,	  606-­‐631.	  
(44)	   Li,	   J.	   J.,	   Vilsmeier	  mechanism	   for	   acid	   chloride	   formation.	   In	  Name	  Reactions,	  
Springer	  Berlin	  Heidelberg:	  2006;	  pp	  605-­‐605.	  
(45)	   Ishizuka,	   N.;	   Matsumura,	   K.-­‐i.;	   Hayashi,	   K.;	   Sakai,	   K.;	   Yamamori,	   T.,	   Synthesis	  
2000,	  6,	  784-­‐788.	  
Chapter	  6	  
200	  
(46)	  Hermann,	  C.	  K.	  F.;	  Campbell,	  J.	  A.;	  Greenwood,	  T.	  D.;	  Lewis,	  J.	  A.;	  Wolfe,	  J.	  F.,	  J.	  
Org.	  Chem.	  1992,	  57,	  5328-­‐5334.	  
(47)	  Yijima,	  C.	  H.,	  Fumio;	  Suda,	  Kohji:,	  Synthesis	  1981,	  8,	  610-­‐611.	  
(48)	   Adibi,	   H.;	   Massah,	   A.	   R.;	   Majnooni,	   M.	   B.;	   Shahidi,	   S.;	   Afshar,	   M.;	   Abiri,	   R.;	  
Naghash,	  H.	  J.,	  Synth.	  Commun.	  2010,	  40,	  2753-­‐2766.	  
(49)	  Fu,	  S.;	  Lian,	  X.;	  Ma,	  T.;	  Chen,	  W.;	  Zheng,	  M.;	  Zeng,	  W.,	  Tetrahedron	  Lett.	  2010,	  
51,	  5834-­‐5837.	  
(50)	  Ton,	  T.	  M.	  U.;	  Tejo,	  C.;	  Tania,	  S.;	  Chang,	  J.	  W.	  W.;	  Chan,	  P.	  W.	  H.,	  J.	  Org.	  Chem.	  
2011,	  76,	  4894-­‐4904.	  
(51)	  Singh,	  D.	  U.;	  Singh,	  P.	  R.;	  Samant,	  S.	  D.,	  Tetrahedron	  Lett.	  2004,	  45,	  4805-­‐4807.	  
(52)	   Cho,	   S.	   H.;	   Yoo,	   E.	   J.;	   Bae,	   I.;	   Chang,	   S.,	   J.	   Am.	   Chem.	   Soc.	  2005,	  127,	   16046-­‐
16047.	  
(53)	  Chan,	  J.;	  Baucom,	  K.	  D.;	  Murry,	  J.	  A.,	  J.	  Am.	  Chem.	  Soc.	  2007,	  129,	  14106-­‐14107.	  
(54)	  Chang,	  J.	  W.	  W.;	  Chan,	  P.	  W.	  H.,	  Angew.	  Chem.	  Int.	  Ed.	  2008,	  47,	  1138-­‐1140.	  
(55)	  Yamada,	  Y.	  Y.,	  Tamotsu;	  Okawara,	  Makoto,	  Chem.	  Lett.	  1975,	  4,	  361-­‐362.	  
(56)	  Wang,	  F.;	   Liu,	  H.;	   Fu,	  H.;	   Jiang,	  Y.;	   Zhao,	  Y.,	  Adv.	  Synth.	  Catal.	  2009,	  351,	  246-­‐
252.	  
(57)	  Wang,	  Z.;	  Zhang,	  Y.;	  Fu,	  H.;	  Jiang,	  Y.;	  Zhao,	  Y.,	  Org.	  Lett.	  2008,	  10,	  1863-­‐1866.	  
(58)	  (a)	  Meerwein,	  H.;	  Schmidt,	  R.,	  Justus	  Liebigs	  Ann.	  Chem.	  1925,	  444,	  221-­‐238;	  (b)	  
Ponndorf,	  W.,	  Angew.	   Chem.	  1926,	  39,	   138-­‐143;	   (c)	   Verley,	   A.,	  Bull.	   Soc.	   Chim.	   Fr.	  
1925,	  37,	  871-­‐874.	  
(59)	  Oppenauer,	  R.	  V.,	  Recl.	  Trav.	  Chim.	  Pays-­‐Bas	  1937,	  56,	  137-­‐144.	  
(60)	  Woodward,	   R.	   B.;	  Wendler,	   N.	   L.;	   Brutschy,	   F.	   J.,	   J.	   Am.	   Chem.	   Soc.	  1945,	  67,	  
1425-­‐1429.	  
(61)	   Adkins,	   H.;	   Elofson,	   R.	  M.;	   Rossow,	   A.	   G.;	   Robinson,	   C.	   C.,	   J.	   Am.	   Chem.	   Soc.	  
1949,	  71,	  3622-­‐3629.	  
(62)	  Kow,	  R.;	  Nygren,	  R.;	  Rathke,	  M.	  W.,	  J.	  Org.	  Chem.	  1977,	  42,	  826-­‐827.	  
(63)	  Namy,	  J.	  L.;	  Souppe,	  J.;	  Collin,	  J.;	  Kagan,	  H.	  B.,	  J.	  Org.	  Chem.	  1984,	  49,	  2045-­‐2049.	  
(64)	  Okano,	  T.;	  Matsuoka,	  M.;	  Konishi,	  H.;	  Kiji,	  J.,	  Chem.	  Lett.	  1987,	  16,	  181-­‐184.	  
(65)	   (a)	  Nakano,	  T.;	  Terada,	  T.;	   Ishii,	  Y.;	  Ogawa,	  M.,	  Synthesis	  1986,	  9,	  774-­‐776;	   (b)	  
Ishii,	   Y.;	  Nakano,	   T.;	   Inada,	   A.;	   Kishigami,	   Y.;	   Sakurai,	   K.;	  Ogawa,	  M.,	   J.	  Org.	   Chem.	  
1986,	  51,	  240-­‐242.	  
Chapter	  6	  
201	  
(66)	  Nakano,	  T.;	  Ishii,	  Y.;	  Ogawa,	  M.,	  J.	  Org.	  Chem.	  1987,	  52,	  4855-­‐4859.	  
(67)	   (a)	   Ooi,	   T.;	   Takahashi,	  M.;	  Maruoka,	   K.,	   J.	   Am.	   Chem.	   Soc.	   1996,	   118,	   11307-­‐
11308;	   (b)	   Ooi,	   T.;	  Miura,	   T.;	  Maruoka,	   K.,	  Angew.	   Chem.	   Int.	   Ed.	  1998,	  37,	   2347-­‐
2349;	  (c)	  Ooi,	  T.;	  Miura,	  T.;	  Maruoka,	  K.,	  J.	  Am.	  Chem.	  Soc.	  1998,	  120,	  10790-­‐10791;	  
(d)	  Ooi,	  T.;	  Itagaki,	  Y.;	  Miura,	  T.;	  Maruoka,	  K.,	  Tetrahedron	  Lett.	  1999,	  40,	  2137-­‐2138;	  
(e)	  Ooi,	  T.;	  Miura,	  T.;	   Itagaki,	  Y.;	   Ichikawa,	  H.;	  Maruoka,	  K.,	  Synthesis	  2002,	  2,	  279-­‐
291.	  
(68)	  Coleman,	  M.	  G.;	  Brown,	  A.	  N.;	  Bolton,	  B.	  A.;	  Guan,	  H.,	  Adv.	  Synth.	  Catal.	  2010,	  
352,	  967-­‐970.	  
(69)	   Warner,	   B.	   P.;	   D'Alessio,	   J.	   A.;	   Morgan	   Iii,	   A.	   N.;	   Burns,	   C.	   J.;	   Schake,	   A.	   R.;	  
Watkin,	  J.	  G.,	  Inorg.	  Chim.	  Acta	  2000,	  309,	  45-­‐48.	  
(70)	  (a)	  Ishihara,	  K.;	  Kurihara,	  H.;	  Yamamoto,	  H.,	  J.	  Org.	  Chem.	  1997,	  62,	  5664-­‐5665;	  
(b)	  Uysal,	  B.;	  Buyuktas,	  B.,	  Chem.	  Pap.	  2010,	  64,	  123-­‐126.	  
(71)	  Kuo,	  L.	  Y.;	  Finigan,	  D.	  M.;	  Tadros,	  N.	  N.,	  Organometallics	  2003,	  22,	  2422-­‐2425.	  
(72)	  Mebane,	  R.	  C.;	  Jensen,	  D.	  R.;	  Rickerd,	  K.	  R.;	  Gross,	  B.	  H.,	  Synth.	  Commun.	  2003,	  
33,	  3373-­‐3379.	  
(73)	  Boronat,	  M.;	  Corma,	  A.;	  Renz,	  M.,	  J.	  Phys.	  Chem.	  B.	  2006,	  110,	  21168-­‐21174.	  
(74)	  Akata,	  B.;	  Yilmaz,	  B.;	  Sacco,	  A.,	  Jr.,	  J.	  Porous	  Mater.	  2008,	  15,	  351-­‐357.	  
(75)	   (a)	   Vol'pin,	   M.	   E.;	   Kukolev,	   V.	   P.;	   Chernyshev,	   V.	   O.;	   Kolomnikov,	   I.	   S.,	  
Tetrahedron	  Lett.	  1971,	  12,	  4435-­‐4438;	  (b)	  Blum,	  J.;	  Sasson,	  Y.;	  Iflah,	  S.,	  Tetrahedron	  
Lett.	  1972,	  13,	   1015-­‐1018;	   (c)	   Imai,	   H.;	   Nishiguchi,	   T.;	   Fukuzumi,	   K.,	   J.	   Org.	   Chem.	  
1974,	  39,	   1622-­‐1627;	   (d)	  Masters,	   C.;	   Kiffen,	   A.	   A.;	   Visser,	   J.	   P.,	   J.	   Am.	   Chem.	   Soc.	  
1976,	  98,	  1357-­‐1364;	  (e)	  Nishiguchi,	  T.;	   Imai,	  H.;	  Fukuzumi,	  K.,	  Chem.	  Lett.	  1977,	  6,	  
1113-­‐1114.	  
(76)	   (a)	   Sasson,	   Y.;	   Blum,	   J.,	   J.	   Org.	   Chem.	   1975,	   40,	   1887-­‐1896;	   (b)	   Imai,	   H.;	  
Nishiguchi,	  T.;	  Fukuzumi,	  K.,	  J.	  Org.	  Chem.	  1976,	  41,	  665-­‐671;	  (c)	  Imai,	  H.;	  Nishiguchi,	  
T.;	  Fukuzumi,	  K.,	  J.	  Org.	  Chem.	  1977,	  42,	  431-­‐434;	  (d)	  Descotes,	  G.;	  Praly,	  J.	  P.;	  Sinou,	  
D.,	  J.	  Mol.	  Catal.	  1979,	  6,	  421-­‐430;	  (e)	  Tabor,	  D.	  C.;	  White,	  F.;	  Collier,	  L.	  W.;	  Evans,	  S.	  
A.,	  J.	  Org.	  Chem.	  1983,	  48,	  1638-­‐1643.	  
(77)	  (a)	  Fragale,	  C.;	  Gargano,	  M.;	  Rossi,	  M.,	  J.	  Mol.	  Catal.	  1979,	  5,	  65-­‐73;	  (b)	  Camus,	  
A.;	   Mestroni,	   G.;	   Zassinovich,	   G.,	   J.	   Mol.	   Catal.	   1979,	   6,	   231-­‐233;	   (c)	   Camus,	   A.;	  
Mestroni,	  G.;	  Zassinovich,	  G.,	  J.	  Organomet.	  Chem.	  1980,	  184,	  C10-­‐C12.	  
Chapter	  6	  
202	  
(78)	  Hamid,	  M.	  H.	  S.	  A.;	  Slatford,	  P.	  A.;	  Williams,	  J.	  M.	  J.,	  Adv.	  Synth.	  Catal.	  2007,	  349,	  
1555-­‐1575.	  
(79)	  Watanabe,	  Y.;	  Ohta,	  T.;	  Tsuji,	  Y.,	  Bull.	  Chem.	  Soc.	  Jpn.	  1983,	  56,	  2647-­‐2651.	  
(80)	  Gunanathan,	  C.;	  Ben-­‐David,	  Y.;	  Milstein,	  D.,	  Science	  2007,	  317,	  790-­‐792.	  
(81)	   Nordstrøm,	   L.	   U.;	   Vogt,	   H.;	  Madsen,	   R.,	   J.	   Am.	   Chem.	   Soc.	   2008,	   130,	   17672-­‐
17673.	  
(82)	  Ghosh,	  S.	  C.;	  Muthaiah,	  S.;	  Zhang,	  Y.;	  Xu,	  X.;	  Hong,	  S.	  H.,	  Adv.	  Synth.	  Catal.	  2009,	  
351,	  2643-­‐2649.	  
(83)	  Nishide,	  K.;	  Node,	  M.,	  Chirality	  2002,	  14,	  759-­‐767.	  
(84)	  Huskens,	   J.;	   de	  Graauw,	   C.	   F.;	   Peters,	   J.	   A.;	   van	  Bekkum,	  H.,	  Recl.	   Trav.	   Chim.	  
Pays-­‐Bas	  1994,	  113,	  488-­‐491.	  
(85)	  Xianming,	  H.;	  Kellogg,	  R.	  M.,	  Recl.	  Trav.	  Chim.	  Pays-­‐Bas	  1996,	  115,	  410-­‐417.	  
(86)	  Krohn,	  K.;	  Knauer,	  B.,	  Liebigs	  Annalen	  1995,	  1995,	  1347-­‐1351.	  
(87)	  Evans,	  D.	  A.;	  Nelson,	  S.	  G.;	  Gagne,	  M.	  R.;	  Muci,	  A.	  R.,	   J.	  Am.	  Chem.	  Soc.	  1993,	  
115,	  9800-­‐9801.	  
(88)	  Noyori,	  R.;	  Hashiguchi,	  S.,	  Acc.	  Chem.	  Res.	  1997,	  30,	  97-­‐102.	  
(89)	   (a)	  Spogliarich,	  R.;	  Kašpar,	   J.;	  Graziani,	  M.;	  Morandini,	  F.,	   J.	  Organomet.	  Chem.	  
1986,	  306,	  407-­‐412;	  (b)	  Botteghi,	  C.;	  Chelucci,	  C.;	  Chessa,	  G.;	  Delogu,	  G.;	  Gladiali,	  S.;	  
Soccolini,	   F.,	   J.	   Organomet.	   Chem.	   1986,	   304,	   217-­‐225;	   (c)	   Genêt,	   J.-­‐P.;	  
Ratovelomanana-­‐Vidal,	  V.;	  Pinel,	  C.,	  Synlett	  1993,	  7,	  478-­‐480;	  (d)	  Gladiali,	  S.;	  Pinna,	  
L.;	  Delogu,	  G.;	  De	  Martin,	  S.;	  Zassinovich,	  G.;	  Mestroni,	  G.,	  Tetrahedron:	  Asymmetry	  
1990,	  1,	  635-­‐648.	  
(90)	  (a)	  Krause,	  H.	  W.;	  Bhatnagar,	  A.	  K.,	  J.	  Organomet.	  Chem.	  1986,	  302,	  265-­‐267;	  (b)	  
Müller,	  D.;	  Umbricht,	  G.;	  Weber,	  B.;	  Pfaltz,	  A.,	  Helv.	  Chim.	  Acta	  1991,	  74,	  232-­‐240.	  
(91)	   (a)	   Bianchi,	  M.;	  Matteoli,	   U.;	  Menchi,	   G.;	   Frediani,	   P.;	   Pratesi,	   S.;	   Piacenti,	   F.;	  
Botteghi,	   C.,	   J.	   Organomet.	   Chem.	   1980,	   198,	   73-­‐80;	   (b)	   Schwink,	   L.;	   Ireland,	   T.;	  
Püntener,	  K.;	  Knochel,	  P.,	  Tetrahedron:	  Asymmetry	  1998,	  9,	  1143-­‐1163;	  (c)	  Püntener,	  
K.;	  Schwink,	  L.;	  Knochel,	  P.,	  Tetrahedron	  Lett.	  1996,	  37,	  8165-­‐8168.	  
(92)	  Hannedouche,	   J.;	   Clarkson,	  G.	   J.;	  Wills,	  M.,	   J.	   Am.	  Chem.	   Soc.	  2004,	  126,	   986-­‐
987.	  
(93)	  Palmer,	  M.	  J.;	  Wills,	  M.,	  Tetrahedron:	  Asymmetry	  1999,	  10,	  2045-­‐2061.	  
Chapter	  6	  
203	  
(94)	  Matharu,	  D.	  S.;	  Morris,	  D.	   J.;	  Kawamoto,	  A.	  M.;	  Clarkson,	  G.	   J.;	  Wills,	  M.,	  Org.	  
Lett.	  2005,	  7,	  5489-­‐5491.	  
(95)	  Hayes,	  A.	  M.;	  Morris,	  D.	  J.;	  Clarkson,	  G.	  J.;	  Wills,	  M.,	  J.	  Am.	  Chem.	  Soc.	  2005,	  127,	  
7318-­‐7319.	  
(96)	  Brunner,	  H.;	  Leitner,	  W.,	  Angew.	  Chem.	  Int.	  Ed.	  1988,	  27,	  1180-­‐1181.	  
(97)	   Braude,	   E.	   A.;	   Hannah,	   J.;	   Linstead,	   R.,	   J.	   Chem.	   Soc.,	   (Resumed)	   1960,	   3249-­‐
3257.	  
(98)	  Taylor,	  J.	  E.;	  Jones,	  M.	  D.;	  Williams,	  J.	  M.	  J.;	  Bull,	  S.	  D.,	  J.	  Org.	  Chem.	  2012,	  77,	  
2808-­‐2818.	  
(99)	  Yates,	  M.	  H.;	  Kallman,	  N.	  J.;	  Ley,	  C.	  P.;	  Wei,	  J.	  N.,	  Org.	  Process	  Res.	  Dev.	  2009,	  13,	  
255-­‐262.	  
(100)	  Woodman,	  E.	  K.;	  Chaffey,	  J.	  G.	  K.;	  Hopes,	  P.	  A.;	  Hose,	  D.	  R.	  J.;	  Gilday,	  J.	  P.,	  Org.	  
Process	  Res.	  Dev.	  2008,	  13,	  106-­‐113.	  
(101)	  (a)	  Pedersen,	  C.	  J.,	  J.	  Am.	  Chem.	  Soc.	  1967,	  89,	  2495-­‐2496;	  (b)	  Pedersen,	  C.	  J.,	  J.	  
Am.	  Chem.	  Soc.	  1967,	  89,	  7017-­‐7036;	  (c)	  Pedersen,	  C.	  J.,	  Angew.	  Chem.	  Int.	  Ed.	  1988,	  
27,	  1021-­‐1027;	  (d)	  Steed,	  J.	  W.,	  Coord.	  Chem.	  Rev.	  2001,	  215,	  171-­‐221.	  
(102)	  (a)	  Kamiński,	  Z.	  J.;	  Paneth,	  P.;	  Rudziński,	  J.,	  J.	  Org.	  Chem.	  1998,	  63,	  4248-­‐4255;	  
(b)	  Edwards,	  J.	  O.;	  Pearson,	  R.	  G.,	  J.	  Am.	  Chem.	  Soc.	  1962,	  84,	  16-­‐24;	  (c)	  Bender,	  M.	  
L.,	  Chem.	  Rev.	  1960,	  60,	   53-­‐113;	   (d)	   Jencks,	  W.	  P.;	  Gilchrist,	  M.,	   J.	  Am.	  Chem.	   Soc.	  
1968,	  90,	  2622-­‐2637.	  
(103)	  (a)	  Cherney,	  A.	  H.;	  Kadunce,	  N.	  T.;	  Reisman,	  S.	  E.,	  J.	  Am.	  Chem.	  Soc.	  2013,	  135,	  
7442-­‐7445;	  (b)	  Wotal,	  A.	  C.;	  Weix,	  D.	  J.,	  Org.	  Lett.	  2012,	  14,	  1476-­‐1479.	  
(104)	  Hashiguchi,	  S.;	  Fujii,	  A.;	  Takehara,	   J.;	   Ikariya,	  T.;	  Noyori,	  R.,	   J.	  Am.	  Chem.	  Soc.	  
1995,	  117,	  7562-­‐7563.	  
(105)	  Maytum,	  H.	  C.;	  Tavassoli,	  B.;	  Williams,	  J.	  M.	  J.,	  Org.	  Lett.	  2007,	  9,	  4387-­‐4389.	  
(106)	  Yamakawa,	  M.;	  Yamada,	   I.;	  Noyori,	  R.,	  Angew.	  Chem.	   Int.	  Ed.	  2001,	  40,	  2818-­‐
2821.	  
(107)	  Winterbottom,	   J.	  M.;	  Marwan,	  H.;	   Viladevall,	   J.;	   Sharma,	   S.;	   Raymahasay,	   S.,	  
Selective	   catalytic	   hydrogenation	   of	   2-­‐butyne-­‐1,4-­‐diol	   to	   cis-­‐2-­‐butene-­‐1,4-­‐diol	   in	  
mass	   transfer	   efficient	   slurry	   reactors.	   In	   Stud.	   Surf.	   Sci.	   Catal.,	   H.U.	   Blaser,	   A.	   B.;	  
Prins,	  R.,	  Eds.	  Elsevier:	  1997;	  Vol.	  Volume	  108,	  pp	  59-­‐66.	  
Chapter	  6	  
204	  
(108)	  Chaudhari,	  R.	  V.;	   Jaganathan,	  R.;	  Kolhe,	  D.	  S.;	  Emig,	  G.;	  Hofmann,	  H.,	  Applied	  
Catalysis	  1987,	  29,	  141-­‐159.	  
(109)	  Telkar,	  M.	  M.;	  Rode,	  C.	  V.;	  Rane,	  V.	  H.;	  Jaganathan,	  R.;	  Chaudhari,	  R.	  V.,	  Applied	  
Catalysis	  A:	  General	  2001,	  216,	  13-­‐22.	  
(110)	  Gräfje,	  H.;	  Körnig,	  W.;	  Weitz,	  H.-­‐M.;	  Reiß,	  W.;	  Steffan,	  G.;	  Diehl,	  H.;	  Bosche,	  H.;	  
Schneider,	   K.;	   Kieczka,	   H.,	   Butanediols,	   Butenediol,	   and	   Butynediol.	   In	   Ullmann's	  
Encyclopedia	  of	  Industrial	  Chemistry,	  Wiley-­‐VCH	  Verlag	  GmbH	  &	  Co.	  KGaA:	  2000.	  
(111)	  Lindlar,	  H.,	  Helv.	  Chim.	  Acta	  1952,	  35,	  446-­‐450.	  
(112)	   (a)	   Fukuda,	   T.,	   Bull.	   Chem.	   Soc.	   Jpn.	   1958,	   31,	   343-­‐347;	   (b)	   Russell,	   T.	   W.;	  
Duncan,	  D.	  M.,	   J.	  Org.	   Chem.	  1974,	  39,	   3050-­‐3052;	   (c)	   Jardine,	   I.;	   Howsam,	  R.	  W.;	  
McQuillin,	  F.	  J.,	  J.	  Chem.	  Soc.,	  C	  1969,	  260-­‐263.	  
(113)	  Cativiela,	  C.;	   Fraile,	   J.	  M.;	  Garciá,	   J.	   I.;	  Mayoral,	   J.	  A.;	  Pires,	  E.;	   Figuéras,	  F.,	   J.	  
Mol.	  Catal.	  1993,	  79,	  305-­‐310.	  
(114)	   (a)	   Trost,	   B.	   M.;	   Kulawiec,	   R.	   J.,	   Tetrahedron	   Lett.	   1991,	   32,	   3039-­‐3042;	   (b)	  
Trost,	  B.	  M.;	  Kulawiec,	  R.	  J.,	  J.	  Am.	  Chem.	  Soc.	  1993,	  115,	  2027-­‐2036.	  
(115)	  Hamid,	  M.	  H.	   S.	  A.;	  Allen,	  C.	   L.;	   Lamb,	  G.	  W.;	  Maxwell,	  A.	  C.;	  Maytum,	  H.	  C.;	  
Watson,	  A.	  J.	  A.;	  Williams,	  J.	  M.	  J.,	  J.	  Am.	  Chem.	  Soc.	  2009,	  131,	  1766-­‐1774.	  
(116)	  Watson,	  A.	   J.	  A.;	  Maxwell,	  A.	  C.;	  Williams,	   J.	  M.	   J.,	  Org.	  Lett.	  2009,	  11,	  2667-­‐
2670.	  
(117)	   Dragutan,	   V.;	   Dragutan,	   I.;	   Delaude,	   L.;	   Demonceau,	   A.,	   Coord.	   Chem.	   Rev.	  
2007,	  251,	  765-­‐794.	  
(118)	  Starikova,	  O.	  V.;	  Dolgushin,	  G.	  V.;	  Larina,	  L.	  I.;	  Ushakov,	  P.	  E.;	  Komarova,	  T.	  N.;	  
Lopyrev,	  V.	  A.,	  Russ.	  J.	  Org.	  Chem.	  2003,	  39,	  1467-­‐1470.	  
(119)	  Warnhoff,	  E.	  W.;	  Reynolds-­‐Warnhoff,	  P.,	  J.	  Org.	  Chem.	  1963,	  28,	  1431-­‐1433.	  
(120)	  Wise,	  N.	  J.;	  Williams,	  J.	  M.	  J.,	  Tetrahedron	  Lett.	  2007,	  48,	  3639-­‐3641.	  
(121)	  Evans,	  D.	  A.;	  Hoveyda,	  A.	  H.,	  J.	  Am.	  Chem.	  Soc.	  1990,	  112,	  6447-­‐6449.	  
(122)	   Collin,	   J.;	   Bezzenine-­‐Lafollée,	   S.;	   Gil,	   R.;	   Jaber,	   N.;	   Martin,	   M.;	   Reboule,	   I.,	  
Synlett	  2009,	  13,	  2051-­‐2067.	  
(123)	  Pham,	  M.	  V.;	  Ye,	  B.;	  Cramer,	  N.,	  Angew.	  Chem.	  Int.	  Ed.	  2012,	  51,	  10610-­‐10614.	  
(124)	  Kretow,	  A.,	  J.	  Gen.	  Chem.	  USSR	  (Engl.	  Transl.)	  1960,	  30,	  1243-­‐1266.	  
(125)	  Borah,	  A.	  J.;	  Phukan,	  P.,	  Chem.	  Commun.	  2012,	  48,	  5491-­‐5493.	  
(126)	  Péron,	  F.;	  Fossey,	  C.;	  Cailly,	  T.;	  Fabis,	  F.,	  Org.	  Lett.	  2012,	  14,	  1827-­‐1829.	  
Chapter	  6	  
205	  
(127)	  Fan,	  R.;	  Li,	  W.;	  Pu,	  D.;	  Zhang,	  L.,	  Org.	  Lett.	  2009,	  11,	  1425-­‐1428.	  
(128)	  Zhu,	  M.;	  Fujita,	  K.-­‐i.;	  Yamaguchi,	  R.,	  Org.	  Lett.	  2010,	  12,	  1336-­‐1339.	  
(129)	  Sone,	  T.;	  Abe,	  Y.;	  Sato,	  N.;	  Ebina,	  M.,	  Bull.	  Chem.	  Soc.	  Jpn.	  1985,	  58,	  1063-­‐1064.	  
(130)	  Seiller,	  B.;	  Heins,	  D.;	  Bruneau,	  C.;	  H.	  Dixneuf,	  P.,	  Tetrahedron	  1995,	  51,	  10901-­‐
10912.	  
(131)	  Nicolaou,	  K.	  C.;	  Mathison,	  C.	  J.	  N.,	  Angew.	  Chem.	  Int.	  Ed.	  2005,	  44,	  5992-­‐5997.	  
(132)	  Slavinskaya,	  R.	  A.	  G.,	  V.	  Z.;	  Nurakhynova,	  M.;	  Sumarokova,	  T.	  N.,	  J.	  Gen.	  Chem.	  
USSR	  (Engl.	  Transl.)	  1981,	  51,	  2779-­‐2787.	  
(133)	  Schnyder,	  A.;	  Indolese,	  A.	  F.,	  J.	  Org.	  Chem.	  2002,	  67,	  594-­‐597.	  
(134)	  Huang,	  W.;	  Xu,	  M.-­‐L.,	  J.	  Chem.	  Res.	  2013,	  37,	  77-­‐79.	  
(135)	  Evans,	  D.	  A.;	  Nagorny,	  P.;	  Xu,	  R.,	  Org.	  Lett.	  2006,	  8,	  5669-­‐5671.	  
(136)	  Inokuma,	  T.;	  Hoashi,	  Y.;	  Takemoto,	  Y.,	  J.	  Am.	  Chem.	  Soc.	  2006,	  128,	  9413-­‐9419.	  
(137)	  Xu,	  L.;	  Zhang,	  S.;	  Trudell,	  M.	  L.,	  Chem.	  Commun.	  2004,	  1668-­‐1669.	  
(138)	   Lee,	   J.;	  Hong,	  M.;	   Jung,	   Y.;	   Cho,	   E.	   J.;	   Rhee,	  H.,	  Tetrahedron	  2012,	  68,	   2045-­‐
2051.	  
(139)	  Chakraborti,	  A.	  K.;	  Gulhane,	  R.,	  Chem.	  Commun.	  2003,	  1896-­‐1897.	  
(140)	  Power,	  M.	  B.;	  Bott,	  S.	  G.;	  Bishop,	  E.	  J.;	  Tierce,	  K.	  D.;	  Atwood,	  J.	  L.;	  Barron,	  A.	  R.,	  
J.	  Chem.	  Soc.,	  Dalton	  Trans.	  1991,	  241-­‐247.	  
(141)	  Stillson,	  G.	  H.;	  Sawyer,	  D.	  W.;	  Hunt,	  C.	  K.,	  J.	  Am.	  Chem.	  Soc.	  1945,	  67,	  303-­‐307.	  
(142)	  Monastyrskaya,	  G.	  K.	  L.,	  Russ.	  J.	  Org.	  Chem.	  1997,	  33,	  1409-­‐1416.	  
(143)	  Nishinaga,	  A.;	  Shimizu,	  T.;	  Toyoda,	  Y.;	  Matsuura,	  T.;	  Hirotsu,	  K.,	  J.	  Org.	  Chem.	  
1982,	  47,	  2278-­‐2285.	  
(144)	  Cai,	  M.;	  Zheng,	  G.;	  Zha,	  L.;	  Peng,	  J.,	  Eur.	  J.	  Org.	  Chem.	  2009,	  10,	  1585-­‐1591.	  
(145)	  Sprecher,	  M.;	  Kost,	  D.,	  J.	  Am.	  Chem.	  Soc.	  1994,	  116,	  1016-­‐1026.	  
(146)	  Wu,	  J.-­‐C.;	  Gong,	  L.-­‐B.;	  Xia,	  Y.;	  Song,	  R.-­‐J.;	  Xie,	  Y.-­‐X.;	  Li,	  J.-­‐H.,	  Angew.	  Chem.	  Int.	  
Ed.	  2012,	  51,	  9909-­‐9913.	  
(147)	  Johnson,	  T.	  C.;	  Totty,	  W.	  G.;	  Wills,	  M.,	  Org.	  Lett.	  2012,	  14,	  5230-­‐5233.	  
(148)	  Fernández-­‐Mateos,	  E.;	  Maciá,	  B.;	   Yus,	  M.,	  Eur.	   J.	  Org.	  Chem.	  2012,	  20,	   3732-­‐
3736.	  
(149)	   Tagat,	   J.	   R.;	   Steensma,	   R.	   W.;	   McCombie,	   S.	   W.;	   Nazareno,	   D.	   V.;	   Lin,	   S.-­‐I.;	  
Neustadt,	  B.	  R.;	  Cox,	  K.;	  Xu,	  S.;	  Wojcik,	  L.;	  Murray,	  M.	  G.;	  Vantuno,	  N.;	  Baroudy,	  B.	  
M.;	  Strizki,	  J.	  M.,	  J.	  Med.	  Chem.	  2001,	  44,	  3343-­‐3346.	  
Chapter	  6	  
206	  
(150)	  Vitale,	  P.;	  D’Introno,	  C.;	  Perna,	  F.	  M.;	  Perrone,	  M.	  G.;	  Scilimati,	  A.,	  Tetrahedron:	  
Asymmetry	  2013,	  24,	  389-­‐394.	  
(151)	  Moteki,	   S.	  A.;	   Toyama,	  K.;	   Liu,	   Z.;	  Ma,	   J.;	  Holmes,	  A.	   E.;	   Takacs,	   J.	  M.,	  Chem.	  
Commun.	  2012,	  48,	  263-­‐265.	  
(152)	  Ankner,	  T.;	  Hilmersson,	  G.	  r.,	  Org.	  Lett.	  2009,	  11,	  503-­‐506.	  
(153)	  Nack,	  W.	  A.;	  He,	  G.;	   Zhang,	   S.-­‐Y.;	   Lu,	  C.;	   Chen,	  G.,	  Org.	   Lett.	  2013,	  15,	   3440-­‐
3443.	  
(154)	  Watson,	  A.	  J.	  A.;	  Maxwell,	  A.	  C.;	  Williams,	  J.	  M.	  J.,	  J.	  Org.	  Chem.	  2011,	  76,	  2328-­‐
2331.	  
(155)	  Wipf,	  P.;	  Kendall,	  C.,	  Org.	  Lett.	  2001,	  3,	  2773-­‐2776.	  
(156)	   Cui,	   X.;	   Shi,	   F.;	   Tse,	  M.	   K.;	   Gördes,	   D.;	   Thurow,	   K.;	   Beller,	  M.;	   Deng,	   Y.,	  Adv.	  
Synth.	  Catal.	  2009,	  351,	  2949-­‐2958.	  
(157)	  Vyas,	  D.	  J.;	  Fröhlich,	  R.;	  Oestreich,	  M.,	  Org.	  Lett.	  2011,	  13,	  2094-­‐2097.	  
	  
	  
